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Introduction  1 
1. General introduction 
 
 The continuous search for biologically active molecules in the pharmaceutical and 
agrochemical industries is one of the largest research areas, in which synthetic organic 
chemistry plays a fundamental role. Most biologically active molecules are synthesized in 
chemical laboratories and not extracted from plants, therefore there is a constant need for the 
development of new methods for selective carbon-carbon and carbon-heteroatom bond 
forming reactions. Such procedures should ideally be mild and highly tolerant towards a wide 
range of functional groups. The development of asymmetric metal-catalyzed reactions has 
played a significant role for the access to biologically relevant molecules. Among the most 
widely used reactions such as hydrogenations, 1  epoxidations 2  or dihydroxylations, 3  
asymmetric allylic substitutions are also considered as a powerful method to access to 
biologically active molecules. 
 
1.1 Transition metal-catalyzed allylic substitutions 
 
Synthetic methods, which allow the stereoselective construction of a carbon skeleton 
in a predictable and reliable fashion, are of great value in organic synthesis. Among the 
methodologies that chemists use to create stereogenic centers, allylic substitution is of 
considerable importance. Transition metal-catalyzed (or -mediated) allylic substitutions are 
particularly important and have become versatile synthetic methodologies in contemporary 
                                                 
1
  a) Rautenstrauch, V.; Hoang-Chong, X.; Churlaud, R.; Abdur-Rashid, K.; Morris, R. H. Chem. Eur. J. 2003, 9, 
4954; b) Blaser, H.-U.; Malan, C.; Pugin, B.; Spindler, F.; Steiner, H.; Studer, M. Adv. Synth. Catal. 2003, 345, 
103; c) Everaere, K.; Mortreux, A.; Carpentier, J.-F. Adv. Synth. Catal. 2003, 345, 67; d) Saluzzo, C.; Lemaire, 
M. Adv. Synth. Catal. 2002, 344, 915; e) Fan, Q. H.; Li, Y. M.; Chan, A. S. C. Chem. Rev. 2002, 102, 3385; f) 
Palmer, M. J.; Wills, M. Tetrahedron Asymmetry 1999, 10, 2045; g) Noyori, R.; Hashiguchi, S. Acc. Chem. Res. 
1997, 30, 97; h) Noyori, R. Angew. Chem. Int. Ed. 2002, 41, 2008. 
2
  a) Behrens, C. H.; Sharpless, K. B. Aldrichim. Acta 1983, 16, 67; b) Rao, A. S. Comprehensive Organic 
Synthesis, (Eds.; Trost, B. M.; Fleming, I.), Pergamon Press, Oxford, 1991, Vol. 7, 357; c) Jacobsen, E. N.; Wu, 
M. H. in Comprehensive Asymmetric Catalysis, (Eds.; Jacobsen, E. N.; Pfaltz, A.; Yamamoto, H.), Springer, 
Berlin, 1999, 649; d) Katsuki, T. in Catalytic Asymmetric Synthesis, 2nd ed.; (Ed.; Ojima, I.), Wiley-VCH, New 
York, 2000, 287; e) Muniz-Fernandez, K.; Bolm, C. in Transition Metals for Organic Synthesis, (Eds.; Beller, 
M.; Bolm, C.), Wiley-VCH, Weinhiem, 1998, Vol. 2, 271. 
3
  For reviews, see: a) Kolb, H. C.; Van nieuwenhze, M. S.; Sharpless, K. B. Chem. Rev. 1994, 94, 2483; b) 
Johnson, R. A. Catalytic asymmetric dihydroxylation discovery and development, in: Catalytic Asymmetric 
Synthesis, (Eds.; Ojima, I.; Sharpless, K. B.), VCH, New York, 2000, 357; c) Wang, Z.-M.; Sharpless, K. B. J. 
Org. Chem. 1994, 59, 8302; d) Ahrgren, L.; Sutin, L. Org. Process Res. Dev. 1997, 1, 425; e) Lu, X.; Xu, Z.; 
Yang, G. Org. Process Res. Dev. 2000, 4, 575; f) Bolm, C.; Gerlach, A. Eur. J. Org. Chem. 1998, 21 ; g) Song, 
C. E.; Lee, S. G. Chem. Rev. 2002, 102, 3495; h) Vos, D. E. D.; Dams, M.; Sels, B. F.; Jacobs, P. A. Chem. Rev. 
2002, 102, 3615; i) Kolb, H. C.; Anderson, P. G.; Sharpless, K. B. J. Am. Chem. Soc. 1994, 116, 1278. 
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organic chemistry.4 The allylic substitution of the substrate 1 with a carbon nucleophile can 
give two different products, the SN2-product or α-product (2a) or the SN2´-product or γ-
product (2b) (Scheme 1). These two products are formed by the direct displacement of a 
leaving group in 1 through an SN2 reaction affording 2a or by the displacement of a leaving 
group in 1 involving an allylic shift of the double bond affording the regioisomer 2b (Scheme 
1).  
R X
              1
X = leaving group
R
Nu
R
Nu
+
αγ γγ α α
Nu
         2a
SN2 (α-product)
        2b
SN2´ (γ-product)
 
 
Scheme 1. Regioselectivity of the allylic substitution reaction. 
 
Because of this regioselectivity issue, the development of methods allowing a selective 
C−C bond formation have been extensively studied and it has been shown that the 
regioselectivities of these processes depend on a variety of factors: i.e. metal ion, ligand, 
nucleophile, leaving group and reaction conditions. A selective C−C bond formation at the γ-
position has attracted more interest, since, in addition to the formation of a new C−C bond in 
the allylic substitution, a new stereogenic center is created (for Nu ≠ R, Nu ≠ vinyl and R ≠ H) 
(Scheme 1).  
A variety of organometallic compounds undergo nucleophilic substitutions on allylic 
substrates. Palladium has been often used as a catalyst for these reactions. Palladium-
catalyzed allylic substitutions and their asymmetric version have been extensively studied and 
widely used in a variety of total syntheses.5 However, in spite of the success achieved with 
                                                 
4
  a) Trost, B. M.; Lee, C. in Catalytic Asymmetric Synthesis, 2nd ed.; (Ed.; Ojima, I.), Wiley-VCH, New York, 
2000, 593; b) Pfaltz, A.; Lautens, M. in Comprehensive Asymmetric Catalysis I-III, (Eds.; Jacobsen, E. N.; Pfaltz, 
A.; Yamamoto, H.), Springer, Berlin, 1999, 833; c) Fristrup, P.; Jensen, T.; Hoppe, J.; Norrby, P.-O. Chem. Eur. 
J. 2006, 12, 5352; d) Tan, Z.; Negishi, E. Angew. Chem. Int. Ed. 2006, 45, 762; e) Hayashi, S.; Hirano, K.; 
Yorimitsu, H.; Oshima, K. J. Am. Chem. Soc. 2006, 128, 2210; f) Watson, I. D. G.; Yudin, A. K. J. Am. Chem. 
Soc. 2005, 127, 17516; g) Hegedus, L. in Organometallic in Synthesis, (Ed.; Schlosser, M.), Wiley, New York, 
1994, 385. 
5
  a) Diederich, F.; Stang, P. J. Eds. Metal-catalyzed Cross-coupling Reactions, Wiley-VCH, Weinheim, 1998; b) 
Tsuji, J. Palladium Reagents and Catalysts. Innovations in Organic Synthesis, John Wiley & Sons, New York, 
1995, 290; c) Godleski, S. A. in Comprehensive Organic Synthesis, (Ed.; Trost, B. M.), Perganon Press, New 
York, 1991, Vol. 4, 585; d) Farina, V.; Drishnamurthy, V.; Scott, W. J. in Organic Reactions, (Ed.; Paquette, L. 
A.), John Wiley & Sons, New York, 1997, Vol. 50, 1; e) Hegedus, L. S. Coord. Chem. Rev. 1996, 147, 443; f) 
Suzuki, A.; Miyaura, N. Chem. Rev. 1995, 95, 2457; g) Reiser, O. Angew. Chem. Int. Ed. Engl. 1993, 32, 547; h) 
Trost, B. M.; VanVranken, D. L. Chem. Rev. 1996, 96, 395; i) Frost, C. G.; Howarth, J.; Williams, J. M. J. 
Tetrahedron: Asymmetry 1992, 3, 1089; j) Consiglio, G.; Waymouth, R. M. Chem. Rev. 1989, 89, 257. 
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palladium-catalyzed allylic substitution reactions, this research area is still challenging. For 
example, the control of the regio- and enantioselectivities for unsymmetrically substituted 
allylic substrates, especially for monosubstituted ones, remain an unsolved problem, because 
the nucleophile usually attacks the terminal carbon in these substrates, when palladium 
complexes are used as catalyst (Scheme 2).6, 7 
 
Ph Ph
OAc
CH2(CO2Me)2
Ph OAc
Ph
CO2MeMeO2C
Ph Ph
CO2MeMeO2C
Ph CO2Me
CO2Me
+
[Pd(allyl)Cl]2 - Ligand (2 mol%)
BSA, KOAc, toluene, −10 oC, 16 h
100%; 85% ee
CH2(CO2Me)2
[Pd(allyl)Cl]2 (1 mol%)
Ligand (2.4 mol%)
BSA, KOAc, CH2Cl2
23 oC, 18 h
Yield = 80-92%
Branched:Linear = 4:96 to 76:24
 
 
Scheme 2. Regioselectivity for palladium-catalyzed substitution reaction.6, 7 
 
Numerous nucleophiles have been used in palladium-catalyzed allylic substitution 
reactions.8 However, the reaction is more difficult with non-stabilized carbanions, such as 
organozinc compounds9  and Grignard reagents.10  Further, for unsymmetrically substituted 
allylic derivatives (Scheme 2) the situation is more complex and challenging, as both regio- 
and enantioselectivity need to be controlled. Accordingly, metals, such as nickel (Scheme 
3),11  iridium (Scheme 4),12  molybdenum (Scheme 5),13  ruthenium (Scheme 6),14  tungsten 
                                                 
6
  Delapierre, G.; Brunel, J. M.; Constantieux, T.; Buono, G. Tetrahedron: Asymmetry 2001, 12, 1345.  
7
  Prétôt, R.; Pfaltz, A. Angew. Chem. Int. Ed. 1998, 37, 323. 
8
  Keinan, E.; Sahai, M. J. Chem. Soc., Chem. Comm.  1984, 10, 648.  
9
  Knochel, P.; Calaza, M. I.; Hupe, E. Carbon-Carbon Bond-Forming Reactions Mediated by Organozincs 
Reagents in Metal-Catalyzed Cross-Coupling Reactions, (Eds.; de Meijere, A.; Diederich, F.), Wiley-VCH, 
Weinheim, 2004, Vol. 2, 619. 
10
  Knochel, P.; Sapountzis, I.; Gommermann, N. Carbon-Carbon Bond Forming Reactions Mediated by 
Organomagnesium Reagents in Metal-Catalyzed Cross-Coupling Reactions, (Eds.; de Meijere, A.; Diederich, 
F.), Wiley-VCH, Weinheim, 2004, Vol. 2, 671. 
11
  a) Bricout, H.; Carpentier, J.-F.; Mortreux, A. Tetrahedron Lett. 1996, 37, 6105; b) Chung, K.-G.; Miyake, Y.; 
Uemura, S. J. Chem. Soc., Perkin Trans. 1 2000, 2725. 
12
  a) Garcia-Yebra, C.; Janssen, J. P.; Rominger, F.; Helmchen, G. Organometallics 2004, 23, 5459; b) Fuji, K.; 
Kinoshita, N; Tanaka, K.; Kawabata, T. Chem. Commun. 1999, 2289; For a review, see: c) Takeuchi, R. Synlett 
2002, 1954. 
13
  a) Belda, O.; Moberg, C. Acc. Chem. Res. 2004, 37, 159; b) Trost, B. M.; Hachiya, I. J. Am. Chem. Soc. 1998, 
120, 1104; c) Lloyd-Jones, G. C.; Krska, S. W.; Hughes, D. L.; Gouriou, L.; Bonnet, V. D.; Jack, K.; Sun, Y.; 
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(Scheme 7),15 rhodium (Scheme 8)16 and copper (Scheme 9-13)17 have emerged as efficient 
systems.  
OAc
Me Me
CO2Me
CO2Me
Me
MeO2C
CO2MeNi(COD)2 - Ligand (2 mol%)
CH2(CO2Me)2 (1.5 equiv)
BSA (1.5 equiv), THF
20 oC, 3.5 min
+
100% conv.
Branched:Linear = 70:30
 
Scheme 3. Regioselectivity for nickel-catalyzed substitution reaction.11a 
 
Ph OAc
Ph
CO2MeMeO2C
Ph CO2Me
CO2Me
[IrCl(COD)]2 - Ligand (2 mol%)
NaCH(CO2Me)2 (3 equiv)
THF, 67 oC, 24 h
Yield = 99%
Branched:Linear = 95:5
+
 
Scheme 4. Regioselectivity for iridium-catalyzed substitution reaction.12a 
OCO2Me
MeO2C CO2Me
CO2Me
CO2Me
Mo(CO)6 (10 mol%)
Ligand (15 mol%)
NaCH(CO2Me)2 
THF, 67 oC
+
Yield = 84-91%
Branched:Linear = 19:1
F F F
 
Scheme 5. Regioselectivity for molybdenum-catalyzed substitution reaction.13f 
 
Ph OCO2t-Bu
NaCH(CO2Me)2 (3 equiv)
Ph
MeO2C CO2Me
Ph
CO2Me
CO2Me[Cp*Ru(NCCH3)3]PF6 
(10 mol%), DMF, r.t., 10 min
+
Yield = 99%
Branched:Linear = 12:1
Cp* = η5−C5Me5
 
Scheme 6. Regioselectivity for ruthenium-catalyzed substitution reaction.14a 
                                                                                                                                                        
Reamer, R. A. J. Am. Chem. Soc. 2004, 126, 702; d) Glorius, F.; Pfaltz, A. Org. Lett. 1999, 1, 141; e) Glorius, F.; 
Neuburger, M.; Pfaltz, A. Helv. Chim. Acta 2001, 84, 3178; f) Palucki, M.; Um, J. M.; Yasuda, N.; Conlon, D. 
A.; Tsay, F.-R.; Hartner, F. W.; Hsiao, Y.; Marcune, B.; Karady, S.; Hughes, D. L.; Dormer, P. G.; Reider, P. J. 
J. Org. Chem. 2002, 67, 5508. 
14
  a) Trost, B. M.; Fraisse, P. L.; Ball, Z. T. Angew. Chem. Int. Ed. 2002, 41, 1059; b) Zhang, S. W.; Mitsudo, 
T.; Kondo, T.; Watanabe, Y. J. Organomet. Chem. 1993, 450, 197; c) Kondo, T.; Ono, H.; Satake, N.; Mitsudo, 
T.; Watanabe, Y. Organometallics 1995, 14, 1945. 
15
  a) Lloyd-Jones, G. C.; Pfaltz, A. Angew. Chem. Int. Ed. 1995, 34, 462; b) Trost, B. M.; Hung, M. H. J. Am. 
Chem. Soc. 1983, 105, 7757; c) Lehmann, J.; Lloyd-Jones, G. C. Tetrahedron 1995, 51, 8863. 
16
  a) Hayashi, T.; Okada, A.; Suzuka, T.; Kawatsura, M. Org. Lett. 2003, 5, 1713; b) Evans, P. A.; Leahy, D. K. 
J. Am. Chem. Soc. 2003, 125, 8974; c) Kazmaier, U.; Stolz, D. Angew. Chem. Int. Ed. 2006, 45, 3072. 
17
  Karlström, A. S. E.; Bäckvall, J.-E. in Modern Organocopper Chemistry, (Ed.; Krause, N.), Wiley-VCH, 
Weinheim, Germany, 2002, 259. 
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Ar
OP(O)(OEt)2
P
O
N W
CO
OC CO
Ph
Ph
NC
Ar
MeO2C CO2Me
Ar
CO2MeMeO2C
NaCH(CO2Me)2, (5 equiv)
THF, −13 oC, 228 h
10 mol% +
Yield = 80%
Branched:Linear = 96:4
Ar = 1-naphthyl
 
Scheme 7. Regioselectivity for tungsten-catalyzed substitution reaction.15a 
Me
OP(O)(OEt)2
N
Zn
O
Ot-Bu
F3COC Me
CO2t-BuF3COCN
Me CO2t-Bu
NCOCF3(2 equiv)
[RhCl(PPh3)3] (2.5 mol%)
P(Oi-Pr)3 (10 mol%)
THF, −78 oC to r.t., 12 h
+
Yield = 98%
Branched:Linear = 99:1
 
Scheme 8. Regioselectivity for rhodium-catalyzed substitution reaction.16c 
 
1.2 Enantioselective copper-catalyzed (and -mediated) allylic substitution reactions 
 
Copper(I) salts are generally less expensive than the corresponding palladium(II) 
salts,18 and are widely used in organic synthesis.19 Copper(I)-catalyzed and -mediated allylic 
substitution reactions allow the use of nucleophiles including organozinc compounds and 
Grignard reagents, thus being complementary to palladium catalysis. Moreover, copper(I)-
catalyzed allylic substitution reactions usually proceed with high SN2´regioselectivity. 20 
Copper(I)-catalyzed allylic substitutions attracted considerable attention, and valuable 
investigations have been carried out to elucidate their mechanisms. 
The chiral information in copper-catalyzed allylic substitution reactions can be 
contained either in the allylic electrophile21 or in the chiral copper catalyst.22 For the later 
                                                 
18
  Price from Aldrich catalog 2005-2006: PdCl2 (99%); 1 g = 65.40 Euro, CuCl (≥98%); 100 g = 29.30 Euro. 
19
  a) Lipshutz, B. H.; Sengupta, S. Org. React. 1992, 41, 135; b) Krause, N.; Gerold, A. Angew. Chem. Int. Ed. 
Engl. 1997, 36, 186; c) Nakamura, E.; Mori, S. Angew. Chem. Int. Ed. Engl. 2000, 39, 3750. 
20
  a) Goering, H. L.; Singleton, V. D., Jr. J. Am. Chem. Soc. 1976, 98, 7854; b) Goering, H. L.; Singleton, V. D., 
Jr. J. Org. Chem. 1983, 48, 1531; c) Ibuka, T.; Nakao, T.; Nishii, S.; Yamamoto, Y. J. Am. Chem. Soc. 1986, 108, 
7420; d) Ibuka, T.; Tanaka, M.; Nishii, S.; Yamamoto, Y. J. Am. Chem. Soc. 1989, 111, 4864; e) Arai, M.; 
Kawasuji, T.; Nakamura, E. J. Org. Chem. 1993, 58, 5121; f) Yamamoto, Y.; Yamamoto, S.; Yatagai, H.; 
Maruyama, K. J. Am. Chem. Soc. 1980, 102, 2318; g) Goering, H. L.; Kantner, S. S. J. Org. Chem. 1984, 49, 422; 
h) Bäckvall, J.-E.; Sellen, M.; Grant, B. J. Am. Chem. Soc. 1990, 112, 6615. 
21
  a) Belelie, J. L.; Chong, J. M. J. Org. Chem. 2001, 66, 5552; b) Ibuka, T.; Habashita, H.; Otaka, A.; Fujii, N.; 
Oguchi, Y.; Uyehara, T.; Yamamoto, Y. J. Org. Chem. 1991, 56, 4370; c) Marino, J. P.; Viso, A.; Lee, J.-D.; de 
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approach, the first report appeared in 1995 by Bäckvall, van Koten and co-workers.22a They 
disclosed the copper-catalyzed asymmetric allylic substitution of allylic acetate 3 using 
butylmagnesium iodide providing the product (R)-4 using the chiral arenethiolato-copper(I) 
complex 5 (Scheme 9).  
 
S NMe2
Me
Cu
Fe
c-Hex OAc
3
S NMe2
Me
Cu
(S,S,S)-5: (trimer)
c-Hex
(R)-4: 100%; 42% ee using 5 (14 mol%), 0 oC
             88%; 64% ee using 6 (13 mol%), r.t.
n-Bu
(Rp,S)-6
n-BuMgI, Cu (cat.)
Et2O/toluene
 
 
Scheme 9. The first copper-catalyzed asymmetric allylic substitution by Bäckvall, van Koten 
and co-workers.22a 
 
The enantiomeric excess of the product, such as 4, heavily depends on several factors 
including the coordinating ability of the leaving group in the allylic substrate, the reaction 
temperature and the sequence of substrate addition. Subsequently, the enantiomeric excess of 
64% was achieved by using the chiral copper catalyst 6 (Scheme 9).22b-c 
A breakthrough in copper-catalyzed asymmetric allylic substitutions was reported in 
1999, when Dübner and Knochel used dialkylzincs as an alkyl source in the presence of a 
novel copper/ferrocenyl amine catalysts (Scheme 10).22d-e To reach high enantioselectivities, 
the catalytic system required a high ratio of ligand to copper, very low reaction temperatures 
                                                                                                                                                        
la Pradilla, R. F.; Fernandez, P.; Rubio, M. B. J. Org. Chem. 1997, 62, 645; d) Smitrovich, J. H.; Woerpel, K. A. 
J. Org. Chem. 2000, 65, 1601; e) Spino, C.; Beaulieu, C. J. Am. Che. Soc. 1998, 120, 11832; f) Spino, C.; 
Beaulieu, C. Angew. Chem., Int. Ed. 2000, 39, 1930; g) Spino, C.; Beaulieu, C.; Lafreniere, J. J. Org. Chem. 
2000, 65, 7091; h) Denmark, S. E.; Marble, L. K. J. Org. Chem. 1990, 55, 1984; i) Fleming, I.; Winter, S. B. D. 
Tetrahedron Lett. 1995, 36, 1733; j) Tiecco, M.; Testaferri, L.; Santi, C.; Tomassini, C.; Bonini, R.; Marini, F.; 
Bagnoli, L; Temperini, A. Org. Lett. 2004, 6, 4751.  
22
  a) van Klaveren, M.; Persson, E. S. M.; del Villar, A.; Grove, D. M.; Bäckvall, J.-E.; van Koten, G. 
Tetrahedron Lett. 1995, 36, 3059; b) Karlström, A. S. E.; Huerta, F. F.; Meuzelaar, G. J.; Bäckvall, J.-E. Synlett 
2001, 923; c) Meuzelaar, G. J.; Karlström, A. S. E.; van Klaveren, M.; Persson, E. S. M.; del Villar, A.; van 
Koten, G.; Bäckvall, J.-E. Tetrahedron 2000, 56, 2895; d) Dübner, F.; Knochel, P. Angew. Chem. Int. Ed. 1999, 
38, 379; e) Dübner, F.; Knochel, P. Tetrahedron Lett. 2000, 41, 9233; f) Alexakis, A.; Malan, C.; Lea, L.; 
Benhain, C.; Fournioux, X. Synlett 2001, 927; g) Alexakis, A.; Croset, K. Org. Lett. 2002, 4, 4147; h) Malda, H.; 
van Zijl, A. W.; Arnold, L. A.; Feringa, B. L. Org. Lett. 2001, 3, 1169; i) Luchaco-Cullis, C. A.; Mizutani, H.; 
Murphy, K. E.; Hoveyda, A. H. Angew. Chem. Int. Ed. 2001, 40, 1456. 
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and the presence of bulky alkyl groups on zinc. For instance, the reaction of cinnamyl 
chloride (7) with dineopentylzinc provided the product (S)-8 with 82% ee under catalysis by 
CuBr·Me2S/9 (1:10) at –90 oC. By using the chiral ligand 10, the reaction could be carried 
out at higher temperature, and the enantiomeric excess was increased up to 96% ee. However, 
the use of unbranched dialkylzinc reagents such as dipentylzinc or the functionalized 
dialkylzinc 11 afforded the corresponding products, such as (S)-12, with only 44-65% ee 
(Scheme 10).  
 
NH2
t-Bu
t-Bu
NH2
Ph Cl
Ph Cl
7
Fe
(R)-9
AcO
Zn 11
7
Fe
Ph
t-Bu
Ph
OAc
(S)-8: 68%; 82% ee using 9, −90 oC
          82%; 96% ee using 10, −30 oC
(S)-12: 63%; 50% ee
(R)-10
(neopentyl)2Zn
CuBr·Me2S (1 mol%)
ligand (10 mol%)
THF, 18 h
CuBr·Me2S (1 mol%)
(R)-10 (10 mol%)
THF, −30 oC, 3 h
2 3
 
 
Scheme 10. Copper-catalyzed asymmetric allylic substitution by Dübner and Knochel.22d-e 
 
Despite the necessity of bulky alkyl groups on zinc, the work of Dübner and Knochel 
was an important milestone in copper-catalyzed asymmetric allylic substitutions. 
Highly enantioselective allylic substitutions with linear dialkylzincs remained a major 
challenge, until Feringa and co-workers proposed chiral phosphoramidites as ligands (Scheme 
11).22h Treatment of cinnamyl bromide (13) with diethylzinc in the presence of CuBr·Me2S 
and phosphoramidite 15 in diglyme at –40 oC afforded (S)-14 with 77% ee. Using 
phosphoramidite 16 with CuOTf in THF led to improved enantioselectivities (86% ee).23 
                                                 
23
  van Zijl, A. W.; Arnold, L. A.; Minnaard, A. J.; Feringa, B. L. Adv. Synth. Catal. 2004, 346, 413. 
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Scheme 11. Copper-catalyzed asymmetric allylic substitution by Feringa and co-workers.22h 
 
Recently, an increasing number of copper-catalyzed asymmetric allylic substitutions 
have emerged. 24  However, asymmetric allylic substitutions catalyzed by chiral copper 
complexes suffer also from a poor scope, and the corresponding chiral copper complexes have 
to be optimized for each class of allylic substrates.  Moreover, the deliberate use of 
functionalized alkylzinc halides (RZnX) instead of dialkylzinc reagents (R2Zn) led to poor 
enantioselectivities.22d-e Therefore, syntheses relying on generally applicable chiral allylic 
electrophiles are more appealing, 21 since allylic alcohols can be readily prepared in optically 
enriched form by several asymmetric syntheses.25 Furthermore, the transfer of chirality using 
chiral precursors has the advantage of being rather predictable. Based on this approach, 
Calaza and Knochel recently reported the use of various functionalized diorganozincs and 
organozinc halides in the presence of CuCN·2LiCl 26   for enantioselective anti-SN2´ 
substitutions with chiral cyclic 2-iodo-allylic alcohol derivatives leading to the substitution 
products in high yields and up to 97% ee (Scheme 12).27  
 
                                                 
24
  Ochima, K.; Yorimitsu, H. Angew. Chem. Int. Ed. 2005, 44, 4435; and references cited therein. 
25
  a) Lin, G.-Q.; Li, Y.-M.; Chan, A. S. C. Principles and Applications of Asymmetric Synthesis, Wiley-
Interscience, New York, 2001; b) Gawley, R. E.; Aube, J. Principles of Asymmetric Synthesis, Pergamon, 
Oxford, 1996; c) Noyori, R. Asymmetric Catalysis in Organic Synthesis, Wiley, New York, 1994; d) Gao, Y.; 
Hanson, R. M.; Klunder, J. M.; Ko, S. Y.; Masamune, H.; Sharpless, K. B. J. Am. Chem. Soc. 1987, 109, 5765; e) 
Carlier, P. R.; Mungall, W. S.; Schröder, G.; Sharpless, K. B. J. Am. Chem. Soc. 1988, 110, 2978. 
26
  Knochel, P.; Yeh, M. C. P.; Berk, S. C.; Talbert, J. J. Org. Chem. 1988, 53, 2390. 
27
  Calaza, M. I.; Hupe, E.; Knochel, P. Org. Lett. 2003, 5, 1059. 
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X
I
CuCN·2LiCl
I
R FGn
(FG-R)2Zn or FG-RZnI
    THF:NMP (3:1)
−30 oC to −10 oC, 14 h
n
70-91%; 91-97% een = 1, 2
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X = OP(O)(OEt)2, OCOC6F5
FG = CO2Et, OAc, CN
 
 
Scheme 12. Stereoselective anti-SN2´substitutions of chiral cyclic 2-iodo-allylic alcohol 
derivatives with organozinc reagents. 27 
 
The reaction proved also to be generally applicable for open-chain substrates. The 
reaction of the (E)-allylic pentafluorobenzoate 17 (94% ee) with dipentylzinc produced the 
expected (E)-substituted product in 83% yield with 90% ee as well as ca. 9% yield of the (Z)-
product (Scheme 13). 28 The formation of the (Z)-product results from an anti-substitution of 
the zinc-copper reagent via a conformation of type 18B (Scheme 13). By comparing the 
allylic 1,3-strain29 of the two possible conformations (18A and 18B) that can undergo an 
anti-SN2´substitution, a higher allylic 1,3-strain (between H1 and R1) in conformer 18B 
(Scheme 13) disfavored the substitution reaction via this conformer. To disfavor this 
conformation further, the (Z)-allylic pentafluorobenzoate was used. With such a substrate, the 
disfavoured conformation of type 18C displays considerable allylic 1,3-strain.29 The (Z)-
allylic pentafluorobenzoates 19 reacted with various linear functionalized zinc-copper 
reagents with high anti-SN2´selectivity allowing excellent stereocontrol for the synthesis of 
acyclic alkenes (Scheme 13). Interestingly, this substitution reaction can be applied to the 
elaboration of stereoselective chiral quaternary centers. The reactions of trisubstituted (Z)-
allylic pentafluorobenzoates furnished the substitution products with high enantiomeric 
excesses (Scheme 14). 30  The applications of this method for the preparation of natural 
products as well as of chiral tertiary alcohols, amines and isocyanates bearing a tertiary chiral 
center with high enantioselectivities were also subsequently reported (Scheme 14).28, 30 
                                                 
28
  Harrington-Frost, N.; Leuser, H.; Calaza, M. I.; Kneisel, F. F.; Knochel, P. Org. Lett. 2003, 5, 2111.  
29
  Hoffmann, R. W. Chem. Rev. 1989, 89, 1841. 
30
  Leuser, H.; Perrone, S.; Liron, F.; Kneisel, F. F.; Knochel, P. Angew. Chem. Int. Ed. 2005, 44, 4627. 
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Scheme 13. Stereoselective anti-SN2´substitutions of (Z)-allylic pentafluorobenzoates with 
polyfunctionalized zinc-copper reagents.28 
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Scheme 14.  Stereoselective anti-SN2´allylic substitutions of the trisubstituted allylic 
pentafluorobenzoates and applications to the preparation of chiral tertiary alcohols, amines 
and isocyanates.30 
 
As mentioned above, copper-catalyzed or -mediated allylic substitution reactions 
usually proceed with high SN2´regioselectivity with various allylic electrophiles. Further, it 
has been shown that organocuprates will undergo anti-SN2´reaction with allylic 
carboxylates,20a-b sulfonates,20c-d halides, 20e and phosphates.31 The allylic substitution reaction 
between an allylic ester and a lithium dialkylcuprate is presently considered to involve three 
                                                 
31
  Yanagisawa, A.; Noritake, Y.; Nomura, N.; Yamamoto, H. Synlett, 1991, 251. 
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steps (Scheme 15).20, 32 The initial loss of the leaving group generates a pi−allylcopper(III) 
intermediate, in which the memory of the position of the leaving group is lost. This 
intermediate equilibrates with a σ-allylcopper(III) intermediates, from which a mixture of α- 
and  γ-allylation products form. The formation of E- and Z-products has been taken as 
evidence of the presence of the σ-allylcopper(III) intermediates, and the regioselecitvity has 
been considered to depend on the reactivity of these intermediates from which the allylation 
products form.  
Recently, based on the reports that Lewis acid favors anti and γ-selective reaction33 
and on the study in mechanism and regioselectivity of reductive elimination of 
pi−allylcopper(III) intermediates by E. Nakamura,34 the mechanism of allylic substitutions 
was proposed to occur via an enyl[σ+pi]-complex without going through a pi−allylcopper(III) 
complex (Scheme 16). 
 
R1
H
X
R1
H
CuR2
H
R1
CuR R
R1 CuR2
H
CuR2
R1
H
R1
H
R
R
R1
H
R1 R
H
R2CuLi
− LiX
pi-allyl Cu(III)
σ-allyl Cu(III) α-Z product
− RCu
σ-allyl Cu(III)
σ-allyl Cu(III)
− RCu
− RCu
α-E product
γ-product
 
 
Scheme 15. Conventional mechanism of allylic carboxylates with lithium diorganocuprate.32 
  
                                                 
32
  a) Karlstorm, A.; Sofia, E.; Bäckvall, J.-E. Chem. Eur. J. 2001, 7, 1981; b) Keinan, E.; Bosch, E. J. Org. 
Chem. 1986, 51, 4006. 
33
  a) Nakamura, E.; Sekiya, K.; Arai, M.; Aoki, S. J. Am. Chem. Soc. 1989, 111, 3091; b) Arai, M.; Nakamura, 
E. J. Org. Chem. 1991, 56, 5489; c) Yamamoto, Y.; Yamamoto, S.; Yatagai, H.; Maruyama, K. J. Am. Chem. 
Soc. 1980, 102, 2318. 
34
  Yamamoto, M.; Kato, S.; Nakamura, E. J. Am. Chem. Soc. 2004, 126, 6287. 
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Scheme 16. Model pathway of allylic substitution reaction of a Lewis acid (M+) complexed 
diorganocuprate by E. Nakamura.34 
 
1.3 Applications of allylic substitutions to natural product syntheses 
 
 Stereoselective allylic substitution reactions serve as a powerful method for total 
syntheses of natural products. While there are only few reports on the use of acyclic 
electrophiles in asymmetric allylic substitution reactions, the majority of applications to total 
synthesis use cyclic electrophiles, particularly five- or six-membered rings.35  
To introduce the carboxyalkyl side chain selectively cis to the lactone function of 
jasmonoids, an anti-SN2´ substitution reaction with zinc cyanocuprates was used by 
Helmchen and Ernst.36  They synthesized the desired product, as starting material for the 
enantioselective synthesis of 12-oxyphytodienoic acid, a biosynthetic precursor for 
jasmonoids (Scheme 17).37 
 
O
O
H
H
Br
Br(CN)ZnCu(CH2)7CO2t-Bu
(2.1-2.5 equiv)
O
O
H
H
CO2t-Bu CO2H
O
7
−78 oC, THF
7
12-Oxophytodienoic acid 
(12-OPDA)
97%
5 steps
 
Scheme 17. Synthetic route to enantiomerically pure jasmonoids by Helmchen.36 
                                                 
35
  a) Trost, B. M.; Crawley, M. L. Chem. Rev. 2003, 103, 2921; b) Mori, M.; Kuroda, S.; Zhang, C.-S.; Sato, Y. 
J. Org. Chem. 1997, 62, 5265; c) Nishimata, T.; Mori, M. J. Org. Chem. 1998, 63, 7586f; d) Nishimata, T.; 
Yamagudhi, K.; Mori, M. Tetrahedron Lett. 1999, 40, 5713 
36
  Ernst, M.; Helmchen, G. Angew. Chem. Int. Ed. 2002, 41, 4054. 
37
  Reviews: a) Sarkar, T. K.; Ghorai, B. K. J. Indian. Chem. Soc. 1999, 76, 693; b) Helmchen, G.; Goeke, A.; 
Lauer, G.; Urmann, M.; Fries, J. Angew. Chem. Int. Ed. Engl. 1990, 29, 1024; c) Sarkar, T. K.; Mukherjee, B.; 
Gosh, S. K. Tetrahedron 1998, 54, 3243; d) Fehr, C.; Galindo, J. Angew. Chem. Int. Ed. 2000, 39, 569. 
Introduction  13 
 Recently, Y. Kobayashi and co-workers developed a new reagent for obtaining high 
regio- and stereoselectivities in the allylic displacement of 4-cyclopenten-1,3-diol 
monoacetate with aryl- and alkenylmagnesium bromides.38 This protocol was successfully 
utilized as the key step in the synthesis of AH-13205, which is an analogue of PGA1 (Scheme 
18).39 
OAc
HO
BrMg
C5H11
OTBS
O CO2H
OH
O CO2H
OHAH-13205
AcO
C5H11
OTBS
C5H11
OTBS
(CH2)6CH2OPMB
CuCN (0.3 equiv), LiCl 
(4 equiv), THF, 0 oC, 1 h
6 steps
PGA1
1.
2. Ac2O (3 equiv), py (5 equiv)
    r.t., 1 h BrMg(CH2)6CH2OPMB 
(1.5 equiv), CuCN (0.3 equiv)
Et2O, 0 oC, 1 h
(3 equiv)
91%; >99:1
>99:1
 
Scheme 18. Synthesis of AH-13205, an analogue of PGA1. 
 
2. Objectives 
 
 Reagents for highly regio- and stereoselective allylic substitution reactions have been 
developed and their application to natural product synthesis has flourished. Therefore, the first 
objective of this project was to develop reaction conditions that allow copper-mediated 
stereoselective allylic substitutions with organozinc reagents and sterically hindered allylic 
electrophiles. This should lead to the core structure of interesting natural products, such as 
damascone, α-ionone and their derivatives (Scheme 19).  
                                                 
38
  a) Kobayashi, Y. Curr. Org. Chem. 2003, 7, 133; b) Hattori, H.; Abbas, A. A.; Kobayashi, Y. Chem. 
Commun. 2004, 884; c) Ito, M.; Matsuumim M.; Murugesh, M. G.; Kobayashi, Y. J. Org. Chem. 2001, 66, 5881; 
d) Ainai, T.; Ito, M.; Kobayashi, Y. Tetrahedron Lett. 2003, 44, 3983; e) Kobayashi, Y.; Nakata, K.; Ainai, T. 
Org. Lett. 2005, 7, 183. 
39
  a) Nials, A. T.; Vardey, C. J.; Denyer, L. H.; Thomas, M.; Sparrow, S. J.; Shephere, G. D.; Coleman, R. A. 
Cardiovasc. Drug Rev. 1993, 11, 165; b) Spada, C. S.; Nieves, A. L.; Woodward, D. F. Ecp. Eye Tes. 2002, 75, 
155; c) Nials, A. T.; Coleman, R. A.; Hartley, D.; Sheldrick, R. L. G. Br. J. Pharmacol. 1991, 102, 24P; d) 
Coleman, R. A.; Kennedy, I.; Sheldrick, R. L. G. Br. J. Pharmacol. 1987, 91, 323P. 
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Scheme 19. Allylic substitution with sterically hindered allylic electrophiles and applications 
to natural product syntheses. 
 
The previously reported use of 2-iodo-substituted cyclic allylic alcohol derivatives as 
precursors for stereoselective allylic substitutions would allow the synthesis of chiral 
iodocycloalkenyl compounds in high enantioselectivities. These types of compounds show 
great potential in organic synthesis. They contain a vinyl iodide moiety in the α-position to 
the stereogenic center, which could be, for example, further functionalized by transition 
metal-catalyzed cross coupling or iodine/metal-exchange reactions. It is also interesting to 
transform these chiral compounds to chiral ketones. Therefore, the second objective of the 
project was the application of chiral iodocycloalkenyl compounds to the preparation of chiral 
compounds such as chiral ketones (Scheme 20).  
 
I
X R1 CuCN·2LiCl
R3
R1
R2
I
R1
R2
O
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R2
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X = leaving group
R22Zn or R2ZnI
hydrolysis
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Scheme 20. Applications of chiral iodocycloalkenyl compounds to the preparation of chiral 
compounds.
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Finally, another objective was to apply the copper(I)-catalyzed stereoselective allylic 
substitution reactions using organozinc reagents to the asymmetric synthesis of (+)-estrone. 
The key step of our proposed synthesis will be using the enantioselective anti-
SN2´substitution to install the chiral quaternary carbon center in the target molecule (Scheme 
21).  
I
Me
X
O-PG
MeO
Zn
CuCN·2LiCl
MeO
O
HO
Me
H
H H
X = leaving group
PG = protecting group
(+)-estrone
2
I
Me
O-PG
 
 
Scheme 21. Synthesis of (+)-estrone via an asymmetric SN2´allylic substitution. 
 
Results and Discussion 
 
1. Copper(I)-mediated enantioselective anti-SN2´substitution reactions with cyclic allylic 
alcohol derivatives 
 
1.1 Introduction 
 
Copper(I)-catalyzed or -mediated asymmetric allylic substitutions using organozinc 
reagents as nucleophiles have been developed in our group.22d-e, 27, 28, 30 Following the 
successful works mentioned above which allowed an excellent transfer of chirality, it is of 
interest to perform an allylic substitution reaction with cyclic allylic systems, such as 20, 
which may be used for the preparation of natural products (Scheme 22).40  
 
                                                 
40
  Soorukram, D.; Knochel, P. Org. Lett. 2004, 6, 2409. 
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Scheme 22. Enantioselective allylic substitution of the cyclic allylic alcohol derivative 20 
leading to α-ionone. 
 
1.2 Preparation of the chiral cyclic allylic alcohol (24) 
 
Asymmetric reduction of prochiral ketones is a commonly used method for preparing 
allylic alcohols.25, 41  Recently, the preparation of various chiral 2-iodocycloalk-2-en-1-ols 
with high optically pure form has been carried out in our group.27, 42 The use of the MeO-CBS 
catalyst 43  ((S)- or (R)-21; 5 mol%, prepared in situ by treatment of (S)- or (R)-
diphenylprolinol (DPP) and B(OMe)3 at 25 oC for 1 h, Scheme 23) and borane N,N-
diethylaniline complex (1 equiv) allowed the reproducible preparation of various chiral 2-
iodocycloalk-2-en-1-ols in high yields and % ee (up to 99% ee). Notably, the catalytic system 
is stable at room temperature (25 oC), which allows a convenient and stereoselective reduction 
of the corresponding prochiral ketones.  
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Scheme 23. Preparation of the MeO-CBS catalysts, (S)- and (R)-21. 
                                                 
41
  For the asymmetric reduction with the CBS-method see: a) Corey, E. J.; Helal, C. J. Angew. Chem. Int. Ed. 
1998, 37, 1986; b) Wallbaum, S.; Martens, J. Tetrahedron: Asymmetry 1992, 3, 1475. 
42
  Gavryushin, A.; Calaza, M. I.; Knochel, P. Unpublished results.    
43
  Cho, B. T. Tetrahedron 2006, 62, 7621; and references cited therein. 
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Thus, treatment of the (S)-MeO-CBS catalyst ((S)-21; 5 mol%) and borane N,N-
diethylaniline complex (1 equiv) with 2-iodo-4,4-dimethylcyclohex-2-en-1-one (23), readily 
obtained from the ketone 22 after an iodination reaction44 in 93% yield,  in THF at 25 oC for 
1.5 h afforded the allylic alcohol (1R)-2-iodo-4,4-dimethylcyclohex-2-en-1-ol (24) in 90% 
and 98% ee 45  (HPLC: Chiralcel OD-H, heptane:i-PrOH = 98:2, flow rate 0.3 mL/min)  
(Scheme 24). The stereochemical outcome observed for the allylic alcohol (R)-24 could be 
explained by the transition state 25 depicted in Scheme 24. 
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Scheme 24. Preparation of the chiral allylic alcohol (R)-24. 
 
Having the chiral allylic alcohol (R)-24 with high enantiomeric excess in hand, our 
attention was focused on the transformation of the hydroxy group into a leaving group. It was 
known that the nature of the leaving group is an important factor, influencing the regio- and 
stereoselectivity of allylic substitution reactions.20, 21 In previous studies, selective anti-SN2´ 
substitutions proceeded smoothly to give the substitution products in good yields and high 
enantioselectivities using either a phosphate (-OP(O)(OEt)2)27 or a pentafluorobenzoate         
(-OCOC6F5)27, 28, 30 as leaving groups. Although allylic phosphates gave better yields of the 
substitution products, in some cases for example the 5-membered analogue, the difficulties 
associated with the purification of the allylic phosphates and their decreased stability limited 
their use. Moreover, the higher reactivity of phosphates as leaving groups compared to 
                                                 
44
  Bovonsombat, P.; Angara, G. J.; NcNelis, E. Tetrahedron Lett. 1994, 35,  6787. 
45
  Kamatani, A.; Overman, L. E. Org. Lett. 2001, 3, 1229. 
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pentafluorobenzoates led to a lower selectivity in these transformations. In order to 
investigate the effect of the leaving groups for performing selective anti-SN2´substitution with 
sterically hindered systems using mixed zinc-copper reagents, the corresponding allylic 
phosphate (R)-26,31 and pentafluorobenzoate (R)-27 were prepared as depicted in Scheme 25.  
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Scheme 25. Preparation of the allylic phosphate (R)-26 and pentafluorobenzoate (R)-27. 
 
Allylic alcohol (R)-24 was converted into the allylic phosphate (R)-26 by treatment 
with diethyl chlorophosphate (2.4 equiv) and N-methylimidazole (2.4 equiv) in Et2O. 
Surprisingly, unlike for the 5-membered analogue, the resulting phosphate could be purified 
by chromatography on silica gel to give the allylic phosphate (R)-26 in 85% with 98% ee. 
Similarly, the allylic pentafluorobenzoate (R)-27 was obtained in 96% with 98% ee after 
treatment of the allylic alcohol (R)-24 with pentafluorobenzoyl chloride (1.3 equiv), pyridine 
(1.3 equiv) and DMAP (0.1 equiv) in Et2O. It should be noted that the allylic phosphate (R)-
26 and pentafluorobenzoate (R)-27 are stable and can be stored at 4 oC for several months 
without decomposition.   
 
1.3 Enantioselective anti-SN2´ substitution reactions of sterically hindered allylic 
phosphate (R)-26 and pentafluorobenzoate (R)-27 with diorganozincs (R2Zn) 
 
In a preliminary experiment, the allylic phosphate (R)-26 was treated with 
dipentylzinc (2 equiv) and CuCN·2LiCl (1 equiv) in a 3:1 solvent mixture of THF and NMP46 
at reaction temperatures from –30 to –10 oC for 14 h. Thereby, the formation of the anti-
substitution product (R)-28a was obtained in 80% yield and 97% ee (Scheme 26).  
 
                                                 
46
  We have observed that NMP strongly enhances the reactivity of zinc-copper reagents. 
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I
Me Me
OCOC6F5
I
Me Me
OP(O)(OEt)2 I
Me Me
R
I
Me Me
Pent
R2Zn (2 equiv)
CuCN·2LiCl (1 equiv)
THF:NMP (3:1)
−30 oC to −10 oC, 14 h
(R)-26: 98% ee
(R)-28a: R = Pent: 80%; 97% ee
(R)-27: 98% ee (R)-28a: 55%; 97% ee
(R)-28b: R = i-Pr: 95%; 98% ee
Pent2Zn (2 equiv)
CuCN·2LiCl (1 equiv)
THF:NMP (3:1)
−30 oC to −10 oC, 14 h
 
 
Scheme 26. Comparison between allylic phosphate (R)-26 and pentafluorobenzoate (R)-27. 
 
Despite the presence of a quaternary center bearing two methyl groups in α-position, 
the anti-SN2´product was obtained selectively and no product derived from a SN2 substitution 
could be detected. To compare the effect of the leaving group, the allylic pentafluorobenzoate 
(R)-27 was also treated with dipentylzinc under the same reaction conditions. In this case, the 
desired product (R)-28a was obtained with the same high enantioselectivity (97% ee), but 
only in 55% of isolated yield.  
Interestingly, the substitution reactions between the allylic phosphate (R)-26 and 
dialkylzinc reagents under our reaction conditions showed high regio- and enantioselectivities. 
Thus, the reaction between the allylic phosphate (R)-26 and more sterically hindered 
secondary dialkylzincs such as i-Pr2Zn (2 equiv), in the presence of CuCN·2LiCl (1 equiv), 
also afforded only the anti-SN2´ product (R)-28b in 95% yield and 98% ee (Scheme 26). 
 
1.4 Enantioselective anti-SN2´substitution reactions of sterically hindered allylic 
phosphate (R)-26 with mixed diorganozincs RZnCH2SiMe3  
 
Since allylic substitution reactions of sterically hindered allylic phosphate (R)-26 with 
a range of functionalized organozinc reagents47 were planned, 3-buten-1-ylzinc iodide (29a) 
                                                 
47
  a) Knochel, P.; Millot, N.; Rodriguez, A. L. Org. React. 2001, 58, 417; b) Yeh, M. C. P.; Knochel, P. 
Tetrahedron Lett. 1988, 29, 2395; c) Knochel, P.; Singer, R. D. Chem. Rev. 1993, 93, 2117; d) Knochel, P.; 
Jones, P. Organozinc Reagents. A practical approach, Oxford University Press, 1999; e) Rao, S. A.; Knochel, P. 
J. Am. Chem. Soc. 1991, 113, 5735.  
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was prepared by the direct insertion of activated zinc47d to 4-iodobut-1-ene.48 The resulting 
zinc reagent 29a was then reacted with the allylic phosphate (R)-26 (Scheme 27).  
 
Me Me
I
OP(O)(OEt)2
ZnI 29a
CuCN·2LiCl (1 equiv)
(R)-26: 98% ee
(2 equiv)
THF:NMP (3:1), −30 oC to 25 oC
no reaction
 
Scheme 27. Attempts to react the allylic phosphate (R)-26 with alkylzinc iodide 29a. 
 
Unfortunately, under the standard reaction conditions which were used for dialkylzinc 
reagents (Scheme 26), the substitution did not take place even at 25 oC. GC-analysis of the 
crude reaction mixture showed only unchanged starting material (R)-26. This result indicated 
that for an allylic substitution of the sterically hindered allylic phosphate (R)-26, highly 
reactive zinc reagents are required. 
 Since the reactivity of mixed diorganozincs (R1ZnR2) is comparable to the one of 
diorganozincs (R2Zn), the organozinc RZnCH2SiMe3 49  (30a; R: CH2=CHCH2CH2−) was 
prepared by the addition of a commercially available solution of Me3SiCH2Li (1 M in pentane, 
1 equiv) to freshly prepared but-3-en-1-ylzinc iodide (29a) (Scheme 28). After stirring at –40 
oC for 1 h, the resulting mixture was ready to be used.  
The reaction between the mixed zinc reagent 30a (2.4 equiv) and the allylic phosphate 
(R)-26 in the presence of CuCN·2LiCl (2.4 equiv) in a 3:1 solvent mixture of THF and NMP 
at reaction temperatures from –30 oC to 25 oC gave the desired anti-SN2´substitution product 
(R)-28c in 85% yield and 98% ee (Scheme 28, Table 1, entry 1). It is worth noting that this 
mixed zinc reagent allows a selective transfer of the but-2-enyl substituent.50 The Me3SiCH2 
group is too unreactive to be transferred and acts only as a spectator ligand. It is also 
important to note that for allylic substitutions a low reaction temperature is usually crucial for 
high enantioselectivity. However, following our protocol (Scheme 28) the reaction could be 
                                                 
48
  Hoarau, S.; Fauchere, J. L.; Pappalardo, L.; Roumestant, M. L.; Viallefont, P. Tetrahedron: Asymmetry 1996, 
7, 2585.   
49
  Berger, S.; Langer, F.; Lutz, C.; Knochel, P.; Mobley, T. A.; Reddy, C. K. Angew. Chem. Int. Ed. 1997, 36, 
1496. 
50
  a) Lutz, C.; Knochel, P. J. Org. Chem. 1997, 62, 7895; b) Reddy, C. K.; Knochel, P. Angew. Chem. Int. Ed. 
1996, 35, 1700; c) Bertz, S. H.; Eriksson, M.; Miao, G.; Snyder, J. P. J. Am. Chem. Soc. 1996, 118, 10906; d) 
Jones, P.; Reddy, C. K.; Knochel, P. Tetrahedron 1998, 54, 1471. 
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carried out at reaction temperatures from –30 oC to 25 oC without erosion of enantiomeric 
excess. 
RZnI
Me Me
I
OP(O)(OEt)2
Me3SiCH2Li
THF
I
Me Me
R
RZnCH2SiMe3
RZnCH2SiMe3 (30a-h)
(2.4 equiv)
CuCN·2LiCl (2.4 equiv)
THF:NMP (3:1)
−30 oC to 25 oC, 14-48 h
(R)-26: 98% ee (R)-28c-j: 65-95%; 95-98% ee
+
−40 oC, 1h
29a-h 30a-h
 
 
Scheme 28. Preparation and enantioselective anti-SN2´ substitution of mixed diorganozincs 
RZnCH2SiMe3 (30a-h). 
 
Under the optimized reaction conditions, the reaction of mixed zinc reagents 30a-h 
(2.4 equiv) with the allylic phosphate (R)-26 in the presence of CuCN·2LiCl (2.4 equiv) in a 
3:1 solvent mixture of THF and NMP at reaction temperatures from –30 oC to 25 oC for 14-48 
h produced the desired anti-SN2´substitution products 28c-j. Despite the steric hindrance of 
the two adjacent methyl groups, a remarkably selective formation of only the SN2´-products in 
yields between 65 and 95% and enantioselectivities of 95-98% was observed (Table 1 and 
Scheme 28).  
Excellent transfer of chirality was achieved. Remarkably, a range of functionalized 
zinc reagents (30b-h) can be used (entries 2-8). The less reactive 2-
cyanoethyl(trimetylsilylmethyl)zinc reagent (30b) required a reaction time of 40 h but 
provided the expected nitrile 28d in 73% yield with a slight erosion of the optical purity 
(95% ee, entry 2). Ester-substituted diorganozincs such as 30c-e (entries 3-5) reacted 
perfectly affording the anti-SN2´substitution products (28e-g) in 97-98% ee. Whereas 
aldehyde and ketone functionalities are not tolerated in this procedure, the use of the 
corresponding acetal and ketal was viable under our mild reaction conditions, leading to the 
desired anti-SN2´substitution products (28h and 28i) in 71-90% yield with 98% ee (entries 6 
and 7). 
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Table 1. Allylic substitution products 28c-j obtained by the reaction of the mixed 
diorganozincs 30a-h with the allylic phosphate (R)-26 in the presence of CuCN·2LiCl.  
 
(CH2)2-
RZnCH2SiMe3
        (R)
NC(CH2)2-
EtO2C(CH2)2-
EtO2C(CH2)3-
AcO(CH2)3-
I
Me Me
I
Me Me CN
I
Me Me CO2Et
I
Me Me
CO2Et
I
Me Me
OAc
2
30a (R)-28c
85 98
Entry Product of type
       (R)-28
Yield
 [%]a
 ee
[%]b
(R)-28d
95
5
30d (R)-28f
98
1
3
30b
73
4
30c (R)-28e
81 97
82
30e (R)-28g
65 97
O
O
(CH2)2-
Me (CH2)2-
O O
Ph(CH2)2-
O
I
Me Me O
I
Me Me
Me
O O
I
Me Me Ph
6
30f (R)-28h
90 98
7
30g (R)-28i
71 98
8
(R)-28j30h
95 98
 
 
a
  Isolated yield of analytical pure product. 
b
 The enantiomeric excess was determined by capillary GC-analysis using chiraldex B-PH and 
chiraldex CB columns. In all cases, the analysis was calibrated with a sample of the racemate. 
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Unfortunately, attempts to react the mixed dialkylzinc reagents 30i,51 30j52 and 30k53 
with the allylic phosphate (R)-26 under the standard reaction conditions did not give any 
conversion as judged by the NMR and GC-analysis (Scheme 29). 
Me Me
I
OP(O)(OEt)2
O
O ZnCH2SiMe3
Me
Me
Me
O B
O
ZnCH2SiMe3
Me
Me
Me Me
ZnCH2SiMe3
Bu
I
Me Me
Bu
I
Me Me
B O
O
Me
Me
Me
Me
I
Me Me
O
O
Me
MeMe
(30i) (2.4 equiv)
CuCN·2LiCl (2.4 equiv)
THF:NMP (3:1), −30 oC to 25 oC
(R)-26: 98% ee
(R)-28k
(30k) (2.4 equiv)
CuCN·2LiCl (2.4 equiv)
THF:NMP (3:1), −30 oC to 25 oC
(R)-28m
(30j) (2.4 equiv)
CuCN·2LiCl (2.4 equiv)
THF:NMP (3:1), −30 oC to 25 oC
(R)-28l
 
Scheme 29. Attempts to react the mixed dialkylzinc reagents 30i, 30j and 30k with allylic 
phosphate (R)-26. 
 
1.5 Applications 
 
Several of the products of type 28 can be used for the preparation of optically active 
α-ionone derivatives (Figure 1). 54  This group of natural products are among the most 
important fragrance constituents due to their distinctive fine violet and rose scents. They are 
formed by the oxidative degradation of carotenes and are widely distributed in vegetables and 
                                                 
51
  For the preparation of RZnI see: a) Knochel, P.; Chou, T.-S.; Jubert, C.; Rajagopal, D. J. Org. Chem. 1993, 
58, 588; b) Knochel, P.; Chou, T.-S.; Chen, H.-G.; Yeh, M.-C. P.; Rozema, M. J. J. Org. Chem. 1989, 54, 5202. 
52
  For the preparation of RZnI see: a) Knochel, P. J. Am. Chem. Soc. 1990, 112, 7431; b) Rozema, M. J.; 
Sidduri, A.-R.; Knochel, P. J. Org. Chem. 1992, 57, 1956. 
53
 Prepared by iodine/lithium-exchange reaction of the corresponding alkenyl iodide, subsequent 
transmetallation to the corresponding zinc organometallic by treatment with a ZnBr2 solution, and reaction of the 
resulting alkenylzinc bromide with LiCH2SiMe3. 
54
  Serra, S.; Fuganti, C.; Brenna, E. Helv. Chim. Acta 2006, 89, 1110; and references cited therein. 
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fruits, especially in tea and tobacco.55  The α- and β-ionones are widely used as flavour 
ingredients 56  and as starting material in several industrial processes, whereas 
regioisomerically and enantiomerically pure α- and γ-ionones are suitable building blocks for 
the synthesis of various natural products. 
Me Me
Me
Me
O Me Me
Me
Me
O Me Me
Me
O
(R)-α-Ionone β-Ionone (R)-γ-Ionone
 
Figure 1. Ionone derivatives. 
 
Thus, palladium-catalyzed oxidation57 of the terminal alkene of cyclohexenyl iodide 
(R)-28c provided the ketone (R)-31 in 82% yield (98% ee). Cross-coupling reaction between 
ketone (R)-31 and MeZnCl in the presence of Pd(dba)2 (5 mol%) and bis-
diphenylphosphinoferrocene (dppf) 58  (5 mol%) led to (R)-dihydro-α-ionone (32) in 70% 
yield and 98% ee (Scheme 30). 
Me Me
I
Me Me
I
Me
O
Me Me
Me
Me
O
(R)-28c: 98% ee
O2, PdCl2 (0.52 equiv)
CuCl2 (1 equiv)
DMF, H2O, 25 oC, 48 h
(R)-31: 82%; 98% ee
MeZnCl, Pd(dba)2 (5 mol%)
dppf (5 mol%), 25 oC, 24 h
(R)-32: 70%; 98% ee
 
Scheme 30. Synthesis of (R)-dihydro-α-ionone (32). 
                                                 
55
  a) Brenna, E.; Fuganti, C.; Serra, S.; Kraft, P. Eur. J. Org. Chem. 2002, 967; b) See also: Fehr, C.; Galindo, J. 
Helv. Chim. Acta 1995, 78, 539; c) Fehr, C. Angew. Chem. Int. Ed. 1996, 35, 2567; d) Fehr, C.; Guntern, O. Helv. 
Chim. Acta 1992, 75, 1023. 
56
  Bauer, K.; Garbe, D.; Surburg, H. Common Fragrance and Flavor Materials, 4th ed.; Wiley-VCH, 
Weinheim, Germany, 2001. 
57
  a) Henry, P. M. in Handbook of Organopalladium Chemistry for Organic Synthesis, (Ed.; Negishi, E.), 
Wiley-Interscience, New York, 2002; Vol. 2, 2119; b) Feringa, B. L. Transition Metals for Organic Synthesis, 
(Eds.; Beller, M.; Bolm, C.), Wiley-VCH, Weinheim, 1998, Vol 2, 307; c) Tsuji, J. Synthesis 1984, 369. 
58
  a) Green, L.; Chauder, B.; Snieckus, V. J. Heterocycl. Chem. 1999, 36, 143; b) Negishi, E.; Valente, L. F.; 
Kobayashi, M. J. Am. Chem. Soc. 1980, 102, 3298; c) Kobayashi, M.; Negishi, E. J. Org. Chem. 1980, 45, 5223; 
d) Negishi, E. Acc. Chem. Res. 1982, 15, 340; e) Tamaru, Y.; Ochiai, H.; Nakamura, T.; Yoshida, Z. 
Tetrahedron Lett. 1986, 27, 955; f) Klement, I.; Rottländer, M.; Tucker, C. E.; Majid, T. N.; Knochel, P.; 
Venegas, P.; Cahiez, G. Tetrahedron 1996, 52, 7201. 
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(R)-α-Ionone (35) was best prepared from the iodoester (R)-28e (Scheme 31). 
Negishi cross-coupling57, 58 with Me2Zn (Pd(dba)2 (5 mol%), dppf (5 mol%), 25 oC, 26 h) 
provided the desired methylated product (R)-33 in 81% yield. Reduction of this intermediate 
with LiAlH4 followed by Swern oxidation gave aldehyde (R)-34 with an overall yield of 91% 
and 98% ee. Phenylselenation with PhSeCl and t-BuOK followed by oxidation and 
elimination (30% aq. H2O2, CH2Cl2, 25 oC) furnished the expected unsaturated aldehyde 
intermediate. The synthesis of (R)-35 was completed by the addition of MeMgCl in THF at 0 
oC followed by oxidation with PDC in DMF (25 oC, 16 h), affording (R)-α-ionone (35) in 
61% yield and 97% ee.59 Attempts of using the iodoacetal (R)-28i as starting material for the 
synthesis of (R)-35 were complicated by acid-catalyzed cyclization side-reactions. 
 
Me Me
I
CO2Et
Me Me
Me
Me
O Me Me
Me
H
O
Me Me
Me
CO2Et
(R)-28e: 97% ee
    Me2Zn, Pd(dba)2 (5 mol%)
    dppf (5 mol%), 25 oC, 26 h
1. LiAlH4, Et2O, 0 oC, 10 min
2. (COCl)2, DMSO, Et3N
    CH2Cl2
(R)-34: 91%; 98% ee
1. PhSeCl, t-BuOK
2. 30% H2O2, CH2Cl2
(R)-35: 61%; 97% ee
(R)-33: 81%; 97% ee
3. MeMgCl, THF, 0 oC
4. PDC, DMF, 25 oC,
   16 h
 
Scheme 31. Synthesis of (R)-α-ionone (35). 
 
2. Copper(I)-mediated stereoselective anti-SN2´substitution reactions and their 
applications  
 
2.1 Application to cross-coupling reactions 
 
The allylic substitution products are interesting, because they contain a double bond, 
which is a versatile functional group in organic synthesis. Particularly, the products which 
                                                 
59
  a) Mori, K.; Puapoomchareon, P. Liebigs Ann. Chem. 1991, 1053; b) Mori, K.; Khlebnikov, V. Liebigs Ann. 
Chem. 1993, 77; c) Mori, K. Synlett 1995, 1097. 
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were obtained from the use of 2-iodo-substituted cyclic allylic precursors are valuable, since 
they contain an alkenyl iodide moiety adjacent to the chiral center, which can be used for 
various further transformations. It can be replaced by various groups using cross-coupling 
reactions (Scheme 32). 
CO2Et
CO2Ph
BrZn
CO2Ph
I
CO2Et
HBu
(R)-36: 95% ee
Bu
CO2Et
(S)-39: 69%; 95% ee
(R)-37: 70%; 95% ee
CO2Et
Bu
Pd(dba)2 (5 mol%)
dppf (5 mol%), 25 oC 
16 h
(R)-38: 75%; 95% ee
PdCl2(PPh3)2 (5 mol%)
CuI (5 mol%), Et3N
25 oC, 25 h
Pd(dba)2 (5 mol%)
dppf (5 mol%)
BuZnI, 67 oC, 12 h
 
Scheme 32. Cross-coupling reactions of compound (R)-36.  
 
Thus, treatment of the cyclohexenyl iodide (R)-36 (95% ee), obtained from a 
stereoselective SN2 allylic substitution reaction of functionalized lithium arylcuprate 60 
prepared by I/Cu exchange, 61  with hex-1-yne in the presence of a catalytic amounts of 
PdCl2(PPh3)2 (5 mol%), CuI (5 mol%)57, 58, 62 provided the expected enyne (R)-37 in 70% 
yield (Scheme 32). Similarly, the reaction of (R)-36 with 4-phenoxycarbonylphenylzinc 
bromide63 in the presence of Pd(dba)2 (5 mol%) and dppf (5 mol%) furnished the desired 
Negishi cross-coupling57, 58, 64 product (R)-38 in 75% yield. Finally, a cross-coupling reaction 
with BuZnI led to the product (R)-39 in 69% yield (Scheme 32). These cross-coupling 
                                                 
60
  a) Calaza, I. M.; Yang, X.; Soorukram, D.; Knochel, P. Org. Lett. 2004, 6, 529; b) Yang, X. Dissertation, 
Ludwig-Maximilians-Universität München, 2005. 
61
  a) Piazza, C.; Knochel, P. Angew. Chem. Int. Ed. 2002, 41, 3263; b) Piazza, C. Dissertation, Ludwig-
Maximilians-Universität München, 2002. 
62
  a) Qing, F.-L.; Gao, W.-Z. Tetrahedron Lett. 2000, 41, 7727; b) Marshall, J. A.; Pinney, K. G. J. Org. Chem. 
1993, 58, 7180. 
63
  Staubitz, A.; Dohle, W.; Knochel, P. Synthesis 2003, 233. 
64
  a) Negishi, E.; Matsushita, M.; Kobayashi, M.; Rand, C. L. Tetrahedron Lett. 1983, 24, 3822; b) Negishi, E.; 
Owczarczyk, Z. Tetrahedron Lett. 1991, 32, 6683. 
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reactions indicated that the carbon-iodine bond can be readily converted into Csp2-Csp3, Csp2-
Csp2 and Csp2-Csp bonds. 
 
2.2 Application to the synthesis of chiral ketones bearing an α-stereogenic center  
 
2.2.1 Introduction 
 
The enantioselective preparation of α-alkylated cyclic and acyclic ketones is an 
important reaction, 65  since chiral α-alkylated carbonyl moieties are present in numerous 
natural products.66  Asymmetric alkylation reactions, for example, the alkylation of chiral 
nucleophiles, the alkylation with chiral electrophiles or the alkylation using chiral additives, 
are commonly used methods in the synthesis of this class of compounds.  
For the alkylation reactions of ketone enolates, the regio- and stereoselectivity of 
enolate formation are essential for the overall selectivity of the alkylation reaction. The 
regioselectivity of ketone deprotonation was extensively investigated.67, 68 The alkylation of 
metalated azaenolates, for example employing metalated imines, hydrazones, 4,5-
dihydrooxazoles, 4,5-dihydroisoxazoles, 5,6-dihydro-4H-1,2-oxazines and 2,5-dialkoxy-3,6-
dihydropyrazines, is a commonly used method for the asymmetric synthesis of 
enantiomerically enriched carbonyl compounds. A generalized reaction sequence for this 
methodology is outlined in Scheme 33. However, this method has limitations with respect to 
the preparation of α-arylsubstituted ketones. 
                                                 
65
  a) Fey, P.; Hartwig, W. in Stereoselective Synthesis, (Eds.; Helmchen, G.; Hoffmann, R. W.; Mulzer, J.; 
Schaumann, E.), Thieme Verlag, Stuttgart, 1996, Vol 2, 969 and 994; b) Corey, E. J.; Enders, D. Tetrahedron 
Lett. 1976, 17, 11; c) Corey, E. J.; Enders, D. Chem. Ber. 1978, 111, 1337; 1362; d) Doyle, A. G.; Jacobsen, E. N. 
J. Am. Chem. Soc. 2005, 127, 62; e) Luchaco-Cullis, C. A.; Hoveyda, A. H. J. Am. Chem. Soc. 2002, 124, 8192; 
f) Liao, S.; Collum, D. B. J. Am. Chem. Soc. 2003, 125, 15114; g) Job, A.; Janeck, C. F.; Bettray, W.; Peters, R.; 
Enders, D. Tetrahedron 2002, 58, 2253; h) Myers, A. G.; Yang, B. H.; Chen, H.; McKinstry, L.; Kopecky, D. J.; 
Gleason, J. L. J. Am. Chem. Soc. 1997, 119, 6496; i) Nakamura, M.; Hatakeyama, T.; Hara, K.; Nakamura, E. J. 
Am. Chem. Soc. 2003, 125, 6362; j) Hirata, T.; Shimoda, K.; Kawano, T. Tetrahedron: Asymmetry 2000, 11, 
1063; k) Ohta, T.; Miyake, T.; Seido, N.; Kumobayashi, H.; Takata, S. J. Org. Chem. 1995, 60, 357; l) Hamada, 
T.; Chieffi, A.; Åhman, J.; Buchwald, S. L. J. Am. Chem. Soc. 2002, 124, 1261; m) Fox, J. M.; Huang, X.; 
Chieffi, A.; Buchwald, S. L. J. Am. Chem. Soc. 2000, 122, 1360. 
66
  a) Enders, D.; Eichenauer, H. Angew. Chem. 1979, 91, 425; b) Enders, D.; Kipphardt, H.; Fey, P. Org. Synth. 
1987, 65, 183; c) Zhou, Y.; Kim, Y.; Mohammed, K. A.; Jones, D. K.; Muhammad, I.; Dunbar, D. H.; Nagle, D. 
G. J. Nat. Prod. 2005, 68, 947; d) Awale, S.; Shrestha, S. P.; Tezuka, Y.; Ueda, J.; Matsushige, K.; Kadota, S. J. 
Nat. Prod. 2005, 68, 858. 
67
  a) Evans, D. A. in Asymmetric Synthesis, (Ed.; Morrison, J. D.), Academic, New York, Vol. 3, 1; and 
references cited therein; b) d’ Angelo, J. Tetrahedron 1976, 32, 2979; c) Caine, D. in Carbon-Carbon Bond 
Formation, (Ed.; Augustine, R. L.), Marcel Dekker, New York, 1979, Vol. 1, 85; d) Pollack, R. M. Tetrahedron 
1989, 45, 4913; and references cited therein. 
68
  a) House, H. O. Modern Synthetic reactions, 2nd ed.; Benjamin/Cummings, Menlo Park, California 1972, 
Chapter 9, 492; b) Carey, F. A.; Sundberg, R. J. Advanced Organic Chemistry, Part B: Reactions and Synthesis, 
2nd ed.; Plenum, New York, 1983, Chapter 1, 1. 
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∗
O
E
−H2O
H2NR*
+ E , − M + H2O, − H2NR*
 
Scheme 33. Classical sequence for the preparation of enantiomerically enriched 2-substituted 
cycloalkanones. 
 
 Recently, palladium-catalyzed cross couplings of ketone enolates were developed and 
provided a general way to prepare α-arylated ketones.69  Especial noteworthy are couplings 
with silyl enol ethers,70 which are less basic and nucleophilic than alkali metal enolates, 
reported by Verkade and Hartwig.71  With this method, couplings of silyl enol ethers, both 
derived from cyclic and acyclic ketones, with a wide range of aryl bromides and chlorides to 
form α-arylated ketones were realized (Scheme 34).  
 
OSiMe3
Me
Cl NO2
O
Me
NO2
+
Pd(OAc)2 (3 mol%) 
P(t-Bu)3 (5.4 mol%)
Bu3SnF (1.4 equiv)
CsF (1.4 equiv)
toluene, 85 oC, 14 h 84%
 
 
Scheme 34. Palladium-catalyzed cross-coupling of silyl enol ethers with aryl bromides and 
chlorides, providing α-arylated ketones. 
 
Based on a copper(I)-mediated allylic substitution of the substrates 40 providing the 
enantiomerically enriched cycloalkenyl iodides 41, our attention was turned to the application 
of these compounds for the preparation of chiral ketones 43 through the intermediate 42. The 
approach is outlined in Scheme 35.  
 
                                                 
69
  a) For a review on palladium-catalyzed α-arylation of carbonyl compounds and nitriles, see: Culkin, D. A.; 
Hartwig, J. F. Acc. Chem. Res. 2003, 36, 234; see also: b) Chae, J.; Yun, J.; Buchwald, S. L. Org. Lett. 2004, 6, 
4809. 
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  For palladium-catalyzed coupling reactions of silyl enol ethers, see: a) Kuwajima, I.; Urabe, H. J. Am. Chem. 
Soc. 1982, 104, 6831; b) Kuwajima, I.; Nakamura, E. Acc. Chem. Res. 1985, 18, 181. For palladium-catalyzed 
coupling reactions of silyl ketene acetals, see: c) Galarini, R.; Musco, A.; Pontellini, R. J. Mol. Catal. 1992, 72, 
L11; d) Agnelli, F.; Sulikowski, G. A. Tetrahedron Lett. 1998, 39, 8807; e) Hama, T.; Liu, X.; Culkin, D. A.; 
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O
R2
R1
M
R2
R1
RM
I
R2
R1
R22Zn or R2ZnI
CuCN·2LiCl
41 42 4340
I
R1X
n n n n
oxidation
n = 0, 1, 2
X = OCOC6F5, OP(O)(OEt)2
RM = n-BuLi, i-PrMgCl·LiCl
M = Li, MgCl
 
 
Scheme 35. Synthesis of chiral ketones bearing an α-stereogenic center through a copper(I)-
mediated allylic substitution. 
 
Chiral ketones 43 bearing an α-stereogenic center should be obtained with high 
enantioselectivity by oxidation of the intermediate chiral cycloalkenylmetallic species 42. 
These organometallic species could be generated from the corresponding cycloalkenyl iodides 
41 by an iodine/metal-exchange. The enantiomerically enriched cycloalkenyl iodides 41 were 
prepared by a copper(I)-mediated anti-SN2´-allylic substitution with zinc organometallics, 
starting from the corresponding allylic alcohol derivatives 40.72 
2.2.2 Synthesis of enantiomerically enriched cycloalkenyl iodides  
 Chiral 2-iodo-substituted cyclic allylic precursors were prepared in high enantiomeric 
excess as shown in Scheme 36.27, 40 (S)-2-Iodocyclopent-2-en-1-yldiethylphosphate (44) was 
obtained in 91% and 95% ee (HPLC: Chiralcel OJ, heptane:i-PrOH = 99:1, flow rate 0.6 
mL/min) by treatment of the corresponding allylic alcohol with diethylchlorophosphate. Both 
enantiomers of pentafluorobenzoates (R)- and (S)-45 were obtained in 94-98% yield with 
98% ee by the reaction of the corresponding allylic alcohols with pentafluorobenzoyl chloride. 
Similarly, pentafluorobenzoate (S)-46 was obtained in 87% yield and 98% ee. Allylic acetate 
(R)-47 was also prepared in 95% yield and 98% ee. Chiral cycloalkenyl iodides 48a-h were 
prepared by stereoselective anti-SN2´ substitution reactions of the cyclic electrophiles (S)-
44,27 (R)- and (S)-45 or (S)-46 with various diorganozincs and organozinc halides in the 
presence of CuCN·2LiCl as shown in Scheme 37. The results are summarized in Table 2. 
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I
OP(O)(OEt)2
∗
I
OH
I
OAc
∗
OCOC6F5
I
n
(S)-44: 91%; 95% ee
n
(S)-46: n = 3: 87%; 98% ee
(S)-45: n = 2: 98%; 98% ee
(R)-45: n = 2: 94%; 98% ee
ClP(O)(OEt)2 (1.1 equiv)
ClCOC6F5 (1.3 equiv) 
py (1.3 equiv)
(R)-47: 95%; 98% ee
Ac2O, py
25 oC
N-methylimidazole 
(2 equiv), Et2O 
25 oC, 6 h
DMAP (0.1 equiv)
Et2O, 25 oC, 16 h
n = 1, 2, 3
 
Scheme 36. Preparation of chiral starting materials 44-47. 
 Primary as well as secondary diorganozinc reagents underwent the substitution 
reactions with the substrates derived from 5-, 6- and 7-membered rings in the presence of 
CuCN·2LiCl in a 3:1 solvent mixture of THF:NMP at reaction temperatures from –30 oC to   
–10 oC. Thereby, anti-SN2´ substitution products 48a-c (entries 1-3) were synthesized in 
good yields and high enantioselectivities.  The complete transfer of chirality from the cyclic 
allylic precursors to the products of type 48 proved also that neither a syn-SN2´substitution 
nor a SN2 substitution occurred, since these reactions would lower the optical purity of 
substitution products 48. Remarkably, a range of organozinc halides underwent anti-
SN2´substitutions with comparable selectivities and yields of isolated products (Scheme 37, 
and entries 4-8, Table 2).  
∗
X
I
∗
I
Rn
THF:NMP (3:1)
−30 to −10 oC
n
(S)-44: n = 1; X = OP(O)(OEt)2; 95% ee
(S)- and (R)-45: n = 2; X = OCOC6F5; 98% ee
(S)-46: n = 3; X = OCOC6F5; 98% ee
48a-h: 50-97%; 91-99% ee
R2Zn or RZnI
CuCN·2LiCl
 
 
Scheme 37. An anti-SN2´substitutions of chiral cyclic phosphate and pentafluorobenzoates 
using organozinc reagents. 
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Table 2. Enantiomerically enriched cycloalkenyl iodides 48a-h 
I
i-Pr
I
Pent
I
Pent
I
X
I
X
(R)-45
i-Pr2Zn
I
c-Hex
Ph
I
II
X
Ph(CH2)2ZnI
CH2=CH(CH2)2ZnI
(R)-45
Ph
I
PhCH2ZnI(R)-45
I
c-HexX
I
Entry Product of 
type 48
Yield
 [%]a
1
(S)-48b
972
3
(S)-48a
96
4
(S)-48d
90
5
(R)-48c
90
8
 ee
[%]b
 94c
 94
99
98c
Allylic
substrate
(R)-45: X = OCOC6F5
(S)-44: X = OP(O)(OEt)2
Zinc reagent
(S)-48e
85
(R)-48g
85
99
98
Pent2Zn
c-HexZnI
6
Pent2Zn
(S)-48f
50 91
7
(R)-45
(S)-45: X = OCOC6F5
(S)-46: X = OCOC6F5
87 96c-HexZnI
(R)-48h
 
a
 Isolated yield of analytical pure product. 
b
 The enantiomeric excess was determined by capillary GC-analysis using chirasil-Dex CB column. In 
all cases, the analysis was calibrated with a sample of the racemate. 
c
 The enantiomeric excess was determined for the corresponding ketone 52. 
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 Chiral aryl substituted cycloalkenyl iodides (R)-48i and (R)-48j were prepared using 
a stereoselective SN2 allylic substitution reactions of chiral 2-iodo-1-cyclohex-2-enyl acetate 
(R)-47 with lithium arylcuprates,60 prepared from an I/Cu-exchange (Scheme 38).61 Treatment 
of lithium arylcuprates with acetate (R)-47 in a 3:1 solvent mixture of THF:ether at –30 oC 
provided chiral aryl substituted cycloalkenyl iodides (R)-48i and (R)-48j, respectively in 
60% (93% ee) and 90% (98% ee). It is noteworthy that a low reaction temperature was 
required to obtain high enantioselectivities (Scheme 38). 
I
OAc
Cu(Nphyl)Li·LiCN
R
Ph
MeMe
I
R
(R)-47: 98% ee
THF:ether (3:1), −30 oC, 48 h
(R)-48i: R = H: 60%; 93% ee
(R)-48j: R = OMe: 90%; 98% ee
(1.2 equiv)
Nphyl =
 
Scheme 38. Stereoselective SN2 allylic substitution of arylcuprates with acetate (R)-47. 
 
Chiral cycloalkenyl iodide (S)-48k was synthesized regio- and stereoselectively as 
shown in Scheme 39.  Thus, the reaction between phenylcopper with the allylic phosphate 
(R)-26 in the presence of TMSCl (0.5 equiv) and LiBr (1.5 equiv) in CH2Cl2 at reaction 
temperatures from –78 oC to 0 oC 73 afforded (S)-48k in moderate yield (50%) and 96% ee 
(Scheme 39).   
Me Me
I
OP(O)(OEt)2
Me Me
I
(R)-26: 99% ee
LiBr (1.5 equiv), CH2Cl2
−78 oC to 0 oC, 48 h
(S)-48k: 50%; 96% ee
PhCu·LiI (3 equiv)
TMSCl (0.5 equiv)
 
 
Scheme 39. Stereoselective anti-SN2´ allylic substitution with PhCu·LiI and allylic phosphate 
(R)-26. 
 
 The anti-SN2´ mechanism was established by using these reaction conditions for the 
preparation of the known compound (R)-48i. Treatment of the allylic phosphate (S)-49 (96% 
                                                 
73
  Asao, N.; Lee, S.; Yamamoto, Y.; Tetrahedron Lett. 2003, 44, 4265. 
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ee) with PhCu·LiI afforded the substituted product in 63% yield (Scheme 40). Comparison of 
the optical rotation led to the conclusion that the substituted product obtained from this 
reaction has the same configuration as (R)-48i.  
I
OP(O)(OEt)2
(S)-49: 96% ee
I
LiBr (1.5 equiv), CH2Cl2 
−78 oC to 0 oC, 48 h
63%; 96% ee
I
(R)-48i
[α]D20 +4.17 (c 0.24, Et2O)
PhCu·LiI (3 equiv)
TMSCl (0.5 equiv)
 
Scheme 40. Experiment to probe the anti-SN2´substitution mechanism. 
 
2.2.3 Oxidation reaction using dioxybis(trimethylsilane)  [(Me3SiO)2] 
 
Having chiral cycloalkenyl iodides of type 48 in hand, our attention was focused on 
an exchange reaction of the alkenyl iodide moiety. The cycloalkenyl iodide (S)-48b was used 
as a model compound to optimize the reaction conditions. Treatment of the cycloalkenyl 
iodide (S)-48b (94% ee) with t-BuLi (2 equiv) at –78 oC in THF74 for 30 min provided the 
corresponding alkenyllithium intermediate (S)-50b quantitatively (determined by GC-
analysis of hydrolyzed reaction aliquots). This intermediate smoothly reacted with 
dioxybis(trimethylsilane)  [(Me3SiO)2]75 (1.5 equiv) at –78 oC (30 min) to afford the desired 
silyl enol ether (S)-51b (Scheme 41). Purification of the silyl enol ethers can be troublesome, 
and therefore a one-pot protocol was carried out. Initially, the deprotection of the resulting 
silyl enol ether (S)-51b to give the corresponding ketone (S)-52b was performed using a 
TBAF solution (1 M in THF, 0 oC, 30 min, Method A). However, the desired product (S)-52b 
was obtained in high yield (86%), but only with 65% ee (capillary GC-chirasildex CB column) 
(Scheme 41). This racemization occurs under the basic reaction conditions of the silyl enol 
ether cleavage. To our delight, using a HF·pyridine complex in a solvent mixture of 
                                                 
74
  a) Negishi, E.; Swanson, D. R.; Rousset, C. J. J. Org. Chem. 1990, 55, 5406; b) Bailey, W. F.; 
Nurmi, T. T.; Patricia, J. J.; Wang, W. J. Am. Chem. Soc. 1987, 109, 2442; c) Bailey, W. F.; Patricia, J. 
J.; Nurmi, T. T.; Wang, W. Tetrahedron Lett. 1986, 27, 1861; d) Bailey, W. F.; Patricia, J. J.; Nurmi, T. 
T. Tetrahedron Lett. 1986, 27, 1865; e) Bailey, W. F.; Rossi, K. J. Am. Chem. Soc. 1989, 111, 765; f) 
Bailey, W. F.; Ovaska, T. V.; Leipert, T. K. Tetrahedron Lett. 1989, 30, 3901; g) Bailey, W. F.; Ovaska, 
T. V. Tetrahedron Lett. 1990, 31, 627; h) Wu, G.; Cederbaum, F. E.; Negishi, E. Tetrahedron Lett. 
1990, 31, 493. 
75
  a) Ricci, A.; Seconi, G.; Curci, R. in Advances in Silicon Chemistry, (Ed.; Larson, G. L.), JAI, Greenwich, 
CT, 1996, Vol. 3, 63; b) Bis(trimethylsilyl)peroxide [(Me3SiO)2] was purchased from ABCR Product List.  
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pyridine:THF76 (25 oC, 30 min, Method B) led to an improved yield and high enantiomeric 
excess. Thereby, the ketone (S)-52b was obtained in 93% yield and 94% ee after purification 
(Scheme 41, Table 3, entry 2). 
I
i-Pr
Li
i-Pr (Me3SiO)2, THF
(S)-48b: 94% ee (S)-50b (S)-51b
OSiMe3
i-Pr
O
i-Pr
t-BuLi 
(2 equiv)
THF, −78 oC
30 min
−78 oC, 30 min
Method A: TBAF, 0 oC, 30 min
Method B: HF·py, 25 oC, 30 min
(S)-52b: 86%; 65% ee using Method A
               93%; 94% ee using Method B
 
Scheme 41. Preparation of chiral ketone by oxidation of alkenyllithium 50b with (Me3SiO)2. 
 
Using these optimized reaction conditions, various chiral cycloalkanones were 
prepared as summarized in Scheme 42 and Table 3. The cyclopentenyl iodide (S)-48a (94% 
ee) was converted into the chiral cyclopentanone (S)-52a in 70% yield and 93% ee (entry 1, 
Table 3). Various primary and secondary 2-alkylsubstituted cyclohexanones were obtained in 
94-98% ee (entries 2-4). The preparation of 2-arylcyclohexanones is more difficult, since the 
α-protons to the aromatic ring and to the carbonyl group are much more acidic and easily 
undergo racemization. Thus, the preparation of (R)-2-phenylcyclohexanone (52e) furnished 
the crude product with 90% ee. However, during the purification by column chromatography, 
a slight erosion of the enantiomeric excess was observed and the ketone (R)-52e was obtained 
in pure form (70% yield) with 86% ee (entry 5). A cyclohexanone (R)-52f bearing a para-
methoxyphenyl substituent proved to be especially sensitive toward racemization and 
attempts to purify it by chromatography either on silica gel or alumina led to a considerable 
racemization (5-24% ee were obtained after purification). However, recrystallization of this 
ketone from diethyl ether provided the pure product (R)-52f in 81% yield and 86% ee (entry 
6). (S)-5,5-Dimethyl-6-phenyl-1-iodocyclohexene (48k)  was converted into the ketone (R)-
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  Evans, D. A.; Kaldor, S. W.; Jones, T. K.; Clardy, J.; Stout, T. J. J. Am. Chem. Soc. 1990, 112, 7001. 
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52i in 69% yield and 92% ee (entry 8). Also a chiral heptanones were prepared by this 
procedure. Thus, the cycloheptenyl iodide (R)-48h was converted into (R)-2-
cyclohexylcycloheptanone (52h) in 76% yield and 96% ee (entry 9). 
X
∗
R
I
X
∗
R
Li
50 52a-i
X
∗
R
O
1. (Me3SiO)2, −78 oC, 30 mint-BuLi (2 equiv)
−78 oC, THF, 30 min 2. HF·py, THF, py, 25 oC
    30 min
93-99% ee 69-93%; 86-98 % ee
n
n n
28a, 48a-e, i-k
 
Scheme 42. Preparation of chiral ketones of type 52. 
 
It is known that organomagnesium reagents have a less polarized carbon-metal bond 
than the corresponding lithium compounds. On the contrary, they show a broader range of 
remarkable functional group tolerance.9, 77, 78 In order to expand the scope of our protocol, the 
exchange reaction using highly reactive Grignard reagent i-PrMgCl·LiCl79 was studied. The 
iodine/magnesium-exchange reaction proceeded smoothly. Thus, treatment of the 
cyclohexenyl iodide (S)-48b with i-PrMgCl·LiCl (2 equiv) at 25 oC for 24 h provided the 
resulting cycloalkenylmagnesium derivative (S)-53 in 95% yield (determined by GC-analysis 
of hydrolyzed reaction aliquots). Unfortunately, attempts to react the magnesium intermediate 
(S)-53 with (Me3SiO)2 (1.5 equiv) at low reaction temperature (–40 oC) did not give rise to 
the desired silyl enol ether. GC-analysis of the hydrolyzed reaction mixture showed only the 
hydrolyzed Grignard reagent. Complex mixtures were obtained when the reaction mixture 
was allowed to warm up to 25 oC (Scheme 43). 
I
i-Pr
(S)-48b: 94% ee (S)-53: 95%
MgCl
i-Pr
25 oC, 24 h
(Me3SiO)2 (1.5 equiv)
complex mixtures
−40 oC to 25 oC
i-PrMgCl·LiCl (2 equiv)
 
 
Scheme 43. Attempts to react the cycloalkenylmagnesium intermediate (S)-53 with 
(Me3SiO)2. 
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Table 3. Preparation of chiral ketones of type 52 by oxidation using (Me3SiO)2. 
I
Pent
O
Pent
I
R
O
R
I
Ar
O
Ar
I
R
Me
Me
O
R
Me
Me
c-Hex
I
c-Hex
O
Product of
type 52
Yield
 [%]b
 ee
[%]a
1
(R)-48h
96
(R)-52i
76 96
9
(S)-48a
94
(S)-52a
70 93c
Entry Cycloalkenyl
 iodide
  ee
 [%]a
(S)-48b: R = i-Pr
 94 (S)-52b: R = i-Pr 93 942
(S)-48c: R = Pent 99 (R)-52c: R = Pent 91 973
(S)-48d: R = c-Hex 98 (S)-52d: R = c-Hex 88 984
(R)-48i: Ar = Ph 93 (R)-52e: Ar = Ph 70 865
(R)-48j: Ar = p-MeO-Ph 98 (R)-52f: Ar =  p-MeO-Ph 81 866
(R)-28a: R = Pent 99 (R)-52g: R = Pent 84 937
(S)-48k: R = Ph 96 (S)-52h: R = Ph 69 928
 
a
 The enantiomeric excess was determined by HPLC- (OD-H column) or capillary GC-analysis 
(chirasildex CB column). In all cases, the analysis was calibrated with a sample of the racemate. 
b
  Isolated yield of analytical pure product. 
c
 The enantiomeric excess was determined for the corresponding lactone after Baeyer-Villiger 
oxidation. 
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2.2.4 Oxidation reaction using B(OMe)3/ NaBO3·4H2O 
 
Although the oxidation of the alkenyllithium derivatives 50 with (Me3SiO)2 proceeded 
in good yields and excellent enantioselectivities, we were concerned about a potential up-
scaling and safety issues associated with this oxidation procedure. Therefore, the alternative 
protocols for an oxidation of the alkenyllithium intermediates 50 were also investigated.  
Transmetallation of lithium derivative (S)-50b to a cycloalkenyl(dimethoxy)borane (S)-54b 
then further oxidation of this intermediate was examined. Thus, lithium intermediate (S)-50b 
was treated with B(OMe)3 80  (2.5 equiv, –78 oC to 25 oC, 24 h) to give the resulting  
cycloalkenyl(dimethoxy)borane (S)-54b which was further oxidized with NaBO3·4H2O81 (25 
oC, 24 h) (Scheme 44). Thereby, cyclohexanone (S)-52b was obtained in comparable yield 
(90%) and with slightly higher enantiomeric excess (97% ee; Table 4, entry 2) compared to 
the one obtained from the oxidation of the alkenyllithium (S)-50b with (Me3SiO)2 (93%, 94% 
ee; Table 3, entry 2). 
i-Pr
I Li
i-Pr
(S)-48b: 97% ee (S)-50b
B(OMe)2
i-Pr
(S)-54b
NaBO3
O
i-Prt-BuLi (2 equiv)
THF, −78oC
30 min
−78 to 25 oC
24 h
(S)-52b: 90%; 97% ee
25 oC, 24 h
B(OMe)3
(2.5 equiv)
 
Scheme 44. Oxidation of intermediate 50b using B(OMe)3 and NaBO3·4H2O. 
 
Under these optimized reaction conditions, several cyclohexenyl iodides of type 48 
were converted into the chiral ketones 52 in good yields and high enantioselectivities 
(Scheme 45 and Table 4). A comparison of the two methods (52a, 52b, 52g and 52i) shows 
that similar enantioselectivities were obtained for cyclohexanones and cycloheptanones, while 
for  cyclopentanone (S)-52a, an enantioselectivity of only 81% ee was obtained using boron-
based reagents (entry 1, Table 4). Various chiral cyclohexanones bearing either a primary or a 
secondary alkyl substituent in an α-position can be prepared in 45-65% yield with 55-98% ee. 
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I
X
∗
R
X
∗
R
Li
50
X
∗
R
O
52a-d, j-n
n
1. B(OMe)3 (2 equiv)
   −78 oC to 25 oC, 24 ht-BuLi (2 equiv)
−78 oC, THF, 30 min 2. NaBO3, 25 oC, 24 h
91-99% ee 45-90%; 55-98 % ee
28a-b, j, 48a-c, f-h
n n
 
Scheme 45. Preparation of ketones of type 50 using B(OMe)3 and NaBO3·4H2O. 
 
The asymmetric formation of quarternary centers is an important problem in organic 
synthesis.82 As mentioned above, our group had developed a protocol for the preparation of 
these compounds via asymmetric allylic substitutions of open-chain substrates in good yields 
and high enantioselectivities.28, 30 The use of a pentafluorobenzoate as leaving group along 
with dialkylzinc reagents in the presence of CuCN·2LiCl proved essential for the success of 
the substitution. The reaction of these copper-zinc reagents with 2-iodo-substituted cyclic 
allylic pentafluorobenzoates followed by oxidation afforded the ketones bearing a chiral 
quaternary center in the α-position to the carbonyl moiety.  
Asymmetric reduction of the ketone 55 with the MeO-CBS catalyst (R)-21 provided 
the allylic alcohol (S)-56 in 67% yield and 96% ee. Treatment of the allylic alcohol (S)-56 
with pentafluorobenzoyl chloride gave the desired cyclic allylic pentafluorobenzoate (S)-57 
in 85% yield with 97% ee (HPLC; Chiralcel OD-H, heptane:i-PrOH = 95:5, flow rate 0.5 mL/ 
min ) (Scheme 46). 
Me
O
Me
O
I
N
B
O
Ph
Ph
OMe
H
BH3·PhNEt2 (1 equiv)
THF, 25 oC, 1.5 h
Me
OH
I
I
Me
OCOC6F5
(S)-57: 85%; 97% ee
I2 (1 equiv)
PDC (0.3 equiv) (5 mol%)
C6F5COCl (1.3 equiv)
py (1.3 equiv), DMAP 
(0.1 equiv), Et2O, 25 oC, 3 h
55: 55% (S)-56: 67%; 96% ee
(R)-21
CH2Cl2, 25 oC
48 h
 
Scheme 46. Synthesis of allylic pentafluorobenzoate (S)-57. 
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Table 4. Preparation of chiral ketones of type 52. 
 
I
Pent
O
Pent
I
R
O
R
I O
I
R
Me
Me
O
R
Me
Me
c-Hex
I
c-Hex
O
Product of
type 52
Yield
 [%]b
 ee
[%]a
1
(R)-48h
98
(R)-52i
86 98
9
(S)-48a
94
(S)-52a
90 81c
Entry Cycloalkenyl
 iodide
  ee
 [%]a
(S)-48b: R = i-Pr 97 (S)-52b: R = i-Pr 90 972
(S)-48e: R = CH2CH2Ph 99 (S)-52j: R = CH2CH2Ph 61 953
(S)-48f: R = CH2Ph 91 (S)-52k: R = CH2Ph 45 554
(R)-48g
98
(R)-52l
46 905
(R)-28b: R =  i-Pr 98 (R)-52m: R =  i-Pr 56 987
(R)-28j: R = CH2CH2Ph 98 (R)-52n: R = CH2CH2Ph 65 978
(R)-28a: R = Pent 99 (R)-52g: R = Pent 86 986
 
a
 The enantiomeric excess was determined by capillary GC-analysis using chirasildex CB column. In 
all cases, the analysis was calibrated with a sample of the racemate. 
b
  Isolated yield of analytical pure product. 
c
 The enantiomeric excess was determined for the corresponding lactone after Baeyer-Villiger 
oxidation. 
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Thus, the reaction of allylic pentafluorobenzoate (S)-57 with Pent2Zn (2.4 equiv) and 
CuCN·2LiCl (1.2 equiv) in THF at 25 oC provided the anti-SN2´substitution product (S)-58 in 
93% yield and 95% ee (Scheme 47). Less than 5% of the SN2-substitution product was 
observed. It should be noted, that unlike for open-chain substrates, the addition of allylic 
pentafluorobenzoate (S)-57 to the solution of the mixed zinc-copper reagents was carried out 
at 25 oC in order to suppress the competitive SN2 substitution reaction. The synthesis of the 
corresponding ketone (S)-59 was accomplished by the following sequence in 70% yield and 
95% ee: (1) iodine/lithium-exchange reaction of (S)-58, (2) transmetallation with B(MeO)3 
and (3) oxidation with NaBO3·4H2O (Scheme 47). 
I
MeC6F5OCO
I
Pent
Me
O
Pent
Me
(S)-57: 97% ee
Pent2Zn (2.4 equiv)
CuCN·2LiCl (1.2 equiv)
THF, 25 oC, 4 h
(S)-58: 93%; 
95% ee
(S)-59: 70%; 
95% ee
1)  t-BuLi (2 equiv) 
    −78 oC, 30 min
2) B(OMe)3, −78 oC to
     25 oC, 24 h
3) NaBO3·4H2O
    25 oC, 24 h
 
Scheme 47. Preparation of ketone (S)-59 bearing a quaternary stereogenic center. 
 
2.2.5 Application: preparation of a chiral caprolactone 
 
As an application of this methodology, the allylic pentafluorobenzoate (S)-45 (98% ee) 
was treated with (CH3)2CH(CH2)3ZnI (2 equiv) in the presence of CuCN·2LiCl (2 equiv) in a 
3:1 solvent mixture of THF:NMP at reaction temperatures from –30 oC to 25 oC providing the 
anti-SN2´ substitution product (S)-60 in 88% yield and 96% ee (Scheme 48). The 
iodine/lithium-exchange reaction with subsequent oxidation of the corresponding lithium 
compound using (Me3SiO)2 followed by deprotection of the intermediate silyl enol ether 
furnished the ketone (R)-61 in 89% yield and 95% ee. Baeyer-Villiger oxidation of the ketone 
(S)-61 with meta-chloroperbenzoic acid (m-CPBA) gave (R)-10-methyl-6-undecanolide (62), 
which is a caprolactone isolated from the marine streptomycete (isolate B6007)83 in 91% 
yield and 95% ee. 
 
                                                 
83
  Striyzke, K.; Schulz, S.; Laatsch, H.; Helmke, E.; Beil, W. J. Nat. Prod. 2004, 67, 395. 
Results and Discussion  41 
I
OCOC6F5
Me ZnI
Me
O
O
Me
Me
I
Me
Me
O
Me
Me
(2 equiv)
CuCN·2LiCl (2 equiv)
THF: NMP (3:1)
−30 oC to 25 oC, 15 h (S)-60: 88%; 96% ee(S)-45: 98% ee
1) t-BuLi (2 equiv)
2) (Me3SiO)2, −78 oC, 30 min
3) HF·py, THF, 25 oC, 30 min
(R)-61: 89%; 95% ee
m-CPBA, CH2Cl2
(R)-62: 91%; 95% ee
0 oC to 25 oC, 18 h
 
 
Scheme 48.  Preparation of (R)-10-methyl-6-undecanolide (62). 
 
3. Formal total synthesis of (+)-estrone via asymmetric allylic substitution 
 
3.1 Introduction 
 
 The total synthesis of steroids represents an attractive research area due to their 
valuable biological activity and various pharmacological applications.84 Since the synthesis of 
estrone (63; Figure 2) by Anner and Miescher in 1948,85 and the syntheses of nonaromatic 
steroids, such as cortisone (64) and aldosterone (65) in the 1950s, a plethora of ingenious 
approaches were explored to synthesize members of steroid family. For more than 30 years, 
the synthesis of estrone (63) has held special interest for organic chemists,86 partly because of 
the follicular hormone activity of estrone itself, and partly because estrone is an important 
precursor in the production of 19-norsteroids,87 which has been used as an oral contraceptive. 
Several of the most widely applied pharmaceuticals contain estrogens 88  and millions of 
women use estradiol in oral contraceptives.89  
In the past decades, many approaches were reported towards this female sex hormone. 
Attention has focused on the development of asymmetric syntheses of estrone itself and 
                                                 
84
  For biological properties, see: Anstead, G. M.; Carlson, K. E.; Katzenellenbogen, J. A. Steroids 1997, 62, 268. 
85
  Anner, G.; Miescher, K. Helv. Chim. Acta 1948, 31, 2173. 
86
  Akhrem, A. A.; Titov, Y. A. Total Steroid Synthesis, Plenum Press, New York, 1970. 
87
  Pappo, R. in The Chemistry and Biochemistry of Steroids, (Ed.; Kharasch, N.), Intra-Science Research 
Foundation, Santa Monica, California., Vol. 3, 1969, 123.  
88
  Simonsen, L. L. P. Pharm. Times 1994, April, 18. 
89
  Djerassi, C. Science 1989, 245, 356. 
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related compounds.90 Among them are the cationic polyolefinic cyclization,91 the more recent 
transition metal-mediated reactions of polyenynes,92 biogenetic-type electrophilic cyclizations 
of polyene precursors93 and the thermally induced radical cyclization of enyne-allenes.94 They 
all allow the construction of the steroidal skeleton in a single step. However, the preparation 
of the precursors is probably rather tedious. The number of total syntheses of steroids is rather 
limited compared to the nearly countless reports, dealing with the partial synthesis of steroids 
and selective functionalization reactions at almost every position of the steroidal tetracycle.95 
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H H
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(+)-estrone (63) cortisone (64) aldosterone (65)
 
 
Figure 2. Representative steroids. 
 
Recently reported examples for enantioselective syntheses of (+)-estrone are given in 
the following schemes. K. Ogasawara described an approach to (+)-estrone starting from a 
                                                 
90
  a) Danishefsky, S.; Cain, P. J. Am. Chem. Soc. 1976, 98, 4975; b) Cohen, N.; Banner, B. L.;  Blount, J. F.; 
Tsai, T.; Saucy, G. J. Org. Chem. 1973, 38, 3229; c) Eder, U.; Sauer, G.; Wlechert, R. Angew. Chem. Int. Ed. 
Engl. 1971, 10, 496; d) Cohen, N.; Banner, B. L.; Elchel, W. F.; Parrish, D. R.; Saucy, G.; Cassal, J.-M.; Meier, 
W.; Fürst, A. J. Org. Chem. 1975, 40, 681. e) Steglich, W.; Fugmann, B.; Lang-Fugmann, S. Eds. Römpp 
Encyclopedia Natural Products, Thieme Verlag, Stuttgart, 2000; f) Corey, E. J.; Cheng, X.-M. The Logic of 
Chemical Synthesis, John Wiley & Sons, New York, 1989; For the total syntheses of steroids, see: g) Zeelen, F. J. 
Nat. Prod. Rep. 1994, 11, 607; h) Groen, M. B.; Zeelen, F. J. Recl. Trav. Chim. Pays-Bas 1986, 105, 465. 
91
  a) Corey, E. J.; Virgil, S. C.; Cheng, H.; Baker, C. H.; Matsuda, S. P. T.; Singh, V.; Sarshar, S. J. Am. Chem. 
Soc. 1995, 117, 11819; b) Johnson, W. S.; Fletcher, V. R.; Chenera, B.; Bartlett, W. R.; Tham, F. S.; Kullnig, R. 
K. J. Am. Chem. Soc. 1993, 115, 497; c) Nicolaou, K. C.; Barnette, W. E.; Ma, P. J. Org. Chem. 1980, 45, 1463. 
92
  a) Crigg, R.; Rasul, R.; Savic, V. Tetrahedron Lett. 1997, 38, 1825; b) Bao, J.; Dragisich, V.; Wenglowsky, 
S.; Wulff, W. D. J. Am. Chem. Soc. 1991, 113, 9873; c) Zhang, Y.; Wu G.; Agnel, G.; Negishi, E. J. Am. Chem. 
Soc. 1990, 112, 8590; d) Vollhardt, K. P. C. Angew. Chem. Int. Ed. Engl. 1984, 23, 539; e) Vollhardt, K. P. C. 
Pure Appl. Chem. 1985, 57, 1819;  f) Lecker, S. H.; Nguyen, N. H.; Vollhardt, K. P. C. J. Am. Chem. Soc. 1986, 
108, 856; g) Sugihara, T.; Copéret, C.; Owczarczyk, Z.; Harding, L. S.; Negishi, E. J. Am. Chem. Soc. 1994, 116, 
7923; h) Gauthier, V.; Cazes, B.; Gore, J. Tetrahedron Lett. 1991, 32, 915; i) Trost, B. M.; Shi, Y. J. Am. Chem. 
Soc. 1993, 115, 9421. 
93
  a) van Tamelen, E. E.; Holten, R. A.; Hopla, R. E.; Konz, W. E. J. Am. Chem. Soc. 1972, 94, 8228; b) van 
Tamelen, E. E.; Anderson, R. J. J. Am. Chem. Soc. 1972, 94, 8225; c) Johnson, W. S.; Wiedhaup, K.; Brady, S. 
F.; Olson, G. L. J. Am. Chem. Soc. 1974, 96, 3979; d) Fish, P. V.; Johnson, W. S.; Jones, G. S.; Tham, F. S.; 
Kullnig, R. K. J. Org. Chem. 1994, 59, 6150; e) Corey, E. J.; Lin, S. J. Am. Chem. Soc. 1996, 118, 8765. 
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  Andemichael, Y. W.; Huang, Y.; Wang, K. K. J. Org. Chem. 1993, 58, 1651. 
95
  Hanson, J. R. Steroids 1996, 13, 373. 
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chiral dioxycyclopentenone building block for a Diels-Alder reaction with Dane’s diene in the 
presence of a Lewis acid (Scheme 49).96 
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Scheme 49. Synthesis of (+)-estrone by K. Ogasawara. 
 
E. J. Corey reported the enantioselective synthesis of estrone using the 
enantioselective [4+2]-cycloaddition, catalyzed by a chiral oxazaborolidinium salt, as the key 
step to construct the estrone skeleton.  The synthesis of (+)-estrone by E. J. Corey, which is 
reminiscent of Ogasawara’s synthesis, is outlined in Scheme 50.97 
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Scheme 50. Synthesis of (+)-estrone by E. J. Corey. 
 
L. F. Tietze described a highly efficient total synthesis of enantiomerically pure 
estrone using two successive Heck reactions as key steps for the construction of the steroidal 
skeleton (Scheme 51).98 
                                                 
96
  Tanaka, K.; Nakashima, H.; Taniguchi, T.; Ogasawara, K. Org. Lett. 2000, 2, 1915. 
97
  Hu, Q.-Y.; Rege, P. D.; Corey, E. J. J. Am. Chem. Soc. 2004, 126, 5984. 
98
  Tietze, L. F.; Nöbel, T.; Spescha, M. J. Am. Chem. Soc. 1998, 120, 8971. 
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Scheme 51. Synthesis of (+)-estrone by L. F. Tietze. 
 
Due to our interest in the applications of copper(I)-mediated asymmetric allylic 
substitution reactions of chiral electrophiles with organozinc reagents to natural products 
synthesis, the remarkable ability of this method, especially to install the chiral quaternary 
carbon center at position 13, for the enantioselective synthesis of (+)-estrone was 
demonstrated (Scheme 52). 
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Scheme 52. Retrosynthetic analysis of (+)-estrone (63) using an asymmetric allylic 
substitution as a key-step. 
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(+)-Estrone (63) could be obtained from the Torgov diene (67) by a reported 
sequence: (1) stereospecific reduction of the 14,15- and 8,9-double bond of 67, respectively 
and (2) HBr-catalyzed ether cleavage.99 The Torgov diene (67) should be obtained by an 
oxidation of the intermediate 68, which would be obtained through palladium-catalyzed Heck 
reaction of the cycloalkenyl iodide 69. Compound 69 may be generated via stereoselective 
anti-SN2´ substitution reaction of allylic pentafluorobenzoate 70 with the dialkylzinc reagent 
71 in the presence of CuCN·2LiCl (key step of the synthesis).  
 
3.3 Synthesis of the chiral polyfunctional cyclopentenol derivative 70 
 
3.3.1 Synthesis of a cyclic electrophile starting from racemic starting materials 
 
Our attention was first focused on the synthesis of the racemic substituted 
cyclopentenone 76. The synthesis was accomplished in a straightforward manner starting 
from 2,5-dimethylfuran (72) (Scheme 53). An oxidation followed by the ring opening 
reaction using magnesium methylperphthalate (MMPP) proved to give efficiently the cis-3-
hexene-2,5-dione (73).100  Cyclization of the diketone 73 under basic reaction conditions 
followed by a rearrangement gave 4-hydroxy-3-methylcyclopent-2-en-1-one (rac-74). The 
direct protection of the secondary alcohol was necessary to facilitate the purification. Thus, 
the crude secondary alcohol rac-74 was treated with TBSCl (1.2 equiv) and imidazole (1.5 
equiv) in DMF to give the cyclopentenone rac-75 in 30% overall yield starting from the furan 
72. Finally, the cyclopentenone rac-75 was converted into α-iodocyclopentenone rac-76 in 
77% yield by treatment with I2 (2.5 equiv) and PDC (0.3 equiv) in CH2Cl2 at 25 oC for 46 h. 
 Considering the envisioned approach to (+)-estrone via asymmetric anti-
SN2´substitution (Scheme 52), the (R)-configuration needed to be installed at carbonyl carbon 
(C-1) of the cyclopentenone rac-76. Asymmetric reduction using (S)-MeO-CBS catalyst was 
used for this purpose (Scheme 54). Thus, treatment of the cyclopentenone rac-76 with in situ 
prepared (S)-MeO-CBS catalyst (5 mol%) and borane N,N-diethylaniline complex (1 equiv) 
afforded the two diastereomers, (1R, 4S)-77a and (1R, 4R)-77b (Scheme 54).  
                                                 
99
  Quinkert, C.; Grosso, M. D.; Doring, A.; Doring, W.; Schenkel, R. I.; Bauch, M.; Dambacher, G. T.; Bats, J. 
W.; Zimmermann, G.; Durner, G. Helv. Chim. Acta 1995, 78, 1345. 
100
 Adembri, G.; Giorgi, G.; Lampariello, R. L.; Paoli, M. L. Sega, A. J. Chem. Soc., Perkin Trans. 1 2000, 2649. 
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Scheme 53. Synthesis of the substituted cyclopentenone rac-76. 
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Scheme 54. Synthesis of allylic pentafluorobenzoates (1R, 4S)-78a and (1R, 4R)-78b. 
 
Fortunately, they could be separated by column chromatography and (1R, 4S)-77a and 
(1R, 4R)-77b were obtained, respectively, in 46% with 84% ee (HPLC; Chiralcel OD, 
heptane:i-PrOH = 99:1, flow rate 0.4 mL/min) and 49% with 99% ee (HPLC; Chiralcel OD, 
heptane:i-PrOH = 95:5, flow rate 0.5 mL/min). Thereafter, both diastereomers were 
transformed separately into the corresponding pentafluorobenzoates (1R, 4S)-78a, and (1R, 
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4R)-78b. The pentafluorobenzoate (1R, 4S)-78a was obtained in 91% with 81% ee. The 
pentafluorobenzoate (1R, 4R)-78b was obtained in 90% with 99% ee (Scheme 54). 
 
3.3.2 Determination of the relative configuration of the starting materials 
 
Attempts to determine the absolute configurations at C-4 of (1R, 4S)-77a and (1R, 
4R)-77b as well as of (1R, 4S)-78a and (1R, 4R)-78b by 2D-NMR experiments failed. It 
proved also difficult to obtain a single crystal suitable for crystal X-ray diffraction analysis. 
However, the absolute stereochemistry could be established through an anti-SN2´ substitution 
reaction (Scheme 55). Thus, allylic pentafluorobenzoates (1R, 4S)-78a and (1R, 4R)-78b 
were subjected to the standard reaction conditions for the anti-SN2´substitution reaction using 
dipentylzinc (2.4 equiv) in the presence of CuCN·2LiCl (1.5 equiv) at 25 oC. The products (1S, 
2R)-79a and (1R, 2R)-79b were obtained after purification, respectively, in 54% with 81% 
ee and 68% with 99% ee. The NOE NMR-experiment for the product (1S, 2R)-79a showed a 
correlation between the proton on carbon, bearing the –OTBS group, and the methylene 
protons of the pentyl substitutent. Therefore, we concluded that the stereocenter at C-4 of 
allylic pentafluorobenzoate (1R, 4S)-78a derived from allylic alcohol (1R, 4S)-77a possess 
(S)-configuration. 
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Scheme 55. Determination of the absolute configuration using anti-SN2´substitution reactions. 
 
In contrast, the stereocenter at C-4 of allylic pentafluorobenzoate (1R, 4R)-78b 
derived from allylic alcohol (1R, 4R)-77b was shown to possess (R)-configuration using the 
same method (Scheme 55). These results indicate that only one isomer of the allylic alcohol 
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77 can be utilized for the envisioned enantioselective synthesis of (+)-estrone. Therefore, we 
explored the alternative methods to access enantiomerically pure alchol (1R, 4R)-77b in high 
yields. 
 
3.3.3 Synthesis of an enantiomerically pure allylic alcohol by enzymatic resolution  
 
We needed an efficient method for obtaining large quantities of enantiomerically pure 
(1R, 4R)-77b derived from pure (4R)-74. Therefore, an enzymatic resolution protocol was 
studied. Furthermore, the high enantioselectivity of the process also might allow the 
conversion of the undesired by-product (4S)-74 to the desired (4R)-74 enantiomer with high 
stereospecificity via a Mitsunobu reaction.101 Thus our initial efforts were directed towards a 
lipase resolution.102 
Enzymatic resolution of various racemic allylic alcohols103 using Amano Lipase AK 
from Pseudomonas Fluorescens104  was carried out previously in our group and excellent 
results (99% ee of the resulting alcohols) were obtained. 105  Thus, 4-hydroxy-3-
methylcyclopent-2-en-1-one (rac-74) was first exposed to the slightly modified reaction 
conditions from those reported using Amano Lipase AK from Pseudomonas Fluorescens in 
the solution of vinyl acetate in hexane (Scheme 56). 
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hexane, 25 oC, 1 h
 
 
Scheme 56. Enzymatic resolution of rac-74 using Amano Lipase AK from Pseudomonas 
Fluorescens. 
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The progress of the reaction was monitored by TLC. In contrast to acyclic substrates, 
rather disappointing results were obtained for our substrate. The reaction was completed 
within only 1 h at 25 oC to give the acetate rac-80 in quantitative yield. The failure of this 
procedure to afford the (4R)-74 in sufficient optical purity forced us to probe alternative 
lipases. Numerous enzymes were reported for the resolution of allylic alcohols,106 including 
an efficient porcine pancreatic lipase (PPL)-catalyzed acetylations of a variety of 2-alkyl-4-
hydroxycyclopent-2-en-1-ones reported by Babiak and Wong.107 They described the excellent 
optical purities for the derived (R)-acetate (≥92% ee) as well as the recovered (S)-alcohols 
(≥92% ee; Scheme 57). 
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Scheme 57. PPL-catalyzed acetylation of 2-alkyl-4-hydroxycyclopent-2-en-1-ones by Babiak 
and Wong.107  
 
To our delight, this enzyme also provided satisfactory results for the cyclopentenone 
substrate rac-74 at 25 oC (Scheme 58). Thus, the alcohol rac-74 was dissolved in vinyl 
acetate, and the resulting solution was treated with enzyme PPL. Acetate (R)-80 was isolated 
by column chromatography in 26% yield and 91% ee (HPLC; Chiralcel OJ, heptane:i-PrOH = 
90:10, flow rate 0.5 mL/min). The unreacted alcohol (S)-74 recovered in 58% was again 
submitted to the enzymatic resolution conditions giving the additional acetate (R)-80 in 20% 
yield with 91% ee and the unreacted alcohol (S)-74 (90% ee). Acetate (R)-80 was combined 
and deacetylated according to the procedure of Wong107 (guanidine, MeOH) to give the 
desired alcohol (R)-74 in 71% yield and 91% ee. The undesired alcohol (S)-74 was inverted 
via a Mitsunobu protocol ((i) PPh3 (2 equiv), DEAD (2 equiv), HCO2H (2 equiv), 25 oC, 12 h, 
(ii) MeOH, Al2O3, 25 oC, 5 h)107 to afford the additional alcohol (R)-74 in 75% yield and 91% 
ee. 
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Scheme 58. Enzymatic resolution of the alcohol rac-74 via porcine pancreatic lipase (PPL) 
in vinyl acetate. 
 
 
 
 
Figure 3. The separation of rac-80 by HPLC (Chiralcel OJ; heptane:i-PrOH = 90:10, flow 
rate 0.5 mL/min). 
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Figure 4. The acetate (R)-80 (91% ee) obtained from enzymatic resolution using PPL and 
vinyl acetate. 
 
 
 
Figure 5.  The remaining alcohol (S)-80 (91% ee, determined from corresponding acetate) 
from enzymatic resolution using PPL and vinyl acetate.  
 
With chiral cyclopentenone (R)-74 in hand, the syntheses of enantiomerically pure 
(1R, 4R)-77b and (1R, 4R)-78b were accomplished as summarized in Scheme 59. Following 
the same sequence described previously, chiral cyclopentenone (R)-74 was smoothly 
converted into the ketone (R)-76 in 75% with 91% ee108 by the protection of the secondary 
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alcohol using TBSCl followed by the iodination reaction. Asymmetric reduction of the ketone 
(R)-76 with (S)-MeO-CBS catalyst afforded chiral allylic alcohol (1R, 4R)-77b in 91% yield 
and 99% ee as the major product, which could be separated from the minor diastereomer (1R, 
4S)-77a (≤ 5%). Finally, chiral allylic alcohol (1R, 4R)-77b was transformed into the 
corresponding pentafluorobenzoate (1R, 4R)-78b in 91% yield and 99% ee. 
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Scheme 59. Synthesis of enantiomerically pure allylic pentafluorobenzoate (1R, 4R)-78b. 
 
3.4 Synthesis of the diorganozinc reagent 
 
 For our approach, the dialkylzinc 71 was required. This was synthesized from Dane’s 
diene (81)109 as depicted in Scheme 60. Dane’s diene was prepared according to a literature 
procedure.110 Treatment of commercially available 6-methoxytetralone with vinylmagnesium 
bromide afforded an allylic alcohol, which was directly submitted to a dehydration reaction 
using quinoline (0.5 equiv) and I2 (cat.) in benzene providing Dane’s diene (81) in 83% yield. 
                                                 
109
  a) Dane, E.; Eder, K. Liebigs Ann. Chem. 1939, 539, 207; b) Dane, E.; Schmitt, J. Liebigs Ann. Chem. 1938, 
536, 196; c) Dane, E.; Schmitt, J. Liebigs Ann. Chem. 1939, 537, 246. For the recent use of Dane’s dienne for the 
syntheses of steroids see: d) Rigby, J. H.; Warshakoon, N. C.; Payen, A. J. J. Am. Chem. Soc. 1999, 121, 8237; e) 
Hanada, K.; Miyazawa, N.; Ogasawara, K. Chem. Pharm. Bull. 2003, 51, 104; f) Tsogoeva, S. B.; Durner, G.; 
Bolte, M.; Gobel, M. Eur.  J. Org. Chem. 2003, 1661. 
110
  Symmes, Jr., C.; Quin, L. D. J. Org. Chem. 1979, 44, 1048. 
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The selective hydroboration of Dane’s diene was conveniently performed using Et2BH, 
readily prepared by mixing BH3·Me2S and Et3B in the ratio 1:2.111 This hydroboration product 
was used for a transmetallation to zinc using neat Et2Zn to give the dialkylzinc reagent 71 in 
95% yield (determined by GC-analysis of the hydrolyzed reaction aliqouts).  
MeO
MeO
HO
MgBr (1.2 equiv)
MeO
Zn
71: 95%
MeO
O
1. Et2BH (1 equiv), 0 oC, 3 h
2. Et2Zn (2 equiv), 25 oC 
   16 h
2
 Dane's diene (81): 83%
THF, 65 oC, 1 h
quinoline (0.5 equiv)
I2 (cat.), benzene, 100 oC
 
Scheme 60. Preparation of the dialkylzinc reagent 71. 
 
3.5 Formal total enantioselective synthesis of (+)-estrone 
 
3.5.1 Enantioselective anti-SN2´ substitution reaction 
 
With enantiomerically enriched allylic pentafluorobenzoate (1R, 4R)-78b and the 
dialkylzinc reagent 71 in hand, our attention was focused on the selective anti-
SN2´substitution reaction. Preliminary experiments indicated that beneficial results were 
obtained by premixing the dialkylzinc 71 (2.4 equiv) and CuCN·2LiCl (2.4 equiv) at 0 oC for 
10 min followed by the addition of a solution of allylic pentafluorobenzoate in THF at 25 oC. 
Under these optimized reaction conditions, allylic pentafluorobenzoate (1R, 4R)-78b was 
treated with dialkylzinc 71 (2.4 equiv) and CuCN·2LiCl (2.4 equiv) at 25 oC to afford the 
anti-SN2´substitution product (1R, 2R)-82 in 66% yield. The removal of the TBS-group 
provided the corresponding alcohol (1R, 2R)-83 in 95% yield, which has allowed us to 
determine the enantiopurity by HPLC-analysis (Chiralcel OJ, heptane:i-PrOH = 85:15, flow 
rate 0.5 mL/min) as well as to confirm the relative stereochemistry of the adjacent methyl and 
hydroxyl groups by NOE NMR-experiments (Scheme 61). 
                                                 
111
  Langer, F.; Schwink, L.; Devasagayaraj, A.; Chavant, P.; Knochel, P. J. Org. Chem. 1996, 61, 8229.  
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MeTBSO
I
OCOC6F5
MeO
Zn
MeO
OTBS
I
Me
MeO
I
Me
H
OH
2
(2.4 equiv)
TBAF, THF
(1R, 4R)-78b: 99% ee
(1R, 2R)-82: 66%; 97% ee (1R, 2R)-83: 95%; 97% ee
71
CuCN·2LiCl (2.4 equiv)
THF, 25 oC, 48 h
NOE
25 oC, 24 h
 
Scheme 61.  Stereoselective anti-SN2´substitution of pentafluorobenzoate (1R, 4R)-78b. 
 
3.5.2 Formation of the C-ring of the steroidal skeletal 
 
3.5.2.1 Attempted formation of the C-ring of the steroidal skeletal using a Heck 
reaction 
 
 The next step of our envisioned (+)-estrone synthesis was the cyclization of the 
cycloalkenyl iodide (1R, 2R)-82 to form the tetracyclic compound 84 (Scheme 62). A Heck 
reaction was our first choice.  The palladium-catalyzed vinylation and ary halides was first 
reported 30 years ago independently by Mizoroki and Heck. 112  The application of this 
powerful reaction to natural product syntheses has flourished recently.113, 114  
 Treatment of the cycloalkenyl iodide (1R, 2R)-82 with Pd(OAc)2 (15 mol%) in the 
presence of Ph3P (30 mol%) and Ag2CO3 (1.1 equiv) in THF at 65 oC for 12 h followed by the 
deprotection of TBS-group using a TBAF solution (1 M in THF) provided a single isomer of 
the product 85 in 57% isolated yield (Scheme 62). The structure of 85 was established by 
NMR experiments. It should be noted that compound 85 is not very stable and decomposes in 
chloroform solution at 25 oC.  
                                                 
112
  a) Mizoroki, T.; Mori, K.; Ozaki, A. Bull. Chem. Soc. Jpn. 1971, 44, 581; b) Heck, R. F.; Nolley, J. P., Jr. J. 
Org. Chem. 1972, 37, 2320. 
113
  Selected reviews include: a) de Meijere, A.; Meyer, F. E. Angew. Chem. Int. Ed. Engl. 1994, 33, 2379; b) 
Bräse, S.; de Meijere, A. in Metal-Catalyzed Cross Coupling Reactions, (Eds.; Stang, P. J.; Diederich, F.), 
Wiley-VCH, Weinheim, 1998, Chapter 3; c) Link, J. T.; Overman, L. E. in Metal-Catalyzed Cross Coupling 
Reactions, (Eds.; Stang, P. J.; Diederich, F.), Wiley-VCH, Weinheim, 1998; Chapter 6; d) Link, J. T. Organic 
Reactions, Wiley, NJ, 2002, Vol. 60, Chapter 2. 
114
  For recent reviews of the asymmetric Heck reaction, see: a) Shibasaki, M.; Vogl, E. M. J. Organomet. Chem. 
1999, 576, 1; b) Donde, Y.; Overman, L. E. in Catalytic Asymmetric Synthesis, (Ed.; Ojima, I.), Wiley-VCH, 
New York, 2000, Chaper 8G. 
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MeO
OTBS
I
Me
(1R, 2R)-82
MeO
Me
OH
H
MeO
Me OTBS
H
84
85: 57%
1. Pd(OAc)2 (15 mol%), Ph3P 
    (30 mol%),  Ag2CO3
    (1.1 equiv), THF, 65 oC, 12 h
2. TBAF, THF, 25 oC, 12 h
 
Scheme 62. Attempted formation of the C-ring of the steroidal skeletal using a Heck reaction. 
 
 A proposed mechanism for the formation of the product 85 is shown in Scheme 63. 
First occurs an oxidative addition of Pd(0)-catalyst into the C-I bond followed by a 
carbopalladation 115  leading to the tetracyclic intermediate 86. We assume that the 
stereochemical outcome of this step might result from the attack of the palladium(II) salt to 
the alkene, which puts the angular methyl group at C-13 in an axial position. As a next step, 
we assume that a second carbopalladation takes place to form the cyclopropane ring followed 
by β-hydride elimination.  
MeO
OTBS
I
Me
MeO
OTBS
Me
MeO
Me
OTBS
H
[Pd]-I
MeO
Me
OTBS
H
MeO
[Pd]-I
H
Me
OTBS
[Pd]-I
Pd(0)
oxidative 
addition
carbopalladation
carbopalladation
β-hydride 
elimination
82 86
-[Pd]
-HI
 
 
Scheme 63. Proposed mechanism of the Heck reaction. 
 
                                                 
115
  Negishi, E.; Copéret, C.; Ma, S.; Liou, S.-Y.; Liu, F. Chem. Rev. 1996, 96, 365. 
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3.5.2.2 Formation of the C-ring of the steroidal skeletal via a ketone intermediate 
 
The failure of the Heck reaction forced us to change our synthesis.116 The alkenyl 
iodide (1R, 2R)-82 was converted to a carbonyl group, according to our protocol developed in 
chapter 2.72 The resulting ketone (2R, 3R)-87 should be selectively cyclized under acidic 
reaction conditions to form the C-ring of the steroidal skeletal 88 (Scheme 64). 
MeO
Me
OTBS
I
MeO
Me
OTBS
O
(1R, 2R)-82 (2R, 3R)-87
Me
MeO
OR
88
hydrolysis cyclization
 
Scheme 64. Envisioned synthesis of 88. 
 
Thus, the cycloalkenyl iodide (1R, 2R)-82 was treated with t-BuLi (2 equiv) at −78 oC 
for 30 min, and then reacted with B(OMe)3 to provide the intermediate 89, which was 
oxidized by NaBO3 to give the ketone (2R, 3R)-87 in 45% yield (Scheme 65). 
 
MeO
Me
OTBS
I
(1R, 2R)-82
MeO
Me
OTBS
B(OMe)2
MeO
Me
OTBS
O
89
(2R, 3R)-87: 45%
1. t-BuLi (2 equiv)
   −78 oC, 30 min
NaBO3, 25 oC, 24 h
2. B(OMe)3 (2.5 equiv)
   −78 oC to 25 oC, 24 h
 
 
Scheme 65. Transformation of the cycloalkenyl iodide (1R, 2R)-82 to the ketone (2R, 3R)-87. 
                                                 
116
  Radical cyclization reactions failed for substrate 82 as well. 
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The ketone (2R, 3R)-87 was then subjected to the cyclization reaction conditions. 
Upon stirring with anhydrous p-TsOH in dry benzene at 25 oC for 16 h,117 the ring closure 
followed by the dehydration gave the tetracyclic intermediate 90, which was directly treated 
with a TBAF solution for the deprotection of the secondary alcohol (Scheme 66).  
 
MeO
OTBS
O
Me
(2R, 3R)-87
MeO
OTBSMe
90
   H+
−H2O
TBAF
MeO
OHMe
91
1. p-TsOH, benzene, 25 oC, 16 h
2. TBAF (2 equiv), 25 oC, 16 h
 
 
Scheme 66. Cyclization of the ketone (2R, 3R)-87. 
 
The crude alcohol 91 is unstable at 25 oC and decomposes during the purification by 
chromatography. Therefore, it was directly further oxidized with CrO3 in the presence of 
Celite118 to give the Torgov diene (67), mp = 141-144 oC, [α]D –95.6 (c 0.5, CHCl3) [lit.: mp 
=  145-146 oC, [α]D –102.6 (c 0.904, CHCl3)],96, 99 in 61% yield starting from (2R, 3R)-87 
with 99% ee119 (Scheme 67). 
 
MeO
OHMe
91
MeO
OMe
CrO3, Celite
Torgov diene (67): 
 61%; 99% ee
CH2Cl2, Et2O
25 oC, 12 h
 
 
Scheme 67. Synthesis of the Torgov diene (67) from an oxidation of the alcohol 91.
                                                 
117
  Kuo, C. H.; Taub, D.; Wendler, N. L. J. Org. Chem. 1968, 33, 3126. 
118
  Gilchrist, T. L.; Summersell, R. J. J. J. Chem. Soc., Perkin Trans. 1 1998, 2603. 
119
  Racemate Torgov diene was generously obtained from Schering Company, Berlin, Germany. 
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The conversion of the Torgov diene (67) into (+)-estrone (63) has been previously 
reported by Quinkert and Ogasawara in 3 steps and 32-37% yield (Scheme 68).96, 99  
 
OMe
MeO
H
H
H
OMe
MeO
H
H2, 5% Pd-CaCO3
(+)-Estrone (63)
OMe
HO
H
H
H
OMe
MeO
Et3SiH, CF3COOH 
benzene, CH2Cl2
BBr3, CH2Cl2, 0 oC
Torgov diene (67)
 
 
Scheme 68. Synthesis of (+)-estrone from the Torgov diene by Ogasawara96 and Quinkert.99 
 
4. Summary  
 
 This work focused on the copper(I)-mediated stereoselective anti-allylic substitution 
reactions using organozinc reagents and chiral cyclic phosphates or pentafluorobenzoates. The 
applications of this method to the preparation of natural products were also reported. In a first 
project, the remarkable ability of mixed zinc-copper organometallics prepared from mixed 
diorganozincs RZnCH2SiMe3 and CuCN·2LiCl to undergo stereoselective anti-
SN2´substitutions with sterically hindered substrates was reported. Excellent transfer of the 
chirality was observed and a range of functionalized zinc reagents could be used (Scheme 69). 
As applications, the odoriferous (R)-dihydro-α-ionone (32) and (R)-α-ionone (35) were 
prepared by this method (Figure 6). 
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Me Me
I
OP(O)(OEt)2
I
Me Me
I
Me Me
CO2Et
O
I
Me Me O
I
Me Me
R
I
Me Me
Ph
(R)-28c: 85%; 98% ee (R)-28h: 90%; 98% ee (R)-28j: 95%; 98% ee(R)-28e: 81%; 97% ee
RZnCH2SiMe3 (30a-h)
(2.4 equiv)
CuCN·2LiCl (2.4 equiv)
THF:NMP (3:1)
−30 oC to 25 oC, 14-48 h(R)-26: 98% ee
       (R)-28c-j:
 65-90%; 95-98% ee
 
Scheme 69. Enantioselective anti-SN2´substitution with RZnCH2SiMe3. 
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Me
O
(R)-32: 49% overall; 98% ee
Me Me
Me
Me
O
 (R)-35: 36% overall; 97% ee
 
Figure 6. (R)-dihydro-α-ionone (32) and (R)-α-ionone (35). 
 
 In a second project, a transformation of the carbon-iodine bond to Csp2-Csp3, Csp2-
Csp2 and Csp2-Csp bonds via cross-coupling reaction was demonstrated (Scheme 70). 
 
CO2Et
CO2PhBrZn
CO2Ph
I
CO2Et
HBu
(R)-36
CO2Et
Bu
(R)-37: 70%
Pd(dba)2 (5 mol%)
dppf (5 mol%), 25 oC 
16 h (R)-38: 75%
PdCl2(PPh3)2 (5 mol%)
CuI (5 mol%), Et3N
25 oC, 25 h
 
 
Scheme 70. Cross-coupling reactions of compound (R)-36. 
 
Further, a short sequence for the preparation of various chiral ketones bearing an α-
stereogenic center with high enantioselectivity was developed. The reaction sequence 
involved a I/Li-exchange reaction followed by an oxidation of the intermediate 
cycloalkenyllithium species using (Me3SiO)2 or (MeO)3B/NaBO3·4H2O (Scheme 71).  
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I
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R1
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R1
O
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O
Me
Me
O
O
R2
R1
n
t-BuLi (2 equiv)
−78 oC
n n              Method B
 (a) B(OMe)3, −78 oC to 25 oC, 24 h
 (b) NaBO3·4H2O, 25 oC, 24 h
(S)-52a: 70%; 93% ee (R)-52i: 69%; 92% ee (R)-52c:76%; 96% ee
             Method A 
(a) (TMSO)2, −78 oC, 30 min
(b) HF·Pyr, THF, 25 oC, 30 min
n = 1, 2, 3
 
 
Scheme 71. Synthesis of chiral ketones. 
 
 The utility of this method has been demonstrated in a short synthesis of (R)-10-
methyl-6-undecanolide (62) with an excellent enantioselectivity (Scheme 72). 
 
I
OCOC6F5
Me ZnI
Me
O
O
Me
Me
I
Me
Me
O
Me
Me
(2 equiv)
CuCN·2LiCl (2 equiv)
THF: NMP (3:1)
−30 oC to 25 oC, 15 h (S)-60: 88%; 96% ee(S)-45: 98% ee
1) t-BuLi (2 equiv)
2) (Me3SiO)2, −78 oC, 30 min
3) HF·py, THF, 25 oC, 30 min
(S)-61: 89%; 95% ee
m-CPBA, CH2Cl2
(R)-62: 91%; 95% ee
0 oC to 25 oC, 18 h
 
 
Scheme 72. Application to the preparation of (R)-10-methyl-6-undecanolide (62). 
 
 As an application to a more complex natural product, the asymmetric allylic 
substitution reaction was applied to the enantioselective synthesis of the Torgov diene (67) 
which is a known intermediate for (+)-estrone synthesis. Thus, the Torgov diene (67) was 
synthesized through a copper(I)-mediated anti-SN2´-substitution reaction in 9 steps and 12% 
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yield starting from chiral allylic alcohol (R)-74. This represents a formal total synthesis of 
(+)-estrone (63) in 12 steps and 4% yield (Scheme 73). 
MeO
OTBS
O
Me
MeO
OTBS
I
MeI
Me
OCOC6F5
TBSO
(2R, 3R)-87: 45%
(1R, 4R)-78b: 99% ee
Me O
MeO
Me O
HO
H
H
H
71
MeO
Zn2
+
 (+)-estrone (63)  Torgov diene (67)
 61%; 99% ee
THF, 25 oC
1. p-TsOH, benzene
   25 oC, 16 h
2. TBAF, 25 oC
3. CrO3, Celite
(1R, 2R)-82: 66%; 97% ee
CuCN·2LiCl
(2.4 equiv)
1. t-BuLi (2 equiv), −78 oC, 30 min
2. B(OMe)3 (2.5 equiv), −78 oC to  
25 oC, 24 h
3. NaBO3, 25 oC, 24 h
3 steps
 
Scheme 73. Synthesis of (+)-estrone (63). 
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1. General conditions 
 
All reactions were carried out with a magnetic stirring and, if air or moisture sensitive, in a 
flamed-dried glassware under a nitrogen or an argon atmosphere. The syringes which were 
used to transfer the reagents and the solvents were purged with nitrogen or argon prior to use. 
 
Solvents 
 
The solvents were dried according to standard methods by distillation over drying agents as 
stated below and were stored under argon or nitrogen. Benzene, dichloromethane and toluene 
were predried over calcium chloride and were distilled from calcium hydride. DMF was 
heated at reflux for 14 h over calcium hydride and was distilled. Ethanol was treated with 
phthalic anhydride (25 g/L) and sodium, heated at reflux for 6 h and distilled. Methanol was 
treated with magnesium turnings (20 g/L), heated at reflux for 6 h and distilled. NMP was 
heated at reflux for 6 h over calcium hydride and distilled.   Pyridine and triethylamine were 
dried over potassium hydroxide and distilled. Tetrahydrofuran (THF) was continuously 
heated at reflux and freshly distilled from sodiumbenzophenone ketyl under nitrogen.  
 
Reagents 
 
• Reagents of >98% purity were used as obtained. 
• n-Butyllithium was used as a solution in hexane. 
• t-Butyllithium was used as a solution in pentane. 
• a CuCN·2LiCl solution (1.0 M in THF) was prepared by drying CuCN (896 mg, 10.0 mmol) 
and LiCl (848 mg, 20.0 mmol) in a Schlenk flask under high vacuum for 5 h at 120 oC. After 
cooling to 25 oC, under an argon atmosphere, dry THF (10 mL) was added and the stirring 
was continued until the salts were dissolved. 
• a ZnBr2 solution (1.50 M in THF) was prepared by drying ZnBr2 (3.40 g, 15.0 mmol) in a 
Schlenk flask under high vacuum for 5 h at 120 oC. After cooling to 25 oC, under an argon 
atmosphere, dry THF (10 mL) was added and the stirring was continued until the salt was 
dissolved. 
• The following reagents and substances were prepared according to literature procedures: 
2-iodocyclopent-2-en-1-one,27 (S)-2-iodocyclopent-2-en-1-ol (95% ee),27 2-iodocyclohex-2-
en-1-one, 27 (R) and (S)-2-iodocyclohex-2-en-1-ol (98% ee),27 Et2BH111 
 
Content determination of organometallic reagents 
 
The organolithium and organomagnesium solutions were titrated using the method of 
Paquette120 and Knochel121 prior to use. The concentration of the organozinc solutions were 
determined by back titration of iodine with an aqueous Na2S2O3 solution. 
 
Chromatography 
 
• Thin layer chromatography (TLC) was performed using aluminium plates covered with SiO2 
(Merck 60, F-254). The chromatograms were developed under UV light and/or by treatment 
of the TLC plate with one of the solutions below followed by gentle heating with a heat gun: 
- KMnO4 (0.3 g), K2CO3 (20 g) and KOH (0.3 g) in water (300 mL) 
                                                 
120
  Lin, H.-S.; Paquette, L. A. Synth. Commun. 1994, 24, 2503. 
121
  Krasovskiy, A.; Knochel, P. Synthesis 2006, 5, 890. 
Experimental Part  64 
- Phosphormolybdic acid (5.0 g),  Ce(SO4)2 (2.0 g) and conc. H2SO4 (12 mL) in 
water (230 mL) 
• Flash column chromatography was performed using SiO2 60 (0.040-0.063 mm; 230-400 
mesh ASTM) or Al2O3 (grade III) from Merck. The diameters of the columns and the amount 
of silica gel were calculated according to the recommendations of W. C. Still.122 
 
Analytical data 
 
• Melting points were determined on a Büchi B-540 apparatus and are uncorrected.  
• NMR spectra were recorded on Brucker ARX 200, AC 300 or WH 400 instruments. 
Chemical shifts are reported as δ-values in ppm relative to the deuterated solvent peak: CDCl3 
(δH: 7.27, δC: 77.0) and Benzene-d6 (δH: 7.16, δC: 128.0).  
For the characterization of the observed signal multiplicities the following abbreviations were 
applied: s (singlet), d (doublet), dd (double doublet), dt (double triplet), t (triplet), m 
(multiplet), br (broad). 
• Optical rotation values were measured on the Perkin-Elmer 241 polarimeter. 
• Infrared spectra were recorded from 4000-400 cm-1 on a Nicolet 510 FT-IR or a Perkin-
Elmer 281 IR spectrometer. The absorption bands are reported in wave number (cm-1). For the 
band characterization the following abbreviations were applied: br (broad), s (strong), m 
(medium), w (weak). 
 • Gas Chromatography (GC): Hewlett-Packard 6890. Chiral columns: Chiraldex B-PH 
(30.0 mm x 0.25 mm), Chirasil-Dex CB (25 mm x 0.25 mm). Carrier gas: H2. 
• High Performance Liquid Chromatography (HPLC) was performed using Gynkotec-
HPLC with a diode-array UV-VIS detector. Chiral columns: OD-H, OD, OJ and AD (Diacel 
Chemical Industries) with n-heptane/i-propanol as mobile phase. Racemic compounds were 
used for optimizing the operating conditions for the resolution of the enantiomer and 
diastereomer peaks. 
• Electron impact mass (EI, 70 eV) spectra were recorded on a Finnigan MAT 95Q or 
Finnigan 90 instrument. High resolution mass spectra (HRMS) were recorded on the same 
instrument. The combination of gas chromatography with mass spectroscopic detection, a 
GC/MS from Hewlett-Packard HP 6890/MSD 5973 was used. 
• Elemental Analysis was carried out on a Heraeus CHN-Rapid-Elementanalyzer in the 
microanalytical laboratories of the Department für Chemie und Pharmazie, Ludwig-
Maximilians Universität München. 
 
2. Typical Procedures (TP) 
 
2.1 Typical procedure for the synthesis of 2-iodocycloalk-2-en-1-ones (TP 1) 38 
 
A flame-dried round bottom flask equipped with a magnetic stirring bar, a nitrogen inlet and a 
rubber septum was charged with cycloalk-2-en-1-one (1.0 equiv) and CH2Cl2. Pyridinium 
dichromate (PDC) (0.30 equiv) and I2 (1.0 equiv) were added to the resulting solution. The 
reaction flask was covered with an aluminium foil and the reaction mixture was stirred at 25 
oC. The progress of the reaction was monitored by thin-layer chromatography (TLC) or gas 
chromatography (GC). After the complete consumption of the starting material, the reaction 
mixture was filtrated, and the residue was washed with pentane. The combined organic layer 
was washed with 2 M HCl, a saturated NaHCO3 solution, a saturated Na2S2O3 solution, brine 
and dried over MgSO4 anhydrous. The crude product was purified by column chromatography 
to afford the desired product. 
                                                 
122
  Still, W. C.; Khan, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923. 
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2.2 Typical procedure for the asymmetric reduction of 2-iodocycloalk-2-en-1-ones (TP 2)  
 
A flame-dried round bottom flask equipped with a magnetic stirring bar, an argon inlet and a 
rubber septum was charged with (R)- or (S)-diphenylprolinol (5 mol%), THF and B(OMe)3 (5 
mol%). The reaction mixture was stirred at 25 oC for 1 h. The borane-N,N-diethylaniline 
complex (1.0 equiv) was added followed by the slow addition of THF solution of 2-
iodocycloalk-2-en-1-ones (1.0 equiv) at 25 oC. The reaction mixture was stirred at 25 oC for 1 
h, and then was carefully quenched with MeOH. The solvents were evaporated under high 
vacuum. The remaining oil was diluted with Et2O, washed with 7% Na2CO3 aqueous solution, 
10% KHSO4 aqueous solution, brine and dried over Na2SO4 anhydrous. Evaporation of the 
solvents and purification by column chromatography afforded the desired chiral allylic 
alcohol. 
 
2.3 Typical procedure for anti-SN2´substitutions of mixed dialkylzinc reagents 
RZnCH2SiMe3 (TP 3)  
 
A flame-dried round bottom flask equipped with a magnetic stirring bar, an argon inlet and a 
rubber septum was charged with freshly prepared alkylzinc halide (a solution in THF, 2.40 
equiv) and cooled to –40 oC, and then the solution of TMSCH2Li (1.0 M in pentane, 2.40 
equiv) was added dropwise. The reaction mixture was stirred for 1 h at –40 oC then warmed 
up to –30 oC. A solution of CuCN·2LiCl (1.0 M solution in THF, 2.40 equiv) and NMP 
(sufficient to give an overall ratio of the solvent mixture of THF:NMP = 3:1) were added 
successively to the resulting mixture. The reaction mixture was stirred at –30 oC for 30 min. 
Diethyl (1R)-2-iodo-4,4-dimethylcyclohex-2-en-1-yl phosphate was added dropwise as a 
solution in THF. The reaction mixture was slowly warmed up to 25 oC during the time stated 
for each compound. A saturated aqueous NH4Cl solution (20 mL) was added followed by 
25% aqueous ammonia solution (1 mL). The reaction mixture was stirred at 25 oC until the 
copper salts had dissolved. The mixture was extracted with Et2O (3 x 20 mL). The combined 
organic phase was washed with brine and dried over Na2SO4. Evaporation of the solvents and 
the purification by column chromatography afforded the desired product.  
 
2.4 Typical procedure for anti-SN2´substitutions of dialkylzincs (TP 4)  
 
A flame-dried round bottom flask equipped with a magnetic stirring bar, an argon inlet and a 
rubber septum was charged with a CuCN·2LiCl solution (1.0 M in THF, 2.24 equiv), NMP 
(sufficient to give an overall ratio of the solvent mixture of THF:NMP = 3:1), and then the 
reaction mixture was cooled to –30 oC. Dialkylzinc (2.24 equiv) was added dropwise to the 
resulting mixture. The reaction mixture was stirred at –30 oC for 30 min, and then the 
pentafluorobenzoate or the diethylphosphate (1.0 equiv) was added dropwise as a solution in 
THF. The reaction mixture was stirred and allowed to warm to –10 oC until the conversion 
was complete (15-25 h).  A saturated aqueous NH4Cl solution (20 mL) was added followed 
by 25% aqueous NH3 solution. The reaction mixture was stirred at 25 °C until the copper salts 
had dissolved, and then was extracted with Et2O (3 x 20 mL). The combined organic phase 
was washed with brine and dried over Na2SO4. Evaporation of the solvents and the 
purification by column chromatography afforded the desired cycloalkenyl iodide. 
 
2.5 Typical procedure for anti-SN2´substitutions of alkylzinc halides (TP 5)  
 
A flame-dried round bottom flask equipped with a magnetic stirring bar, an argon inlet and a 
rubber septum was charged with a CuCN·2LiCl solution (1.0 M in THF, 2.0 equiv) then 
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cooled to –30 oC. The alkylzinc halide (2.0 equiv) was added to a solution. The resulting 
mixture was stirred at –30 oC for 30 min, and then the pentafluorobenzoate (1.0 equiv) was 
added dropwise as a solution in NMP (sufficient to give an overall ratio of the solvent mixture 
of THF:NMP = 3:1). The reaction mixture was stirred and warmed to the indicated 
temperature. A saturated aqueous NH4Cl solution (20 mL) was added followed by 25% 
aqueous NH3 solution. The reaction mixture was stirred at 25 °C until the copper salts had 
dissolved then was extracted with Et2O (3 x 20 mL). The combined organic phase was 
washed with brine and dried over Na2SO4. Evaporation of the solvents and purification by 
column chromatography afforded the desired cycloalkenyl iodide. 
 
2.6 Typical procedure for SN2 substitutions of arylcuprates (TP 6)  
 
A flame-dried round bottom flask equipped with a magnetic stirring bar, an argon inlet and a 
rubber septum was charged with CuCN (0.11 g, 1.20 mmol) and dry THF (2 mL), was then 
cooled to 0 °C. Freshly titrated solution of PhMe2CCH2Li (0.50 M in Et2O, 5 mL, 2.40 mmol) 
was added dropwise to the resulting suspension. The resulting mixture was stirred at 25 °C for 
10 min, and then was cooled to 0 °C. A solution of aryl iodide (1.20 mmol) in THF (2 mL) was 
added to the resulting solution of (PhMe2CCH2)2Cu(CN)Li, and the mixture was stirred at 0 °C 
until I/Cu-exchange was complete (30 min). The reaction mixture was cooled to –40 °C, and a 
solution of (1R)-2-iodocyclohex-2-en-1-yl acetate (0.27 g, 1.0 mmol) in THF (1.5 mL) was 
added dropwise. The reaction mixture was stirred at the temperature indicated in each case. A 
saturated aqueous NH4Cl solution (20 mL) was added followed by 25% aqueous NH3 solution 
(1 mL). The reaction mixture was stirred at 25 °C until the copper salts had dissolved then was 
extracted with Et2O (3 x 20 mL). The combined organic phase was washed with brine and dried 
over Na2SO4. Evaporation of the solvents and purification by column chromatography afforded 
the desired cycloalkenyl iodide. 
 
2.7 Typical procedure for the preparation of chiral ketones bearing α-stereogenic center 
by the oxidation using (TMSO)2 (TP 7) 
 
A flame-dried round bottom flask equipped with a magnetic stirring bar, an argon inlet and a 
rubber septum was charged with a cycloalkenyl iodide (0.50 mmol, 1.0 equiv) and THF (4.0 
mL). The reaction mixture was cooled to –78 oC, and then t-BuLi (1.60 M in pentane, 0.63 
mL, 1.0 mmol, 2.0 equiv) was added dropwise. The reaction mixture was stirred at –78 oC for 
30 min, then (TMSO)2 (neat, 0.16 mL, 0.75 mmol, 1.50 equiv) was added (Caution: explosion, 
the reagent must be transferred by using a plastic syringe and a Teflon needle and was added 
slowly). The reaction mixture was continuously stirred at –78 oC for 30 min, was then poured 
into water, and extracted with pentane (3 x 25 mL). The combined organic phase was dried 
over MgSO4. The solvents were evaporated and the crude product was used in the next step 
without further purification. A flame-dried round bottom flask equipped with a magnetic 
stirring bar, an argon inlet and a rubber septum was charged with dry pyridine (0.40 mL) and 
a HF·pyridine complex (70%) (0.02 mL, 0.50 mmol, 1.0 equiv). A THF (2 mL) solution of 
the crude silyl enol ether was added dropwise at 25 oC. The reaction mixture was stirred for 
30 min at 25 oC, was then poured into water, and extracted with Et2O (3 x 25 mL). The 
combined organic phase was washed with brine and dried over MgSO4. The solvents were 
evaporated and the crude product was purified indicated in each case to give the desired chiral 
ketone. 
 
2.8 Typical procedure for the preparation of chiral ketones bearing α-stereogenic center 
by the oxidation using B(OMe)3/NaBO3·4H2O (TP 8) 
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A flame-dried round bottom flask equipped with a magnetic stirring bar, an argon inlet and a 
rubber septum was charged with a cycloalkenyl iodide (0.50 mmol, 1.0 equiv) and THF (4 
mL). The reaction mixture was cooled to –78 oC, and then t-BuLi (1.60 M in pentane, 0.63 
mL, 1.0 mmol, 2.0 equiv) was added dropwise. The reaction mixture was stirred at –78 oC for 
30 min, then
 
B(OMe)3 (neat, 0.14 mL, 1.25 mmol, 2.50 equiv) was added dropwise. The 
reaction mixture was slowly warmed to 25 oC and stirred for 24 h, then a suspension of 
NaBO3·4H2O (10.0 equiv, 769 mg, 5.0 mmol) in H2O (6 mL) was added at 25 oC. After 
stirring at 25 oC for 24 h, the mixture was poured into water, extracted with Et2O (3 x 25 mL). 
The combined organic phase was washed with brine and dried over MgSO4. The solvents 
were evaporated and the crude product was purified by column chromatography to give the 
desired chiral ketone. 
 
3. Copper(I)-mediated enantioselective anti-SN2´substitution reactions with sterically 
hindered cyclic allylic alcohol derivatives 
 
2-Iodo-4,4-dimethylcyclohex-2-en-1-one (23) 
 
I
O
Me Me
 
 
Prepared according to TP 1 using 4,4-dimethylcyclohex-2-en-1-one (2.64 mL, 20.0 mmol), 
CH2Cl2 (130 mL), PDC (2.26 g, 6.0 mmol) and I2 (5.08 g, 20.0 mmol). The reaction mixture 
was stirred at 25 oC for 26 h. Additional I2 (1.0 g, 3.9 mmol) was added and the reaction 
mixture was stirred for additional 25 h. The crude product was purified by column 
chromatography (silica gel, 8% Et2O:pentane) to afford the product 23 as a pale yellow oil 
(4.64 g, 93% yield).  
The data were in agreement with those reported.123 
 
1H NMR (CDCl3, 300 MHz): δ = 7.46 (s, 1H), 2.71-2.63 (m, 2H), 1.96-1.89 (m, 2H), 1.21-
1.17 (m, 6H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 192.3, 168.5, 102.2, 38.4, 36.4, 33.7, 27.79, 27.76 ppm. 
IR (film): 2960 (m), 2927 (m), 2865 (m), 1690 (s), 1584 (m), 1468 (m), 1320 (m), 1144 (m), 
802 (m) cm-1. 
MS (EI, 70 eV), m/z (%): 250 (M+, 55), 235 (6), 222 (9), 207 (6), 123 (100), 95 (13), 80 (20), 
67 (23), 55 (9). 
 
(1R)-2-Iodo-4,4-dimethylcyclohex-2-en-1-ol (24) 
 
I
OH
Me Me
 
 
Prepared according to TP 2 using (S)-diphenylprolinol (167 mg, 0.66 mmol, 5 mol%), THF 
(14 mL) and B(OMe)3 (78 µL, 0.66 mmol, 5 mol%). The reaction mixture was stirred at 25 oC 
for 1 h. Then the borane-N,N-diethylaniline complex (2.35 mL, 13.2 mmol, 1.0 equiv) was 
                                                 
123
  Souza, F. E. S.; Sutherland, H. S.; Carlini, R.; Rodrigo, R. J. Org. Chem. 2002, 67, 6568. 
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added followed by the slow addition of the solution of 2-iodo-4,4-dimethylcyclohex-2-en-1-
one (23) (3.30 g, 13.2 mmol) in THF (14 mL) over 1 h. The reaction mixture was 
continuously stirred for 1 h, then was carefully quenched with MeOH (6 mL). The crude 
product was purified by column chromatography (silica gel, 20% Et2O:pentane) to afford the 
product (R)-24 as a colourless oil (3.01 g, 90% yield). 
 
HPLC (Chiralcel OD-H; heptane:i-PrOH = 98:2, 0.3 mL/min): tR/min = 27.61 (minor), 33.78 
(major); 98% ee. 
[α]D20 +41.6 (c 0.9, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ = 6.17 (s, 1H), 4.06 (t, J = 5.2 Hz, 1H), 2.05-1.91 (m, 2H), 
1.85-1.74 (m, 1H), 1.62-1.51 (m, 1H), 1.48-1.38 (m, 1H), 0.97 (s, 3H), 0.93 (s, 3H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 150.7, 102.9, 72.4, 37.8, 32.6, 29.23, 29.21, 28.4 ppm. 
IR (film): 3370 (br), 2956 (s), 2935 (s), 2863 (s), 1043 (s) cm-1. 
MS (EI, 70 eV), m/z (%): 252 (M+, 25), 125 (100), 100 (61), 107 (80), 95 (51), 79 (33), 69 
(18), 55 (38). 
C8H13IO HRMS (EI): Calcd.: 252.0011 
Found: 252.0038 
 
Diethyl (1R)-2-iodo-4,4-dimethylcyclohex-2-en-1-yl phosphate (26) 
 
I
OP(O)(OEt)2
Me Me
 
 
N-Methylimidazole (0.95 mL, 12.0 mmol, 2.40 equiv) was added to the solution of (1R)-2-
iodo-4,4-dimethylcyclohex-2-en-1-ol (24) (1.26 g, 5.0 mmol) in dry Et2O (9 mL). The 
reaction mixture was cooled to 0 oC (ice-bath), and then the diethyl chlorophosphate (1.74 mL, 
12.0 mmol, 2.40 equiv) was added dropwise. The ice-bath was removed and the reaction 
mixture was stirred at 25 oC for 16 h, then was quenched with a saturated NaCl solution (20 
mL) and extracted with Et2O (3 x 20 mL). The combined organic phase was dried over 
Na2SO4 anhydrous. The crude product was purified by column chromatography (silica gel, 
50% Et2O:pentane) to afford the product (R)-26 as a colourless oil (1.65 g, 85% yield). 
 
GC (Chiraldex B-PH, 30 mm x 0.25 mm); conditions: 40 oC (2 min), ramp of 20 oC/min to 
160 oC (90 min): tR/min = 65.714 (major), 68.826 (minor); 98% ee. 
[α]D20 +27.5 (c 1.1, CH2Cl2) 
1H NMR (CDCl3, 600 MHz): δ = 6.21 (s, 1H), 4.70-4.65 (m, 1H), 4.17-4.05 (m, 2H), 4.05-
3.91 (m, 2H), 2.00-1.86 (m, 2H), 1.57-1.47 (m, 1H), 1.40-1.30 (m, 1H), 1.28-1.17 (m, 6H), 
0.90 (s, 3H), 0.85 (s, 3H) ppm. 
13C NMR (CDCl3, 150 MHz): δ = 153.5, 94.1, 78.2, 64.5, 64.1, 37.5, 31.3, 29.4, 28.5, 27.4, 
16.5, 16.4 ppm. 
IR (film): 2959 (m), 1275 (s), 1028 (s), 983 (s) cm-1. 
MS (EI, 70 eV), m/z (%): 261 (100), 155 (45), 127 (41), 107 (78), 99 (62), 91 (45), 79 (22).  
C12H22IO4P   HRMS (EI): Calcd.: 388.0300 
Found: 388.0259 
C12H22IO4P  Anal.  Calcd.: C 37.13, H 5.71 
Found: C 37.14, H 5.73 
 
(1R)-2-Iodo-4,4-dimethylcyclohex-2-en-1-yl 2,3,4,5,6-pentafluorobenzoate (27) 
Experimental Part  69 
I
OCOC6F5
Me Me
 
 
Pyridine (1.30 equiv, 7.80 mmol, 0.60 mL), DMAP (0.10 equiv, 0.60 mmol, 73 mg) and 
pentafluorobenzoyl chloride (1.30 equiv, 7.80 mmol, 1.10 mL) were added to a solution of 
(1R)-2-iodo-4,4-dimethylcyclohex-2-en-1-ol (24) (1.48 g, 5.87 mmol) in dry Et2O (30 mL) at 
25 oC. The reaction mixture was stirred at 25 oC for 2 h, then was quenched with a saturated 
NH4Cl solution (20 mL) and extracted with Et2O (3 x 20 mL). The combined organic phase 
was washed with brine and dried over Na2SO4 anhydrous. The crude product was purified by 
column chromatography (silica gel, 2% Et2O:pentane) to afford the product (R)-27 as a white 
solid (2.52 g, 96% yield). 
mp = 51.3-53.2 oC 
GC (Chiraldex CB, 25 mm x 0.25 mm); conditions: 60 oC (1 min), ramp of 20 oC/min to 160 
oC: tR/min = 19.878 (major), 20.931 (minor); 98% ee. 
[α]D20 +52.8 (c 0.375, CH2Cl2) 
1H NMR (CDCl3, 600 MHz): δ = 6.39 (s, 1H), 5.57 (t, J = 4.26 Hz, 1H), 2.17-2.03 (m, 1H), 
2.00-1.88 (m, 1H), 1.65-1.43 (m, 2H), 1.00 (s, 3H), 0.97 (s, 3H) ppm. 
13C NMR (CDCl3, 150 MHz): δ = 157.3, 153.4, 146.0, 143.9, 142.5, 140.6, 138.3, 135.0, 89.8, 
75.4, 36.2, 30.2, 28.2, 25.97, 25.94 ppm.  
IR (neat): 1733 (s), 1651 (w), 1498 (s), 1338 (s), 1221 (s), 998 (s), 966 (s), 888 (m), 739 (s) 
cm-1. 
MS (EI, 70 eV), m/z (%): 319 (44), 195 (100), 167 (8), 107 (6), 92 (10). 
C15H12 F5IO2   HRMS (EI): Calcd.: 319.0757 [M-I]+ 
Found: 319.0724 [M-I]+ 
 
(6R)-1-Iodo-5,5-dimethyl-6-pentylcyclohex-1-ene (28a) 
 
I
Me Me Me
 
 
Prepared according to TP 4 by using diethyl (1R)-2-iodo-4,4-dimethylcyclohex-2-en-1-yl 
phosphate (26) (194 mg, 0.50 mmol, 1.0 equiv), THF (0.8 mL), a CuCN·2LiCl solution (1.0 
M in THF, 0.56 mL, 0.56 mmol, 1.12 equiv), NMP (1.3 mL) and the dipentylzinc solution 
(4.8 M in THF, 0.23 mL, 1.12 mmol, 2.24 equiv). The reaction mixture was warmed to –10 
oC and stirred for 14 h. Purification by column chromatography (silica gel, pentane) afforded 
the product (R)-28a as a colourless oil (122 mg, 80% yield). 
 
GC (Chiraldex B-PH, 30 mm x 0.25 mm); conditions: 125 oC constant: tR/min = 19.079 
(minor), 19.965 (major); 97% ee. 
[α]D20 +60.2 (c 1.25, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ = 6.12 (t, J = 3.8 Hz, 1H), 2.05-1.95 (m, 2H), 1.92-1.86 (m, 
1H), 1.50-1.38 (m, 3H), 1.38-1.10 (m, 7H), 0.92 (s, 3H), 0.88 (s, 3H), 0.83 (t, J = 6.7 Hz, 3H) 
ppm. 
13C NMR (CDCl3, 75 MHz): δ = 136.3, 106.0, 56.8, 35.5, 32.9, 32.3, 30.8, 29.6, 28.4, 28.0, 
27.4, 22.9, 14.5 ppm. 
IR (film): 2955 (s), 2929 (s), 2870 (s), 1466 (m), 1385 (w), 1365 (w), 924 (w), 828 (w), 742 
(w) cm-1. 
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MS (EI, 70 eV), m/z (%): 306 (M+, 29), 251 (10), 250 (98), 236 (40), 180 (22), 179 (12), 123 
(22), 109 (31), 93 (33), 81 (100), 67 (79), 55 (19). 
C13H23I  HRMS (EI): Calcd.: 306.0844 
Found: 306.0818 
C13H23I  Anal.  Calcd.: C 50.99, H 7.57 
Found: C 51.19, H 7.68 
 
(6R)-1-Iodo-6-isopropyl-5,5-dimethylcyclohex-1-ene (28b) 
 
I
Me
Me MeMe
 
 
Prepared according to TP 4 by using diethyl (1R)-2-iodo-4,4-dimethylcyclohex-2-en-1-yl 
phosphate (26) (388 mg, 1.0 mmol), THF (1.6 mL),  the diisopropylzinc solution (5.10 M in 
THF, 0.44 mL, 2.24 mmol, 2.24 equiv), a CuCN·2LiCl solution (1.0 M in THF, 2.24 mL, 2.24 
mmol, 2.24 equiv) and NMP (1.3 mL). The reaction mixture was stirred at –30 oC for 21 h. 
After purification by column chromatography (silica gel, pentane), the cyclohexenyl iodide 
(R)-28b was obtained as a colourless oil (265 mg, 95% yield). 
The separation of the enantiomers was not possible under a variety of conditions in chiral 
HPLC or capillary GC. The enantiomeric excess was determined for the corresponding ketone 
(R)-52j. 
 
[α]D20 +81.7 (c 0.36, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ = 6.32 (t, J = 3.6 Hz, 1H), 2.15-1.98 (m, 4H), 1.60-1.40 (m, 
1H), 1.20-1.08 (m, 1H), 1.15 (d, J = 7.1 Hz, 3H), 1.00 (d, J = 7.1 Hz, 3H), 0.94 (s, 3H), 0.89 
(s, 3H) ppm.  
13C NMR (CDCl3, 75 MHz): δ = 137.5, 99.8, 62.0, 37.0, 29.8, 28.9, 28.7, 28.5, 27.7, 25.0, 
21.1 ppm. 
IR (film): 2956 (s), 2927 (s), 2870 (s), 1463 (s), 1386 (m), 1366 (m), 1325 (w), 1253 (w) cm-1. 
MS (EI, 70 eV), m/z (%): 278 (M+, 68), 236 (17), 222 (100), 151 (17), 108 (46), 95 (60), 77 
(14), 67 (13). 
C11H19I  HRMS (EI): Calcd.: 278.0531 
Found: 278.0513 
 
(6R)-6-(But-3-en-1-yl)-1-iodo-5,5-dimethylcyclohex-1-ene (28c) 
 
I
Me Me
 
 
Prepared according to TP 3 by using freshly prepared 3-butenylzinc iodide47 (1.59 M solution 
in THF, 2.30 mL, 3.60 mmol, 2.40 equiv), TMSCH2Li (1.0 M in pentane, 3.60 mL, 3.60 
mmol, 2.40 equiv), a solution of CuCN·2LiCl (1.0 M solution in THF, 3.60 mL, 3.60 mmol, 
2.40 equiv), NMP (2.2 mL) and the solution of diethyl (1R)-2-iodo-4,4-dimethylcyclohex-2-
en-1-yl phosphate (26) (582 mg, 1.50 mmol, 1.0 equiv) in THF (1.5 mL). The reaction 
mixture was slowly warmed up to 25 oC and stirred for 14 h. Purification by column 
chromatography (silica gel, pentane) afforded the product (R)-28c as a colourless oil (371 mg, 
85% yield). 
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GC (Chiraldex B-PH, 30 mm x 0.25 mm); conditions: 125 oC constant: tR/min = 14.418 
(minor), 15.151 (major); 98% ee. 
[α]D20 +81.2 (c 1.20, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ = 6.21 (t, J = 3.8 Hz, 1H), 5.84-5.70 (m, 1H), 5.02-4.86 (m, 
2H), 2.14-1.90 (m, 4H), 1.66-1.36 (m, 3H), 1.22-1.10 (m, 2H), 0.93 (s, 3H), 0.90 (s, 3H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 139.2, 136.7, 114.9, 105.3, 56.0, 35.5, 34.1, 31.5, 30.7, 28.4, 
27.9, 27.4 ppm. 
IR (film): 2954 (s), 2921 (s), 2871 (s), 1640 (m), 1446 (m), 1386 (m), 1366 (m), 1327 (w), 
992 (m), 911 (s) cm-1. 
MS (EI, 70 eV), m/z (%): 249 (3), 248 (32), 236 (20), 193 (8), 163 (43), 121 (11), 107 (46), 
91 (47), 79 (100), 66 (47), 55 (16). 
C12H19I   HRMS (EI): Calcd.: 290.0531 
Found: 290.0561 
C12H19I  Anal.  Calcd.: C 49.67, H 6.60 
Found: C 49.53, H 6.73 
 
3-[(1R)-2-Iodo-6,6-dimethylcyclohex-2-en-1-yl]propanenitrile (28d) 
 
I
Me Me CN
 
 
Prepared according to TP 3 by using freshly prepared 2-cyanoethylzinc iodide47 (1.15 M 
solution in THF, 2.10 mL, 2.40 mmol, 2.40 equiv), TMSCH2Li (1.0 M in pentane, 2.40 mL, 
2.40 mmol, 2.40 equiv), a solution of CuCN·2LiCl (1.0 M solution in THF, 2.40 mL, 2.40 
mmol, 2.40 equiv), NMP (1.8 mL) and the solution of diethyl (1R)-2-iodo-4,4-
dimethylcyclohex-2-en-1-yl phosphate (26) (388 mg, 1.0 mmol, 1.0 equiv) in THF (1 mL). 
The reaction mixture was slowly warmed up to 25 oC and stirred for 40 h. Purification by 
column chromatography (silica gel, 25% Et2O:pentane) afforded the product (R)-28d as a 
colourless oil (211 mg, 73% yield). 
 
GC (Chiraldex B-PH, 30 mm x 0.25 mm); conditions: 40 oC (2 min), ramp of 20 oC/min to 
160 oC: tR/min = 34.912 (minor), 35.911 (major); 95% ee. 
[α]D20 +70.4 (c 1.0, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ = 6.36 (t, J = 3.4 Hz, 1H), 2.53-2.44 (m, 2H), 2.14-1.78 (m, 
5H), 1.50-1.20 (m, 2H), 1.01 (s, 3H), 0.96 (s, 3H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 140.0, 121.5, 102.9, 56.8, 37.0, 32.3, 29.5, 29.3, 29.2, 28.8, 
18.9 ppm.   
IR (film): 2958 (s), 2922 (s), 2873 (s), 2246 (m), 1732 (w), 1633 (m), 1445 (m), 1427 (m), 
1388 (m), 919 (m) cm-1. 
MS (EI, 70 eV), m/z (%): 289 (M+, 1), 261 (2), 233 (8), 162 (100), 146 (9), 132 (7), 121 (31), 
106 (70), 91 (28), 79 (59), 65 (16), 53 (13). 
C11H16IN   HRMS (EI): Calcd.: 289.0327 
Found: 289.0304 
C11H16IN  Anal.  Calcd.: C 45.96, H 5.58, N 4.84 
Found: C 45.97, H 5.63, N 4.68 
 
Ethyl 3-[(1R)-2-iodo-6,6-dimethylcyclohex-2-en-1-yl]propanoate (28e) 
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I
Me Me CO2Et
 
 
Prepared according to TP 3 by using freshly prepared 2-carboethoxyethylzinc iodide47 (1.64 
M solution in THF, 0.80 mL, 1.20 mmol, 2.40 equiv), TMSCH2Li (1.0 M in pentane, 1.20 mL, 
1.20 mmol, 2.40 equiv), a solution of CuCN·2LiCl (1.0 M solution in THF, 1.20 mL, 1.20 
mmol, 2.40 equiv), NMP (1 mL) and the solution of diethyl (1R)-2-iodo-4,4-
dimethylcyclohex-2-en-1-yl phosphate (26) (194 mg, 0.50 mmol, 1.0 equiv) in THF (1 mL). 
The reaction mixture was slowly warmed up to 25 oC and stirred for 45 h. Purification by 
column chromatography (silica gel, 10% Et2O:pentane) afforded the product (R)-28e as a 
colourless oil (134 mg, 81% yield). 
 
GC (Chiraldex B-PH, 30 mm x 0.25 mm); conditions: 40 oC (2 min), ramp of 20 oC/min to 
160 oC: tR/min = 28.641 (minor), 29.421 (major); 97% ee. 
[α]D20 +62.7 (c 0.95, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ =  6.17 (t, J = 3.8 Hz, 1H), 3.99 (q, J = 7.2 Hz, 2H), 2.32-2.22 
(m, 2H), 1.98-1.76 (m, 4H), 1.74-1.60 (m, 1H), 1.40-1.26 (m, 1H), 1.16-1.04 (m, 1H), 1.12 (t, 
J = 7.2 Hz, 3H), 0.85 (s, 3H), 0.82 (s, 3H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 172.1, 135.8, 101.7, 59.0, 53.9, 33.8, 32.4, 28.9, 26.7, 26.2, 
25.7, 25.3, 12.9 ppm.   
IR (film): 2957 (m), 2922 (m), 2873 (m), 1737 (s), 1446 (m), 1367 (m), 1324 (m), 1253 (m), 
1178 (m) cm-1. 
MS (EI, 70 eV), m/z (%): 291 (5), 248 (4), 209 (100), 163 (38), 121 (47), 107 (16), 93 (22), 
79 (22), 55 (6). 
C13H21IO2  HRMS (EI): Calcd.: 337.0665 [M+H]+ 
Found: 337.0644 [M+H]+ 
 
Ethyl 4-[(1R)-2-iodo-6,6-dimethylcyclohex-2-en-1-yl]butanoate (28f) 
 
I
Me Me
CO2Et
 
 
Prepared according to TP 3 by using freshly prepared 3-carboethoxypropylzinc iodide47 (1.52 
M solution in THF, 1.60 mL, 2.40 mmol, 2.40 equiv), TMSCH2Li (1.0 M in pentane, 2.40 mL, 
2.40 mmol, 2.40 equiv), a solution of CuCN·2LiCl (1.0 M solution in THF, 2.40 mL, 2.40 
mmol, 2.40 equiv), NMP (1.8 mL) and the solution of diethyl (1R)-2-iodo-4,4-
dimethylcyclohex-2-en-1-yl phosphate (26) (388 mg, 1.0 mmol, 1.0 equiv) in THF (1 mL). 
The reaction mixture was slowly warmed up to 25 oC and stirred for 48 h. Purification by 
column chromatography (silica gel, 20% CH2Cl2:pentane) afforded the product (R)-28f as a 
colourless oil (286 mg, 82% yield). 
 
GC (Chiraldex B-PH, 30 mm x 0.25 mm); conditions: 40 oC (2 min), ramp of 20 oC/min to 
160 oC: tR/min = 38.837 (minor), 40.045 (major); 98% ee. 
[α]D20 +42.5 (c 0.80, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ =  6.19 (t, J = 3.8 Hz, 1H), 4.06 (q, J = 7.2 Hz, 2H), 2.23 (t, J 
= 7.4 Hz, 2H), 2.08-1.94 (m, 2H), 1.94-1.86 (m, 1H), 1.70-1.34 (m, 5H), 1.22-1.10 (m, 1H), 
1.18 (t, J = 7.2 Hz, 3H), 0.91 (s, 3H), 0.89 (s, 3H) ppm. 
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13C NMR (CDCl3, 75 MHz): δ = 172.5, 135.4, 103.7, 59.2, 55.1, 34.1, 33.8, 30.3, 29.3, 27.0, 
26.5, 26.0, 23.7, 13.3 ppm.   
IR (film): 2957 (m), 2921 (m), 2872 (m), 1735 (s), 1446 (m), 1368 (m), 1250 (m), 1179 (m), 
856 (m) cm-1. 
MS (EI, 70 eV), m/z (%): 351 [(M+H)+, 8], 305 (7), 223 (100), 193 (11), 177 (22), 167 (18), 
121 (11), 93 (26), 41 (22). 
C14H23IO2  Anal. Calcd.: C 48.01, H 6.62 
Found: C 47.53, H 6.97 
 
3-[(1R)-2-Iodo-6,6-dimethylcyclohex-2-en-1-yl]propyl acetate (28g) 
 
I
Me Me
OAc
 
 
Prepared according to TP 3 by using freshly prepared 3-acetoxypropylzinc iodide47 (1.59 M 
solution in THF, 1.50 mL, 2.40 mmol, 2.40 equiv), TMSCH2Li (1.0 M in pentane, 2.40 mL, 
2.40 mmol, 2.40 equiv), a solution of CuCN·2LiCl (1.0 M solution in THF, 2.40 mL, 2.40 
mmol, 2.40 equiv), NMP (1.8 mL) and the solution of diethyl (1R)-2-iodo-4,4-
dimethylcyclohex-2-en-1-yl phosphate (26) (388 mg, 1.0 mmol, 1.0 equiv) in THF (1 mL). 
The reaction mixture was slowly warmed up to 25 oC and stirred for 46 h. Purification by 
column chromatography (silica gel, 5% Et2O:pentane) afforded the product (R)-28g as a 
colourless oil (218 mg, 65% yield). 
 
GC (Chiraldex B-PH, 30 mm x 0.25 mm); conditions: 40 oC (2 min), ramp of 20 oC/min to 
160 oC: tR/min = 32.538 (minor), 33.254 (major); 97% ee. 
[α]D20 +57.6 (c 0.75, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ = 6.23 (t, J = 3.8 Hz, 1H), 4.07-3.93 (m, 2H), 2.06-1.90 (m, 
3H), 1.99 (s, 3H), 1.72-1.36 (m, 5H), 1.22-1.12 (m, 1H), 0.93 (s, 3H), 0.90 (s, 3H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 171.5, 137.0, 104.8, 65.1, 56.2, 35.5, 30.7, 28.6, 28.4, 28.3, 
28.0, 27.3, 21.4 ppm. 
IR (film): 2955 (m), 2920 (m), 2872 (m), 1741 (s), 1449 (w), 1365 (m), 1241 (s), 1043 (m) 
cm-1. 
MS (FAB), m/z (%): 337 [(M+H)+, 8], 277 (100), 248 (46), 220 (29), 149 (89). 
C13H21IO2  HRMS (EI): Calcd.: 336.0586 
Found: 336.0615 
 
2-{2-[(1R)-2-Iodo-6,6-dimethylcyclohex-2-en-1-yl]ethyl}-1,3-dioxolane (28h) 
 
I
Me Me O
O
 
 
Prepared according to TP 3 by using freshly prepared [2-(1,3-dioxolan-2-yl)ethyl]zinc 
iodide47 (1.72 M solution in THF, 1.40 mL, 2.40 mmol, 2.40 equiv), TMSCH2Li (1.0 M in 
pentane, 2.40 mL, 2.40 mmol, 2.40 equiv), a solution of CuCN·2LiCl (1.0 M solution in THF, 
2.40 mL, 2.40 mmol, 2.40 equiv), NMP (1.8 mL) and the solution of diethyl (1R)-2-iodo-4,4-
dimethylcyclohex-2-en-1-yl phosphate (26) (388 mg, 1.0 mmol, 1.0 equiv) in THF (1 mL). 
The reaction mixture was slowly warmed up to 25 oC and stirred for 41 h. Purification by 
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column chromatography (silica gel, 10% Et2O:pentane) provided the product (R)-28h as a 
colourless oil (303 mg, 90% yield). 
 
GC (Chiraldex B-PH, 30 mm x 0.25 mm); conditions: 40 oC (2 min), ramp of 20 oC/min to 
160 oC: tR/min = 42.135 (minor), 43.020 (major); 98% ee. 
[α]D20 +63.8 (c 0.95, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ =  6.23 (t, J = 3.8 Hz, 1H), 4.78 (t, J = 4.5 Hz, 1H), 3.94-3.88 
(m, 2H), 3.82-3.76 (m, 2H), 2.08-1.94 (m, 3H), 1.74-1.62 (m, 3H), 1.61-1.54 (m, 1H), 1.47-
1.40 (m, 1H), 1.18-1.14 (m, 1H), 0.93 (s, 3H), 0.91 (s, 3H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 137.1, 105.2, 104.6, 65.28, 65.22, 56.1, 35.5, 33.6, 30.7, 
28.6, 28.1, 27.4, 26.2 ppm. 
IR (film): 2955 (s), 2873 (s), 1142 (s), 1087 (m), 1038 (s), 943 (m) cm-1. 
MS (EI, 70 eV), m/z (%): 335 [(M-H)+, 8], 330 (72), 248 (51), 204 (67), 99 (69), 73 (100). 
C13H21IO2  HRMS (EI): Calcd.: 335.0508 [M-H]+ 
Found: 335.0519 [M-H]+ 
C13H21IO2  Anal.  Calcd.: C 46.44, H 6.30 
Found: C 46.75, H 6.39 
 
2-{2-[(1R)-2-Iodo-6,6-dimethylcyclohex-2-en-1-yl]ethyl}-2-methyl-1,3-dioxolane (28i) 
 
I
Me Me
Me
O O
 
 
Prepared according to TP 3 by using freshly prepared [2-(2-methyl-1,3-dioxolan-2-
yl)ethyl]zinc iodide47 (1.35 M solution in THF, 0.90  mL, 1.20 mmol, 2.40 equiv), 
TMSCH2Li (1.0 M in pentane, 1.20 mL, 1.20 mmol, 2.40 equiv), a solution of CuCN·2LiCl 
(1.0 M solution in THF, 1.20 mL, 1.20 mmol, 2.40 equiv), NMP (1.0 mL) and the  solution of 
diethyl (1R)-2-iodo-4,4-dimethylcyclohex-2-en-1-yl phosphate (26) (194 mg, 0.50 mmol, 1.0 
equiv) in THF (1 mL). The reaction mixture was slowly warmed up to 25 oC and stirred for 
48 h. Purification by column chromatography (silica gel, 10% Et2O:pentane) provided the 
product (R)-28i as a colourless oil (125 mg, 71% yield). 
 
GC (Chiraldex B-PH, 30 mm x 0.25 mm); conditions: 40 oC (2 min), ramp of 20 oC/min to 
160 oC: tR/min = 42.098 (minor), 43.023 (major); 98% ee. 
[α]D20 +62.8 (c 0.58, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ =  6.31 (t, J = 3.8 Hz, 1H), 4.02-3.92 (m, 4H), 2.18-2.04 (m, 
2H), 2.02-1.98 (m, 1H), 1.82-1.58 (m, 4H), 1.56-1.46 (m, 1H), 1.37 (s, 3H), 1.28-1.20 (m, 
1H), 1.01 (s, 3H), 0.99 (s, 3H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 136.5, 110.0, 104.6, 64.60, 64.58, 55.9, 38.1, 35.1, 30.4, 
28.2, 27.7, 27.0, 25.9, 23.6 ppm. 
IR (film): 2955 (s), 2874 (s), 1448 (m), 1376 (m), 1253 (m), 1217 (m), 1138 (m), 1056 (s), 
855 (s) cm-1. 
MS (EI, 70 eV), m/z (%): 350 (M+, 4), 248 (10), 121 (4), 99 (7), 87 (100), 79 (7). 
C14H23IO2  HRMS (EI): Calcd.: 350.0743 
Found: 350.0743 
C14H23IO2  Anal.  Calcd.: C 48.01, H 6.62 
Found: C 48.52, H 6.13 
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{2-[(1R)-2-Iodo-6,6-dimethylcyclohex-2-en-1-yl]ethyl}benzene (28j) 
 
I
Me Me
 
 
Prepared according to TP 3 by using freshly prepared 2-phenylethylzinc iodide47 (1.60 M 
solution in THF, 1.25 mL, 2.0 mmol, 2.0 equiv), TMSCH2Li (1.0 M in pentane, 2.0 mL, 2.0 
mmol, 2.0 equiv), a solution of CuCN·2LiCl (1.0 M solution in THF, 2.0 mL, 2.0 mmol, 2.0 
equiv), NMP (1.8 mL) and the solution of diethyl (1R)-2-iodo-4,4-dimethylcyclohex-2-en-1-
ylphosphate (26) (388 mg, 1.0 mmol, 1.0 equiv) in THF (2 mL). The reaction mixture was 
stirred at −30 oC for 41 h. After purification by column chromatography (silica gel, pentane), 
the product (R)-28j was obtained as a colourless oil (323 mg, 95% yield). 
 
GC (Chirasil-Dex CB, 25 mm x 0.25 mm); conditions: 60 oC (1 min), ramp of 20 oC/ min to 
160 oC; tR (min) = 29.682 (minor), 30.429 (major); 98% ee. 
[α]D20 +63 (c 0.38, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ = 7.28-7.06 (m, 5H), 6.25 (t, J = 3.54 Hz, 1H), 2.72-2.52 (m, 
2H), 2.14-1.92 (m, 3H), 1.88-1.66 (m, 2H), 1.52-1.40 (m, 1H), 1.24-1.12 (m, 1H), 0.97 (s, 
3H), 0.94 (s, 3H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 143.1, 136.9, 128.8 (2 carbons), 128.7 (2 carbons), 126.2, 
105.1, 56.3, 36.2, 35.5, 34.6, 31.0, 28.4, 28.0, 27.4 ppm. 
IR (film): 2866 (s), 2916 (s), 1495 (w), 1452 (m), 920 (m) cm-1. 
MS (EI, 70 eV), m/z (%): 340 (M+, 2), 284 (5), 236 (88), 213 (12), 157 (73), 129 (20), 109 
(33), 104 (54), 91 (100). 
C16H21I  HRMS (EI): Calcd.: 340.0688 
Found: 340.0692 
C16H21I  Anal.  Calcd.: C 56.48, H 6.22 
Found: C 56.19, H 6.10 
 
4-[(1R)-2-Iodo-6,6-dimethylcyclohex-2-en-1-yl]butan-2-one (31) 
 
I
Me Me
Me
O
 
 
The mixture of (6R)-6-(but-3-en-1-yl)-1-iodo-5,5-dimethylcyclohexene ((R)-28c) (145 mg, 
0.50 mmol), PdCl2 (46 mg, 0.26 mmol, 0.52 equiv) and CuCl2 (67 mg, 0.50 mmol, 1.0 equiv) 
in the solvent mixture of DMF (1.5 mL) and water (0.15 mL) was stirred under an oxygen 
atmosphere for 48 h at 25 oC. The reaction mixture was diluted with Et2O (25 mL) and 
washed with water. The organic phase was dried over an anhydrous Na2SO4. The solvents 
were evaporated. The residual oil was purified by column chromatography (silica gel, 10% 
Et2O:pentane) to afford the product (R)-31 as a pale yellow oil (126 mg, 82% yield). 
 
GC (Chiraldex B-PH, 30 mm x 0.25 mm); conditions: 40 oC (2 min), ramp of 20 oC/min to 
160 oC: tR/min = 23.303 (minor), 23.736 (major); 98% ee. 
[α]D20 +71 (c 0.57, CH2Cl2) 
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1H NMR (CDCl3, 300 MHz): δ = 6.26 (t, J = 3.9 Hz, 1H), 2.60-2.40 (m, 2H), 2.11 (s, 3H), 
2.09-1.80 (m, 4H), 1.71-1.60 (m, 1H), 1.48-1.35 (m, 1H), 1.24-1.14 (m, 1H), 0.94 (s, 3H), 
0.89 (s, 3H) ppm.  
13C NMR (CDCl3, 75 MHz): δ = 208.9, 137.6, 103.5, 55.5, 43.5, 35.6, 30.7, 30.3, 28.3, 28.0, 
27.4, 25.8 ppm. 
IR (film): 2956 (m), 2921 (m), 2872 (m), 1716 (s), 1429 (m), 1386 (m), 1161 (m) cm-1. 
MS (EI, 70 eV), m/z (%): 248 (20), 233 (8), 179 (100), 161 (10), 121 (45), 105 (16), 93 (34), 
79 (23), 65 (8), 55 (8). 
C12H19IO  Anal. Calcd.: C 47.07, H 6.25 
Found: C 47.16, H 6.42 
 
4-[(1R)-2,6,6-Trimethylcyclohex-2-en-1-yl]butan-2-one [(R)-dihydro-α-ionone; 32] 
 
Me
Me Me
Me
O
 
 
ZnCl2 (136 mg, 1.0 mmol) was dried by gentle heating under high vacuum. After cooling to 
25 oC under an argon atmosphere, the resulting solid was dissolved in THF (0.5 mL). The 
resulting mixture was treated with MeLi (1.40 M in Et2O, 0.70 mL, 1.0 mmol). After stirring 
at 25 oC for 15 min, the resulting solution was transferred to a flame-dried round bottom flask 
which was charged with the mixture of (R)-31 (100 mg, 0.33 mmol), Pd(dba)2 (9 mg, 17 
µmol, 5 mol%), and dppf (9 mg, 17 µmol, 5 mol%) in THF (1 mL). The reaction mixture was 
stirred at 25 oC for 24 h, then was diluted with Et2O (25 mL) and washed with water. The 
organic phase was dried over an anhydrous Na2SO4. The solvents were evaporated. The 
residual oil was purified by column chromatography (silica gel, 10% Et2O:pentane) to afford 
the product (R)-32 as a pale yellow oil (44 mg, 70% yield). 
 
GC (Chiraldex B-PH, 30 mm x 0.25 mm); conditions: 100 oC constant: tR/min = 41.143 
(minor), 45.071 (major); 98% ee. 
[α]D20 +149 (c 0.55, EtOH) 
1H NMR (CDCl3, 300 MHz): δ =  5.27 (br, s, 1H), 2.44-2.34 (m, 2H), 2.06 (s, 3H), 1.94-1.84 
(m, 2H), 1.76-1.62 (m, 1H), 1.62-1.45 (m, 4H), 1.43-1.27 (m, 2H), 1.12-1.01 (m, 1H), 0.84 (s, 
3H), 0.89 (s, 3H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 209.5, 135.9, 121.4, 89.2, 48.8, 44.1, 32.9, 31.9, 30.3, 28.0, 
24.8, 23.9, 23.3 ppm. 
IR (film): 2957 (s), 2917 (s), 2870 (s), 1716 (s), 1449 (m), 1363 (s), 1160 (m) cm-1. 
MS (EI, 70 eV), m/z (%): 194 (M+, 1), 176 (18), 161 (6), 136 (84), 121 (100), 107 (23), 95 
(97), 81 (44), 67 (20), 55 (18). 
C13H22O  HRMS (EI): Calcd.: 194.1671 
Found: 194.1654 
 
Ethyl 3-[(1R)-2,6,6-trimethylcyclohex-2-en-1-yl]propanoate (33) 
 
Me
Me Me
CO2Et
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A flame-dried round bottom flask equipped with a magnetic stirring bar, an argon inlet and a 
rubber septum was charged with ethyl 3-[(1R)-2-iodo-6,6-dimethylcyclohex-2-en-1-
yl]propanoate ((R)-28e) (347 mg, 1.03 mmol), Pd(dba)2 (30 mg, 0.05 mmol, 5 mol%), dppf 
(28 mg, 0.05 mmol, 5 mol%) and THF (2 mL). Me2Zn (2.0 M in toluene, 1.50 mL, 3.10 mmol, 
3.0 equiv) was added dropwise to the resulting suspension. The resulting mixture was stirred 
at 25 oC for 26 h. The reaction mixture was quenched by the dropwise addition of a saturated 
NH4Cl solution. The mixture was extracted with Et2O (3 x 25 mL). The combined organic 
phase was washed with water, dried over an anhydrous Na2SO4. The solvents were 
evaporated. The residual oil was purified by column chromatography (silica gel, 5% 
Et2O:pentane) to afford ethyl 3-[(1R)-2,6,6-trimethylcyclohex-2-en-1-yl]propanoate124 (33) as 
a pale yellow oil (186 mg, 81% yield). 
 
1H NMR (CDCl3, 300 MHz): δ =  5.26 (br, s, 1H), 4.04 (q, J = 7.2 Hz, 2H), 2.26 (t, J = 8.0 
Hz, 2H), 1.94-1.84 (m, 2H), 1.80-1.66 (m, 1H), 1.65-1.43 (m, 4H), 1.44-1.26 (m, 2H), 1.18 (t, 
J = 7.2 Hz, 3H), 1.11-0.99 (m, 1H), 0.85 (s, 3H), 0.80 (s, 3H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 174.4, 136.0, 121.4, 60.6, 48.9, 34.9, 33.0, 31.9, 28.0, 27.9, 
26.2, 23.8, 23.3, 14.6 ppm. 
IR (film): 2959 (m), 2871 (m), 1737 (s), 1448 (m), 1375 (m), 1256 (m), 1180 (m), 1158 (m) 
cm-1. 
MS (EI, 70 eV), 224 (M+, 38), 209 (61), 179 (17), 168 (100), 163 (26), 136 (21), 121 (61), 
107 (19), 94 (84), 81 (45). 
 
3-[(1R)-2,6,6-Trimethylcyclohex-2-en-1-yl]propanal (34) 
 
Me
Me Me
H
O
 
 
A solution of LiAlH4 (1.0 M in Et2O, 1.41 mL, 1.41 mmol, 2.0 equiv) was added dropwise to 
the solution of ethyl 3-[(1R)-2,6,6-trimethylcyclohex-2-en-1-yl]propanoate (33) (160 mg, 
0.71 mmol) in dry Et2O (2.5 mL) at 0 oC. The reaction mixture was vigorously stirred for 10 
min, then was carefully quenched with Na2SO4·10H2O. The precipitate was removed by 
filtration, and the filtrate was concentrated to afford the corresponding alcohol as a colourless 
oil. A solution of DMSO (0.11 mL) in CH2Cl2 (0.40 mL) was added dropwise to a stirred 
solution of oxalyl chloride (0.07 mL, 0.82 mmol) in CH2Cl2 (2.6 mL) under a nitrogen 
atmosphere at –60 oC. After stirring for 5 min, a solution of the alcohol obtained as described 
above in the solvent mixture of CH2Cl2:DMSO (3:1, 1.0 mL) was added dropwise. The 
reaction mixture was stirred for additional 20 min, then dry Et3N (0.50 mL, 3.56 mmol) was 
added at –60 oC and the stirring was continued for additional 10 min. The reaction mixture 
was warmed to 25 oC, and water was added. The organic layer was separated, and the aqueous 
phase was further extracted with Et2O (3 x 25 mL). The combined organic phase was washed 
with water, dried over an anhydrous Na2SO4. The solvents were evaporated. The residual oil 
was purified by column chromatography (silica gel, 5% Et2O:pentane) to afford the product 
(R)-34 as a colourless oil (117 mg, 91% yield). 
 
1H NMR (CDCl3, 200 MHz): δ = 9.74 (t, J = 1.8 Hz, 1H), 5.35 (br, s, 1H), 2.53-2.41 (m, 2H), 
2.04-1.90 (m, 2H), 1.90-1.30 (m, 7H), 1.22-1.06 (m, 1H), 0.92 (s, 3H), 0.87 (s, 3H) ppm. 
IR (film): 2955 (s), 2917 (s), 2870 (m), 1727 (s), 1450 (w) cm-1. 
                                                 
124
  Fernandez-Mateos, A.; CoCa, G. P.; Gonzalez, R. R.; Hernandez, C. T. J. Org. Chem. 1996, 61, 9097. 
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MS (EI, 70 eV), m/z (%): 180 (M+, 4), 165 (2), 147 (8), 136 (100), 121 (62), 109 (19), 93 (48), 
81 (90), 68 (42), 55 (31). 
C12H20O  HRMS (EI): Calcd.: 180.1514 
Found: 180.1519 
 
(2E)-3-[(1R)-2,6,6-Trimethylcyclohex-2-en-1-yl]acrylaldehyde 
 
Me
Me Me O
H
 
 
Phenylselenyl chloride (107 mg, 0.56 mmol, 1.30 equiv) and potassium tert-butoxide (71 mg, 
0.63 mmol) were added to the solution of the aldehyde (R)-34 (75 mg, 0.42 mmol) in THF (5 
mL) at –78 oC. The reaction mixture was stirred at –78 oC under a nitrogen atmosphere for 1 h. 
Additional potassium tert-butoxide (71 mg, 0.63 mmol) was added at –78 oC, and the reaction 
mixture was stirred at –78 oC for additional 2 h. Additional potassium tert-butoxide (141 mg, 
1.26 mmol) was added at –78 oC, and the mixture was stirred at –78 oC for additional 2 h. The 
reaction mixture was poured into a saturated NH4Cl solution and extracted with Et2O (3 x 20 
mL). The combined organic layer was washed with brine, dried over an anhydrous Na2SO4. 
The solvents were evaporated. The residual oil was purified by column chromatography 
(silica gel, 5% Et2O:pentane) to give a selenylated compound as a pale yellow oil. A 
hydrogen peroxide solution (30% solution in water, 0.05 mL) was added to the solution of the 
resulting selenylated compound obtained as described above in CH2Cl2 (4 mL). The reaction 
mixture was stirred at 25 oC for 20 min, then was treated with a saturated NaHCO3 solution, 
extracted with Et2O (3 x 25 mL). The combined organic phase was dried over an anhydrous 
MgSO4. Purification by column chromatography (silica gel, 15% Et2O:pentane) afforded 
(2E)-3-[(1R)-2,6,6-trimethylcyclohex-2-en-1-yl]acrylaldehyde as a pale yellow oil (51 mg, 
70% yield). 
 
1H NMR (CDCl3, 300 MHz): δ =  9.46 (d, J = 7.9 Hz, 1H), 6.61 (dd, J = 15.5, 9.7 Hz, 1H), 
6.04 (dd, J = 15,5, 7.9 Hz, 1H), 5.47 (br, s, 1H), 2.36 (d, J = 9.7 Hz, 1 H), 2.04-1.95 (m, 2H), 
1.53-1.48 (m, 3H), 1.46-1.33 (m, 1H), 1.24-1.13 (m, 1H), 0.88 (s, 3H), 0.81 (s, 3H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 194.2, 159.8, 134.4, 131.9, 123.5, 54.9, 33.0, 31.5, 28.2, 
27.1, 23.4, 23.1 ppm. 
IR (film): 2959 (m), 2918 (m), 1693 (s), 1450 (w), 1122 (m) cm-1. 
MS (EI, 70 eV), m/z (%): 178 (M+, 22), 163 (13), 122 (70), 107 (100), 93 (64), 79 (51), 65 (9), 
53 (10). 
C12H18O  HRMS (EI): Calcd.: 178.1358 
Found: 178.1377 
 
(3E)-4-[(1R)-2,6,6-Trimethylcyclohex-2-en-1-yl]but-3-en-2-one (α-ionone; 35) 
 
Me
Me Me O
Me
 
 
MeMgCl (2.95 M in THF, 0.12 mL) was added to a solution of (2E)-3-[(1R)-2,6,6-
trimethylcyclohex-2-en-1-yl]acrylaldehyde obtained as described above (51 mg, 0.29 mmol) 
in THF (3 mL) at 0 oC. The reaction mixture was stirred at 0 oC for 15 min under a nitrogen 
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atmosphere, then was poured into a saturated NH4Cl solution, extracted with Et2O (3 x 20 
mL). The combined organic phase was dried over an anhydrous Na2SO4.The solvents were 
evaporated to give the corresponding alcohol as colourless oil. Pyridinium dichromate (PDC) 
(219 mg, 0.58 mmol) and Celite (219 mg) were added to a solution of the resulting alcohol 
obtained as described above in DMF (3 mL). The reaction mixture was stirred at 25 oC for 16 
h under a nitrogen atmosphere. The reaction mixture was filtered. The solvents were 
evaporated then the crude material was purified by column chromatography (silica gel, 15% 
Et2O:pentane) to give the product (R)-35 as a colourless oil (48 mg, 87% yield). 
GC (Chiraldex B-PH, 30 mm x 0.25 mm); conditions: 100 oC constant: tR/min = 46.128 
(minor), 50.609 (major); 97% ee. 
[α]D20 +43 (c 0.75, CHCl3) 
1H NMR (CDCl3, 400 MHz): δ = 6.61 (dd, J = 15.9, 6.1 Hz, 1H),  6.04 (d, J = 15.9 Hz, 1H), 
5.49 (br, s, 1H), 2.32-2.23 (m, 1H), 2.25 (s, 3H), 2.08-2.00 (m, 2H), 1.58-1.54 (m, 3H), 1.50-
1.40 (m, 1H), 1.26-1.18 (m, 1H), 0.92 (s, 3H), 0.85 (s, 3H) ppm. 
13C NMR (CDCl3, 100 MHz): δ = 198.4, 149.0, 132.3, 131.9, 122.7, 54.3, 32.5, 31.2, 27.8, 
26.9, 26.8, 23.0, 22.8 ppm. 
IR (film): 2958 (m), 2918 (m), 2867 (m), 1697 (m), 1676 (s), 1620 (m), 1436 (m), 1364 (m), 
1252 (s), 988 (m) cm-1. 
MS (EI, 70 eV), m/z (%): 192 (M+, 21), 177 (10), 136 (44), 121 (100), 109 (19), 93 (60), 77 
(20). 
C13H20O  HRMS (EI): Calcd.: 192.1514 
Found: 192.1512 
 
4. Copper(I)-mediated stereoselective anti-SN2´substitution reactions and their 
convertions 
 
Ethyl 4-[(1R)-2-hex-1-yn-1-ylcyclohex-2-en-1-yl]benzoate (37) 
 
Bu
CO2Et
 
 
A flame-dried round bottom flask equipped with a magnetic stirring bar, an argon inlet and a 
rubber septum was charged with PdCl2(PPh3)2 (35 mg, 0.05 mmol), CuI (10 mg, 0.05 mmol) 
and THF (2 mL). A solution of ethyl 4-[(1R)-2-iodocyclohex-2-en-1-yl]benzoate (36) (335 
mg, 1.20 mmol, 95% ee) in THF (2 mL) was added dropwise to the resulting mixture. The 
reaction mixture was stirred at 25 oC for 5 min, then dry Et3N (304 mg, 3.0 mmol) and hex-1-
yne (90 mg, 1.10 mmol) were added consecutively. The resulting yellow solution was stirred 
at 25oC for 25 h. The reaction mixture was quenched with a saturated aqueous NH4Cl solution 
(20 mL) and extracted with Et2O (3 x 20 mL). The combined organic phase was washed with 
brine and dried over Na2SO4. Evaporation of the solvents and the purification by column 
chromatography (silica gel, Et2O:pentane, 80:1) afforded the product (R)-37 as a colourless 
oil (205 mg, 70% yield). 
 
[α]D20 +1.4 (c 0.7, CH2Cl2)  
Experimental Part  80 
1H NMR (CDCl3, 300 MHz): δ = 7.92-7.86 (m, 2H), 7.24-7.18 (m, 2H), 6.22-6.17 (m, 1H), 
4.30 (q, J = 7.1 Hz, 2H), 3.46-3.40 (m, 1H), 2.16-2.08 (m, 2H), 2.04-1.88 (m, 3H), 1.64-1.40 
(m, 4H), 1.36-1.24 (m, 2H), 1.22-1.10 (m, 2H), 1.10-0.96 (m, 2H), 0.67 (t, J = 7.2 Hz, 3H) 
ppm. 
13C NMR (CDCl3, 75 MHz): δ = 167.1, 150.8, 135.7, 129.7 (2 carbons), 128.7 (2 carbons), 
123.2, 89.5, 81.9, 61.1, 45.8, 32.4, 31.1, 28.7, 26.1, 22.0, 19.5, 19.2, 14.7, 13.9 ppm. 
IR (film): 2933 (m), 1719 (s), 1610 (m), 1275 (s), 1178 (m), 1102 (m), 1022 (m) cm-1. 
MS (EI, 70 eV), m/z (%): 310 (M+, 100), 295 (7), 281 (23), 265 (44), 253 (19), 237 (42), 225 
(12), 209 (12), 195 (43), 181 (51), 165 (72), 152 (33), 134 (28), 119 (29), 115 (29), 103 (35), 
91 (41), 77 (17). 
C21H26O2  HRMS (EI):  Calcd.: 310.1933 
Found: 310.1946 
 
Ethyl phenyl 4,4'-(1R)-cyclohex-2-ene-1,2-diyldibenzoate (38) 
 
CO2Et
O
O
 
 
A flame-dried round bottom flask equipped with a magnetic stirring bar, an argon inlet and a 
rubber septum was charged with benzoic acid 4-iodo phenyl ester (243 mg, 0.75 mmol) and 
THF (1 mL), and cooled to –20 oC. i-PrMgCl (1.45 M in THF, 0.8 mL) was added dropwise, 
and the resulting mixture was stirred at –20 oC for 30 min. A solution of ZnBr2 (1.5 M in THF, 
1.5 mL) was added dropwise to the resulting mixture. After stirring at –20 oC for 15 min, the 
reaction mixture was warmed up to 25 oC and stirred for 30 min, and then was cannulated to 
the flame-dried round bottom flask which was charged with Pd(dba)2 (14 mg, 5 mol%), dppf 
(14 mg, 5 mol%), ethyl 4-[(1R)-(2-iodocyclohex-2-en-1-yl)] benzoate (36) (178 mg, 0.50 
mmol, 95% ee) and THF (3 mL). The reaction mixture was stirred at 25 oC for 16 h, then was 
quenched with a saturated aqueous NH4Cl solution (20 mL) and extracted with Et2O (3 x 20 
mL). The combined organic phase was washed with brine and dried over Na2SO4 anhydrous. 
Evaporation of the solvents and the purification by column chromatography (silica gel, 10% 
Et2O:pentane) afforded the product (R)-38 as a white solid (160 mg, 75% yield). 
 
mp = 128 oC 
[α]D20 –95 (c 0.6, CH2Cl2)  
1H NMR (CDCl3, 300 MHz): δ = 8.10-8.04 (m, 2H), 7.88-7.82 (m, 2H), 7.58-7.50 (m, 1H), 
7.44-7.36 (m, 1H), 7.24-7.18 (m, 4H), 6.98-6.92 (m, 2H), 6.38-6.32 (m, 1H), 4.26 (q, J = 7.1 Hz, 
2H), 4.02-3.94 (m, 2H), 2.32-2.20 (m, 2H), 2.12-1.98 (m, 1H), 1.82-1.70 (m, 1H), 1.58-1.42 (m, 
2H), 1.28 (t, J = 7.1 Hz, 3H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 167.0, 165.5, 150.9, 149.9, 139.7, 137.0, 133.9 (2 carbons), 
130.5 (2 carbons), 129.9 (2 carbons), 129.0 (2 carbons), 128.9 (2 carbons), 128.7 (2 carbons), 
127.2 (2 carbons), 121.6 (2 carbons), 61.1, 43.2, 32.9, 26.4, 17.9, 14.7 ppm. 
IR (film): 2934 (m), 1731 (s), 1720 (s), 1609 (m), 1506 (m), 1275 (s), 1205 (s), 1173 (s), 1102 
(m), 1082 (m), 1065 (m), 1024 (m), 741 (s) cm-1. 
MS (EI, 70 eV), m/z (%): 426 (M+, 5), 115 (2), 106 (8), 105 (100), 78 (2), 77 (19), 51 (2). 
C28H26O4  HRMS (EI):  Calcd.: 426.1831 
Experimental Part  81 
Found: 426.1812 
C28H26O4   Anal:  Calcd.: C 78.85, H 6.14 
Found: C 78.59, H 6.25 
 
Ethyl 4-[(1S)-2-butylcyclohex-2-en-1-yl]benzoate (39) 
 
CO2Et
Me
 
 
A solution of iodobutane (0.64 g, 3.50 mmol) in THF (1.5 mL) was added to the zinc foil (690 
mg, 10.0 mmol) previously activated with 1,2-dibromoethane (79 µL) and TMSCl (49 µL) in 
THF (1 mL). The reaction mixture was heated at 40 oC for 4 h. GC–analysis of a hydrolyzed 
reaction aliquot showed the complete formation of the zinc reagent. A flame-dried round 
bottom flask was charged with Pd(dba)2 (14 mg, 0.03 mmol), dppf (14 mg, 0.03 mmol) and 
THF (1 mL). Then the solution of ethyl 4 [(1R)-(2-iodocyclohex-2-en-1-yl) benzoate (36) 
(0.18 mg, 0.50 mmol, 95% ee) in THF (2 mL) was added dropwise followed by the addition 
of freshly prepared butylzinc iodide obtained as described above (1.40 M in THF, 1.5 mL). 
The reaction mixture was heated at 67 oC for 12 h. After cooling to 25 oC, the reaction 
mixture was quenched with a saturated aqueous NH4Cl solution (20 mL) and extracted with 
Et2O (3 x 20 mL). The combined organic phase was washed with brine and dried over 
Na2SO4 anhydrous. Evaporation of the solvents and the purification by column 
chromatography (silica gel, pentane:Et2O = 100:2) afforded the product (S)-39 as a colourless 
oil (99 mg, 69% yield). 
 
[α]D20 –74 (c 1.25, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ = 7.92-7.86 (m, 2H), 7.20-7.14 (m, 2H), 5.66-5.62 (m, 1H), 
4.29 (q, J = 6.9 Hz, 2H), 3.36-3.28 (m, 1H), 2.08-1.96 (m, 2H), 1.94-1.82 (m, 1H), 1.80-1.00 (m, 
12H), 0.74 (t, J = 6.9 Hz, 3H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 165.7, 150.2, 137.0, 128.4 (2 carbons), 127.5 (2 carbons), 
127.2, 123.0, 59.7, 43.1, 34.6, 31.7, 28.9, 24.4, 21.4, 17.8, 13.4, 13.0 ppm. 
IR (film): 2930 (m), 1720 (s), 1609 (m), 1276 (s), 1177 (m), 1102 (s), 1023 (m). 
MS (EI, 70 eV), m/z (%): 286 (M+, 100), 241 (34), 229 (91), 216 (24), 215 (24), 201 (12), 171 
(39), 157 (31), 141 (32), 129 (60), 115 (28), 91 (24), 77 (14).  
C19H26O2  HRMS (EI):  Calcd.: 286.1933 
Found: 286.1915 
 
Diethyl (1S)-2-iodocyclopent-2-en-1-yl phosphate (44) 
 
I
(EtO)2(O)PO
 
 
N-Methylimidazole (0.74 mL, 9.36 mmol, 2.0 equiv) was added to the solution of (1S)-2-
iodocyclopent-2-en-1-ol (983 mg, 4.68 mmol) in dry CH2Cl2 (10 mL). The reaction mixture 
was cooled to 0 oC, and then chloro diethylphosphate (0.75 mL, 5.15 mmol, 1.10 equiv) was 
Experimental Part  82 
added dropwise. The reaction mixture was stirred at 25 oC for 6 h, then was poured into the 
pH 7 buffer, extracted with CH2Cl2 (3 x 20 mL), and dried over Na2SO4 anhydrous. After the 
evaporation of the solvents, the crude product was purified by column chromatography 
(Alumina grade III, Et2O, 0.1% Et3N) to afford the product (S)-44 as a colourless oil (1.48 g, 
91% yield). 
 
HPLC (Chiralcel OJ, heptane:i-PrOH = 99:1, 0.6 mL/min); tR (min) = 30.296 (major), 38.945 
(minor); 95% ee. 
[α]D20 –4.7 (c 1.4, CH2Cl2)  
1H NMR (CDCl3, 300 MHz): δ = 6.45-6.40 (m, 1H), 5.30-5.25 (m, 1H), 4.24-4.08 (m, 4H), 
2.60-2.48 (m, 1H), 2.43-2.26 (m, 2H), 2.17-2.06 (m, 1H), 1.39-1.31 (m, 6H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 146.4, 93.9, 88.2, 64.5, 64.3, 33.3, 31.2, 16.6, 16.5 ppm. 
IR (neat): 2983 (m), 2932 (w), 1443 (w), 1393 (w), 1265 (s), 1165 (m), 1027 (s), 989 (s), 818 
(m), 571 (w) cm-1. 
MS (EI, 70 eV), m/z (%): 219 (M+-I, 100), 209 (6), 194 (14), 192 (51), 163 (51), 155 (28), 
138 (3), 127 (24), 111 (5), 99 (37), 83 (20), 66 (22), 65 (45). 
C9H16IO4P  HRMS (EI):  Calcd.: 344.9753 [M-H]+ 
Found: 344.9747 [M-H]+ 
 
(1S)-2-Iodocyclohex-2-en-1-ol 
 
I
OH
 
 
Prepared according to TP 2 using (R)-diphenylprolinol (127 mg, 0.50 mmol, 5 mol%), THF 
(10 mL), B(OMe)3 (60 µL, 0.50 mmol, 5 mol%), borane-N,N-diethylaniline complex (1.78 
mL, 10.0 mmol, 1.0 equiv) and 2-iodocyclohex-2-en-1-one (2.22 g, 10.0 mmol) in THF (10 
mL). The reaction mixture was continuously stirred for 1 h then was carefully quenched with 
MeOH (7 mL). The crude product was purified by column chromatography (silica gel, 25% 
Et2O:pentane) to afford (1S)-2-iodocyclohex-2-en-1-ol as a colourless oil (1.94 g, 87% yield). 
 
1H NMR (CDCl3, 300 MHz): δ = 6.44 (t, J = 4.09 Hz, 1H), 4.13 (t, J = 4.92 Hz, 1H), 2.20-
1.53 (m, 7H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 141.4, 104.0, 72.5, 32.3, 29.8, 18.1 ppm. 
IR (film): 3369 (br), 2939 (s), 2862 (m), 1426 (m), 1329 (m), 1078 (m), 1051 (s), 971 (s) cm-1. 
MS (EI, 70 eV), m/z (%): 224 (M+, 36), 206 (4), 196 (17), 127 (10), 97 (100), 79 (21), 67 (13), 
55 (15). 
C6H9IO  HRMS (EI):  Calcd.: 223.9698 
Found: 223.9711 
C6H9IO   Anal:  Calcd.: C 32.17, H 4.05 
Found: C 32.06, H 3.90 
 
(1S)-2-Iodocyclohex-2-en-1-yl 2,3,4,5,6-pentafluorobenzoate (45) 
 
I
OCOC6F5
 
 
Experimental Part  83 
Pyridine (1.30 equiv, 10.4 mmol, 0.84 mL), DMAP (0.10 equiv, 0.80 mmol, 98 mg) and 
pentafluorobenzoyl chloride (1.30 equiv, 10.4 mmol, 1.50 mL) were added to the solution of 
(1S)-2-iodocyclohex-2-en-1-ol (1.79 g, 7.98 mmol) in dry Et2O (40 mL) at 25 oC. The 
reaction mixture was stirred at 25 oC for 16 h, and then was quenched with a saturated NH4Cl 
solution (20 mL) and extracted with Et2O (3 x 20 mL). The combined organic phase was 
washed with brine and dried over Na2SO4 anhydrous. The crude product was purified by 
column chromatography (silica gel, 5% Et2O:pentane) to afford the product (S)-45 as a 
colourless oil (3.27 g, 98% yield). 
 
HPLC (Chiralcel OD-H, heptane:i-PrOH = 98:2, 0.2 mL/min); tR (min) = 30.3 (minor), 33.1 
(major); 98% ee. 
[α]D20 –57 (c 1.4, CH2Cl2)  
1H NMR (CDCl3, 300 MHz): δ = 6.65 (dd, J = 4.4, 3.5 Hz, 1H), 5.65-5.55 (m, 1H), 2.22-2.10 
(m, 2H), 2.05-1.92 (m, 2H), 1.73-1.64 (m, 2H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 158.3, 147.0, 145.1, 145.0, 143.6, 141.4, 139.4, 135.9, 92.3, 
76.5, 29.9, 29.1, 16.8 ppm. 
IR (neat): 2949 (m), 1738 (s), 1652 (s), 1525 (s), 1504 (s), 1425 (m), 1341 (s), 1225 (s), 1102 
(m), 998 (s) cm-1. 
MS (EI, 70 eV), m/z (%): 292 (M+-I, 12), 291 (90), 247 (5), 206 (4), 196 (22), 195 (100), 167 
(31), 148 (3), 117 (15), 80 (8), 79 (31), 77 (17). 
C13H8F5IO2   Anal:  Calcd.: C 37.35, H 1.93 
Found: C 37.40, H 1.93 
 
2-Iodocyclohept-2-enone 
O
I
 
 
The solution of I2 (21.3 g, 4.20 equiv, 84.0 mmol) in the solvent mixture of pyridine:CCl4 (1:1, 
84 mL) was added dropwise to the solution of cyclohept-2-en-1-one (2.20 mL, 20.0 mmol) in 
the solvent mixture of pyridine:CCl4 (1:1, 84 mL) at 0 oC under a nitrogen atmosphere. The 
reaction mixture was warmed to 25 oC and stirred for 48 h. The reaction mixture was diluted 
in Et2O (200 mL), washed with H2O (100 mL), 1 M HCl (2 x 40 mL), H2O (40 mL), a 
saturated Na2S2O3 and dried over MgSO4 anhydrous. Purification by column chromatography 
(silica gel, 20% Et2O:pentane) provided 2-iodocyclohept-2-enone as a yellow oil (2.42 g, 51% 
yield).  
The analytical data were in agreement with those reported.125 
 
1H NMR (CDCl3, 300 MHz): δ = 7.60 (t, J = 6.41 Hz, 1H), 2.80-2.64 (m, 2H), 2.50-2.32 (m, 
2H), 1.90-1.74 (m, 4H) ppm. 
MS (EI, 70 eV), m/z (%): 236 (M+, 100), 207 (21). 
 
(1S)-2-Iodocyclohep-2-ten-1-ol 
I
OH
 
 
                                                 
125
 Mayasundari, A.; Young, D. G. J. Tetrahedron Lett. 2001, 42, 203. 
Experimental Part  84 
Prepared according to TP 2 using (R)-diphenylprolinol (63 mg, 0.25 mmol, 5 mol%), THF (5 
mL), B(OMe)3 (0.03 mL, 0.25 mmol, 5 mol%), borane-N,N-diethylaniline complex (0.89 mL, 
5.0 mmol, 1.0 equiv) and 2-iodocyclohept-2-en-1-one (1.18 g, 5.0 mmol) in THF (5 mL). The 
reaction mixture was continuously stirred for 1 h, and then was carefully quenched with 
MeOH (2 mL). The crude product was purified by column chromatography (silica gel, 10% 
Et2O:pentane) to afford (1S)-2-iodocyclohept-2-en-1-ol as a pale yellow oil (610 mg, 51% 
yield). 
 
GC (Chirasil-Dex CB, 25 mm x 0.25 mm); conditions: 60 oC (1 min), ramp of 2 oC/min to 
160 oC: tR/min = 40.879 (minor), 41.100 (major); 99% ee. 
[α]D20 –51 (c 0.24, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ = 6.61-6.55 (m, 1H), 4.31-4.25 (m, 1H), 2.20-1.40 (m, 9H) 
ppm. 
13C NMR (CDCl3, 75 MHz): δ = 142.9, 110.4, 77.3, 33.1, 30.8, 26.0, 24.7 ppm. 
IR (film): 3369 (br), 2939 (s), 2862 (m), 1426 (m), 1329 (m), 1078 (m), 1051 (s), 971 (s) cm-1. 
MS (EI, 70 eV), m/z (%): 238 (M+, 27), 220 (54), 196 (5), 127 (9), 111 (51), 93 (66), 77 (41), 
67 (49), 55 (100). 
C7H11IO  HRMS (EI): Calcd.: 237.9855 
Found: 237.9860 
 
(1S)-2-Iodocyclohept-2-en-1-yl 2,3,4,5,6-pentafluorobenzoate (46) 
 
I
OCOC6F5
 
 
Pyridine (1.30 equiv, 0.26 mL, 3.25 mmol), DMAP (0.10 equiv, 30 mg, 0.25 mmol) and 
pentafluorobenzoyl chloride (1.30 equiv, 0.47 mL, 3.25 mmol) were added to the solution of 
(1S)-2-iodocyclohept-2-en-1-ol (595 mg, 2.50 mmol) in dry Et2O (13 mL) at 25 oC. The 
resulting suspension was stirred at 25 oC for 16 h. The reaction mixture was poured into a 
saturated NH4Cl solution (20 mL), extracted with Et2O (3 x 20 mL). The combined organic 
phase was washed with brine and dried over Na2SO4 anhydrous. The crude product was 
purified by column chromatography (silica gel, 2% Et2O:pentane) to afford the product (S)-
46 as a pale yellow oil (941 mg, 87% yield). 
 
GC (Chirasil-Dex CB, 25 mm x 0.25 mm); conditions: 60 oC (1 min), ramp of 2 oC/min to 
160 oC: tR/min = 61.867 (minor), 62.530 (major); 98% ee. 
[α]D20 –68 (c 0.36, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ = 6.74 (t, J = 6.69 Hz, 1H), 5.78-5.70 (m, 1H), 2.26-1.50 (m, 
8H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 158.4, 148.0, 147.6, 145.5, 144.2, 139.8, 136.5, 108.5, 97.3, 
83.1, 30.9, 30.4, 26.1, 24.3 ppm. 
IR (film): 2937 (s), 2864 (m), 1736 (s), 1652 (s), 1524 (s), 1499 (s), 1452 (m), 1422 (m), 
1332 (s), 1227 (s), 1006 (s), 945 (m) cm-1. 
MS (EI, 70 eV), m/z (%): 305 (M+-I, 22), 195 (100), 167 (5), 117 (2), 93 (6), 77 (4). 
C14H10F5IO2  HRMS (EI): Calcd.: 305.0601 [M-I]+ 
Found: 305.0585 [M-I]+ 
 
(1R)-2-Iodocyclohex-2-en-1-yl acetate (47) 
Experimental Part  85 
I
OAc
 
 
Acetic anhydride (3.5 mL) was added to a solution of (1R)-2-iodocyclohex-2-en-1-ol (1.48 g, 
6.61 mmol) in pyridine (5.9 mL) at 25 oC. The reaction mixture was stirred at 25 oC for 2 h, 
then was diluted with Et2O, washed with 2 M HCl (50 mL), H2O, a saturated aqeous NaHCO3 
solution, brine and dried over Na2SO4 anhydrous. The crude product was purified by column 
chromatography (10% Et2O:pentane) to give the product (R)-47 as a colourless oil (1.61 g, 91% 
yield). 
 
GC (TFA gamma-cyclodextrin); conditions: 40 oC (2 min), ramp of 20 oC/ min to 150 oC; 
tR(min) = 10.24 (major), 11.04 (minor); 98% ee. 
[α]D20 +22 (c 1.08, CHCl3) 
1H NMR (CDCl3, 300 MHz): δ = 6.65-6.64 (m, 1H), 5.40-5.39 (m, 1H), 2.11 (s, 3H), 2.11-
1.70 (m, 6H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 170.5, 143.9, 95.8, 73.8, 30.3, 29.5, 21.6, 17.8 ppm. 
IR (film): 2944 (w), 1735 (s), 1427 (w), 1371 (m), 1233 (s), 977 (m), 917 (w), 730 (w) cm-1. 
MS (EI, 70 eV), m/z (%): 206 (M-AcO-H+, 4), 139 (85), 126 (15), 97 (100 ), 79 (47), 55 (4). 
C8H11I O2 Anal.:  Calcd.: C 36.11, H 4.17 
Found: C 36.38, H 4.06 
 
(5S)-1-Iodo-5-pentylcyclopent-1-ene (48a) 
 
I
Me
 
 
Prepared according to TP 4 by using diethyl (1S)-2-iodocyclopent-2-en-1-yl phosphate (44) 
(95% ee, 346 mg, 1.0 mmol), THF (1.6 mL), the dipentylzinc solution (5.70 M in THF, 0.40 
mL, 2.24 mmol, 2.24 equiv), a CuCN·2LiCl solution (1.0 M in THF, 2.24 mL, 2.24 mmol, 
2.24 equiv) and NMP (1.3 mL). The reaction mixture was warmed to –10 oC and stirred for 
15 h. After purification by column chromatography (silica gel, pentane), the cyclopentenyl 
iodide (S)-48a was obtained as a colourless oil (253 mg, 96% yield). 
 
GC (Chirasil-Dex CB, 25 mm x 0.25 mm); conditions: 60 oC (1 min), ramp of 5 oC/ min to 
160 oC; tR(min) = 16.296 (major), 16.446 (minor); 94% ee. 
[α]D20 +13 (c 0.31, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ = 6.10-6.00 (m, 1H), 2.68-2.47 (m, 1H), 2.35-2.10 (m, 2H), 
2.08-1.90 (m, 2H), 1.68-1.42 (m, 3H), 1.40-0.98 (m, 5H), 0.92-0.75 (m, 3H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 139.6, 102.6, 52.4, 34.9, 33.7, 32.4, 28.7, 26.6, 23.0, 14.5 
ppm. 
IR (film): 2956 (s), 2926 (s), 2854 (s), 1466 (m), 1378 (w) cm-1. 
MS (EI, 70 eV), m/z (%): 264 (M+, 45), 194 (37), 193 (38), 137 (21), 95 (21), 81 (43), 67 (96), 
66 (100). 
C10H17I  HRMS (EI): Calcd.: 264.0375 
Found: 264.0382 
 
(6S)-1-Iodo-6-isopropylcyclohex-1-ene (48b) 
Experimental Part  86 
I
Me
Me
 
 
Prepared according to TP 4 by using (1R)-2-iodocyclohex-2-en-1-yl 2,3,4,5,6-
pentafluorobenzoate ((R)-45) (98% ee, 2.09 g, 5.0 mmol), THF (8 mL), a CuCN·2LiCl solution 
(1.0 M in THF, 11.2 mL, 11.2 mmol, 2.24 equiv), NMP (7 mL) and the diisopropylzinc solution 
(5.10 M in THF, 2.20 mL, 11.2 mmol, 2.24 equiv). The reaction mixture was warmed to –10 oC 
and stirred for 16 h. Purification by column chromatography (silica gel, pentane) afforded the 
product (S)-48b as a colourless oil (1.21 g, 97% yield). 
The separation of the enantiomers was not possible under a variety of conditions in chiral 
HPLC or capillary GC. The enantiomeric excess was determined for the corresponding ketone 
(S)-52b. 
 
[α]D20 –79 (c 1.12, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ = 6.60-6.45 (m, 1H), 2.32-2.17 (m, 2H), 2.08-1.94 (m, 2H), 
1.80-1.63 (m, 2H), 1.61-1.47 (m, 2H), 0.96 (d, J = 6.6 Hz, 3H), 0.75 (d, J = 6.6 Hz, 3H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 140.4, 109.0, 48.7, 32.2, 29.7, 23.6, 21.3, 20.4, 15.5 ppm. 
IR (film): 2959 (s), 2859 (s), 1682 (w), 1464 (m), 1386 (w), 1368 (w), 1030 (w), 1003 (w), 
805 (w), 692 (w) cm-1. 
MS (EI, 70 eV), m/z (%): 250 (M+, 91), 208 (30), 123 (68), 79 (100), 67 (23). 
C9H15I  HRMS (EI): Calcd.: 250.0218 
Found: 250.0214 
 
(6R)-1-Iodo-6-pentylcyclohex-1-ene (48c) 
 
I
Me
 
 
Prepared according to TP 4 by using (1R)-2-iodocyclohex-2-en-1-yl 2,3,4,5,6-
pentafluorobenzoate ((R)-45) (98% ee, 418 mg, 1.0 mmol), THF (1.6 mL), a CuCN·2LiCl 
solution (1.0 M in THF, 2.24 mL, 2.24 mmol, 2.24 equiv), NMP (1.3 mL) and the 
dipentylzinc solution (5.70 M in THF, 0.40 mL, 2.24 mmol, 2.24 equiv). The reaction mixture 
was warmed to –10 oC and stirred for 16 h. Purification by column chromatography (silica gel, 
pentane) afforded the product (R)-48c as a colourless oil (250 mg, 90% yield). 
 
GC (Chirasil-Dex CB, 25 mm x 0.25 mm); conditions: 40 oC (1 min), ramp of 20 oC/ min to 
160 oC; tR(min) = 9.535 (minor), 9.625 (major); 99% ee. 
[α]D20 –2.3 (c 1.12, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ = 6.40-6.30 (m, 1H), 2.31-2.19 (m, 1H), 2.10-1.93 (m, 2H), 
1.87-1.51 (m, 5H), 1.45-1.10 (m, 7H), 0.94-0.75 (m, 3H) ppm.  
13C NMR (CDCl3, 75 MHz): δ = 138.2, 107.3, 44.9, 34.6, 31.8, 29.6, 28.1, 26.4, 22.6, 18.4, 
14.1 ppm. 
IR (film): 2929 (s), 2857 (s), 1683 (w), 1456 (m), 961 (w) cm-1. 
MS (EI, 70 eV), m/z (%): 278 (M+, 38), 208 (26), 151 (16), 109 (17), 95 (96), 91 (10), 81 
(100), 77 (21), 69 (11), 67 (39), 55 (12). 
C11H19I  HRMS (EI): Calcd.: 278.0531 
Found: 278.0503 
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(6S)-6-Cyclohexyl-1-iodocyclohex-1-ene (48d) 
 
I
 
 
Prepared according to TP 5 by using (1R)-2-iodocyclohex-2-en-1-yl 2,3,4,5,6-
pentafluorobenzoate ((R)-45) (98% ee, 418 mg, 1.0 mmol), THF (1.6 mL), a CuCN·2LiCl 
solution (1.0 M in THF, 2.24 mL, 2.24 mmol, 2.24 equiv), NMP (1.3 mL) and cyclohexylzinc 
iodide (1.96 M in toluene, 1.14 mL, 2.24 mmol, 2.24 equiv). The reaction mixture was warmed 
to –10 oC and stirred for 16 h. Purification by column chromatography (silica gel, pentane) 
afforded the product (S)-48d as a colourless oil (261 mg, 90% yield). 
The separation of the enantiomers was not possible under a variety of conditions in chiral 
HPLC or capillary GC. The enantiomeric excess was determined for the corresponding ketone 
(S)-52d. 
 
[α]D20 –76 (c 1.12, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ = 6.55-6.40 (m, 1H), 2.32-2.12 (m, 1H), 2.09-0.84 (m, 17H) 
ppm. 
13C NMR (CDCl3, 75 MHz): δ = 140.3, 108.6, 48.6, 43.1, 31.2, 29.7, 27.1, 26.7, 26.6, 26.5, 
25.2, 21.4 ppm. 
IR (film): 1925 (s), 2851 (s), 1448 (m), 986 (w) cm-1. 
MS (EI, 70 eV), m/z (%): 290 (M+, 51), 208 (100), 163 (24), 121 (2), 105 (3), 91 (12), 83 (56), 
81 (63), 79 (41), 67 (12), 55 (44). 
C12H19I  HRMS (EI): Calcd.: 290.0531 
Found: 290.0505 
 
{2-[(1S)-2-Iodocyclohex-2-en-1-yl]ethyl}benzene (48e) 
 
I
 
 
Prepared according to TP 5 by using (1R)-2-iodocyclohex-2-en-1-yl 2,3,4,5,6-
pentafluorobenzoate ((R)-45) (98% ee, 418 mg, 1.0 mmol), NMP (1.1 mL), 2-phenylethylzinc 
iodide (1.60 M in THF, 1.25 mL, 2.0 mmol, 2.0 equiv) and a CuCN·2LiCl solution (1.0 M in 
THF, 2.0 mL, 2.0 mmol, 2.0 equiv). The reaction mixture was slowly warmed up to 25 oC and 
stirred for 48 h. Purification by column chromatography (silica gel, pentane) afforded the 
product (S)-48e as a colourless oil (266 mg, 85% yield). 
 
GC (Chirasil-Dex CB, 25 mm x 0.25 mm); conditions: 60 oC (1 min), ramp of 20 oC/ min to 
160 oC; tR (min) = 25.323 (minor), 25.960 (major); 99% ee. 
[α]D20 –3.1 (c 0.36, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ = 7.28-7.06 (m, 5H), 6.34 (dt, J = 1.55, 3.90 Hz, 1H), 2.72-
2.60 (m, 1H), 2.54-2.40 (m, 1H), 2.34-2.22 (m, 1H), 2.10-1.94 (m, 3H), 1.88-1.74 (m, 1H), 
1.74-1.48 (m, 4H) ppm. 
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13C NMR (CDCl3, 75 MHz): δ = 142.5, 139.2, 128.8 (2 carbons), 128.7 (2 carbons), 126.2, 
106.8, 44.8, 36.8, 33.3, 30.0, 28.5, 19.1 ppm. 
IR (film): 2933 (s), 2858 (m), 1496 (m), 1454 (m), 1327 (w) cm-1. 
MS (EI, 70 eV), m/z (%): 312 (M+, 7), 208 (22), 185 (100), 156 (4), 143 (16), 129 (12), 117 
(32), 104 (54), 91 (73), 79 (21). 
C14H17I  HRMS (EI): Calcd.: 312.0375 
Found: 312.0382 
 
{[(1S)-2-Iodocyclohex-2-en-1-yl]methyl}benzene (48f) 
 
I
 
 
Prepared according to TP 5 by using (1S)-2-iodocyclohex-2-en-1-yl 2,3,4,5,6-
pentafluorobenzoate ((R)-45) (98% ee, 418 mg, 1.0 mmol), NMP (1.2 mL), benzylzinc iodide 
(0.81 M in THF, 2.50 mL, 2.0 mmol, 2.0 equiv) and a CuCN·2LiCl solution (1.0 M in THF, 1.0 
mL, 1.0 mmol, 1.0 equiv). The reaction mixture was warmed up to 25 oC and stirred for 5 days. 
Purification by column chromatography (silica gel, pentane) afforded the product (S)-48f as a 
colourless oil (149 mg, 50% yield). 
 
GC (Chirasil-Dex CB, 25 mm x 0.25 mm); conditions: 60 oC (1 min), ramp of 205 oC/ min to 
160 oC; tR (min) = 17.395 (minor), 17.803 (major); 91% ee. 
[α]D20 +12 (c 0.34, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ = 7.26-7.16 (m, 2H), 7.16-7.08 (m, 3H), 6.36 (dt, J = 1.22, 
4.09 Hz, 1H), 3.20 (dd, J = 2.34, 13.11 Hz, 1H), 2.54-2.44 (m, 1H), 2.37 (dd, J = 2.34, 13.11 
Hz, 1H), 2.07-1.95 (m, 2H), 1.66-1.41 (m, 4H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 140.7, 139.4, 129.5 (2 carbons), 128.7 (2 carbons), 126.5, 
106.1, 47.8, 41.0, 30.0, 27.6, 17.9 ppm. 
IR (film): 2930 (m), 1494 (m), 1452 (m), 964 (m), 739 (s) cm-1. 
MS (EI, 70 eV), m/z (%): 298 (M+, 61), 206 (50), 171 (100), 129 (14), 115 (9), 91 (90), 79 
(39). 
C13H15I  HRMS (EI): Calcd.: 298.0218 
Found: 298.0224 
 
(6R)-6-(But-3-en-1-yl)-1-iodocyclohex-1-ene (48g) 
 
I
 
 
Prepared according to TP 5 by using (1S)-2-iodocyclohex-2-en-1-yl 2,3,4,5,6-
pentafluorobenzoate ((S)-45) (98% ee, 836 mg, 2.0 mmol), NMP (2.2 mL), but-3-en-1-ylzinc 
iodide (2.11 M in THF, 2.12 mL, 4.48 mmol, 2.24 equiv) and a CuCN·2LiCl solution (1.0 M in 
THF, 4.48 mL, 4.48 mmol, 2.40 equiv). The reaction mixture was warmed up to 25 oC and 
stirred for 66 h. Purification by column chromatography (silica gel, pentane) afforded the 
product (R)-48g as a colourless oil (445 mg, 85% yield). 
 
GC (Chirasil-Dex CB, 25 mm x 0.25 mm); conditions: 60 oC (1 min), ramp of 5 oC/ min to 
160 oC; tR (min) = 17.665 (major), 17.955 (minor); 98% ee. 
[α]D20 –2.1 (c 0.34, CH2Cl2) 
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1H NMR (CDCl3, 300 MHz): δ = 6.32 (dt, J = 1.44, 4.09 Hz, 1H), 5.84-5.66 (m, 1H), 5.04-
4.86 (m, 2H), 2.32-2.18 (m, 1H), 2.18-2.04 (m, 1H), 2.02-1.88 (m, 3H), 1.88-1.66 (m, 2H), 
1.66-1.46 (m, 3H), 1.42-1.28 (m, 1H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 139.0, 138.8, 115.2, 107.0, 44.6, 34.2, 31.3, 30.0, 28.3, 18.8 
ppm. 
IR (film): 2931 (m), 1449 (m), 1327 (m), 992 (m), 959 (m), 908 (s) cm-1. 
MS (EI, 70 eV), m/z (%): 262 (M+, 3), 220 (100), 208 (15), 135 (32), 107 (5), 93 (34), 79 (33), 
67 (10). 
C10H15I  HRMS (EI): Calcd.: 262.0218 
Found: 262.0219 
 
(7R)-7-Cyclohexyl-1-iodocyclohep-1-tene (48h) 
 
I
 
 
Prepared according to TP 5 by using (1S)-2-iodocyclohep-2-ten-1-yl 2,3,4,5,6-
pentafluorobenzoate ((S)-46) (98% ee, 432 mg, 1.0 mmol), NMP (1.3 mL), cyclohexylzinc 
iodide (1.01 M in THF, 1.98 mL, 2.0 mmol, 2.0 equiv) and a CuCN·2LiCl solution (1.0 M in 
THF, 2.0 mL, 2.0 mmol, 2.0 equiv). The reaction mixture was warmed to –10 oC and stirred for 
16 h. Purification by column chromatography (silica gel, pentane) afforded the product (R)-48h 
as a colourless oil (264 mg, 87 % yield). 
The separation of the enantiomers was not possible under a variety of conditions in chiral 
HPLC or capillary GC. The enantiomeric excess was determined for the corresponding ketone 
(R)-52i. 
 
[α]D20 –19 (c 0.31, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ = 6.60-6.50 (m, 1H), 2.58-2.48 (m, 1H), 2.30-2.16 (m, 1H), 
2.10-2.00 (m, 1H), 1.96-1.52 (m, 11H), 1.48-1.10 (m, 5H), 0.96-0.80 (m, 1H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 141.8, 107.4, 59.6, 39.3, 32.4, 30.7, 30.4, 27.2, 26.9 (2 
carbons), 26.71, 26.68, 25.5 ppm. 
IR (film): 2922 (s), 2850 (s), 1446 (s) cm-1. 
MS (EI, 70 eV), m/z (%): 304 (M+, 32), 222 (44), 177 (13), 121 (6), 95 (100), 83 (47). 
C13H21I  HRMS (EI): Calcd.: 304.0688 
Found: 304.0702 
 
 [(1R)-2-Iodo-2-cyclohexen-1-yl]benzene (48i) 
 
I
 
 
According to TP 6, the suspension of CuCN (108 mg, 1.20 mmol, 1.20 equiv) in THF (2 mL) 
was treated with PhMe2CCH2Li (0.50 M in Et2O, 5.0 mL, 2.40 mmol, 2.0 equiv). A solution 
of phenyl iodide (245 mg, 1.20 mmol, 1.20 equiv) in THF (2 mL) was added to the resulting 
solution of (PhMe2CCH2)2Cu(CN)Li. After the completion of I/Cu-exchange, a solution of 
(1R)-2-iodocyclohex-2-en-1-yl acetate (47) (98% ee, 266 mg, 1.0 mmol) in THF (1.5 mL) 
was added dropwise. The reaction mixture was stirred at –40 oC for 5 days. After purification 
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by column chromatography (silica gel, pentane), the cyclohexenyl iodide (R)-48i was 
obtained as a colourless oil (171 mg, 60% yield). 
GC (Chirasil-Dex CB, 25 mm x 0.25 mm); conditions: 60 oC (2 min), ramp of 20 oC/ min to 
160 oC; tR(min) = 12.453 (major), 12.701 (minor); 93% ee. 
[α]D20 +4.2 (c 0.24, Et2O) 
1H NMR (CDCl3, 300 MHz): δ = 7.35-7.00 (m, 5H), 6.62-6.56 (m, 1H), 3.70-3.56 (br, s, 1H), 
2.16-2.00 (m, 3H), 1.80-1.66 (m, 1H), 1.66-1.50 (m, 2H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 144.5, 140.6, 128.7 (3 carbons), 127.0 (2 carbons), 101.7, 
53.0, 34.1, 29.7, 18.2 ppm. 
IR (film): 2935 (s), 1492 (m), 1451 (m), 986 (m), 700 (s) cm-1. 
MS (EI, 70 eV), m/z (%): 284 (M+, 100), 206 (38), 157 (41), 129 (55), 115 (30), 91 (47), 77 
(13). 
C12H13I  HRMS (EI): Calcd.: 284.0062 
Found: 284.0035 
 
1-[(1R)-2-Iodo-2-cyclohexen-1-yl]-4-methoxybenzene (48j) 
 
I
OMe
 
 
According to TP 6, the suspension of CuCN (54 mg, 0.60 mmol, 1.20 equiv) in THF (1 mL) 
was treated with PhMe2CCH2Li (0.50 M in Et2O, 2.40 mL, 1.20 mmol, 2.0 equiv). A solution 
of 4-iodoanisole (140 mg, 0.60 mmol, 1.20 equiv) in THF (1 mL) was added to the resulting 
solution of (PhMe2CCH2)2Cu(CN)Li. After the completion of I/Cu-exchange, a solution of 
(1R)-2-iodocyclohex-2-en-1-yl acetate (47) (98% ee, 133 mg, 0.50 mmol) in THF (0.75 mL) 
was added dropwise. The reaction mixture was stirred at –30 oC for 42 h. After purification by 
column chromatography (silica gel, 2% Et2O:pentane), the cyclohexenyl iodide (R)-48j was 
obtained as a colourless oil (141 mg, 90% yield). 
 
GC (Chirasil-Dex CB, 25 mm x 0.25 mm); conditions: 60 oC (1 min), ramp of 20 oC/ min to 
160 oC; tR(min) = 27.756 (major), 28.758 (minor); 98% ee. 
[α]D20 +15 (c 1.04, CH2Cl2) 
1H NMR (CDCl3, 300 MHZ): δ = 7.04 (d, J = 8.4 Hz, 2H), 6.79 (d, J = 8.4 Hz, 2H), 6.56 (m, 
1H), 3.73 (s, 3H), 3.57 (m, 1H), 2.12-1.54 (m, 6H) ppm. 
13C NMR (CDCl3, 75 MHZ): δ = 158.7, 140.4, 136.7 (2 carbons), 129.7 (2 carbons), 114.1, 
102.5, 55.6, 52.2, 34.1, 29.7, 18.2 ppm. 
IR (film): 2933 (s), 2832 (s), 1610 (s), 1510 (s), 1463 (s), 1302 (m), 1249 (s), 1176 (s), 1036 
(s), 828 (m), 602 (w) cm-1. 
MS (EI, 70 eV), m/z (%): 314 (M+, 100), 286 (4), 208 (18), 187 (31), 171 (10), 159 (24), 144 
(22), 121 (43), 108 (23), 77 (11). 
C13H15IO  HRMS (EI): Calcd.: 314.0168 
Found: 314.0150 
 
[(1S)-2-Iodo-6,6-dimethylcyclohex-2-en-1-yl]benzene (48k) 
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Me Me
I
 
 
n-BuLi (1.60 M in hexane, 3.30 mL, 5.25 mmol, 1.05 equiv) was added dropwise to a 
solution of phenyl iodide (0.56 mL, 5.0 mmol, 5.0 equiv) in Et2O (4 mL) at –78 oC, and then 
the reaction mixture was stirred for 10 min at –78 oC. A CuI·2LiCl solution (1.0 M in THF, 
5.0 mL, 5.0 mmol, 5.0 equiv) and LiBr (130 mg, 1.50 equiv) were added to the resulting PhLi 
solution. The reaction mixture was stirred at 0 oC for 10 min, and then the solvents were 
removed under high vacuum. A CH2Cl2 (2 mL) was added and the reaction mixture was 
stirred for 5 min at 0 oC. After the removal of CH2Cl2, additional CH2Cl2 (10 mL) was added 
and the mixture was cooled to –78 oC. TMSCl (0.06 mL, 0.50 equiv) and a CH2Cl2 (1 mL) 
solution of (1R)-4,4-dimethyl-2-iodocyclohex-2-en-1-yl diethylphosphate (26) (99% ee, 388 
mg, 1.0 mmol) were added. The reaction mixture was warmed to 0 oC and stirred for 5 days. 
A saturated aqueous NH4Cl solution (20 mL) was added followed by 25% aqueous NH3 
solution (1 mL). The reaction mixture was stirred at 25 °C until the copper salts had dissolved, 
then was extracted with Et2O (3 x 20 mL). The combined organic phase was washed with 
brine and dried over Na2SO4 anhydrous. Evaporation of the solvents and the purification by 
column chromatography (silica gel, pentane) afforded the product (S)-48k as a colourless oil.  
 
GC (Chirasil-Dex CB, 25 mm x 0.25 mm); conditions: 40 oC (2 min), ramp of 20 oC/ min to 
160 oC; tR(min) = 15.239 (major), 15.435 (minor); 96% ee. 
[α]D20 +171 (c 0.26, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ = 7.28-7.16 (m, 3H), 7.14-7.05 (m, 2H), 6.49 (t, J = 3.87 Hz, 
1H), 3.23 (s, 1H), 2.23-2.14 (m, 2H), 1.60-1.42 (m, 1H), 1.22-1.12 (m, 1H), 1.08 (s, 3H), 0.53 
(s, 3H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 148.1, 145.1, 135.4 (2 carbons), 134.8, 134.5 (2 carbons), 
108.9, 72.2, 43.3, 36.9, 36.8, 35.5, 34.7 ppm. 
IR (film): 2925 (m), 1452 (m), 937 (m), 745 (s), 700 (s) cm-1. 
MS (EI, 70 eV), m/z (%): 312 (M+, 63), 256 (100), 185 (7), 155 (5), 129 (67), 91 (8). 
C14H17I  HRMS (EI): Calcd.: 312.0375 
Found: 312.0360 
 
Diethyl (1S)-2-iodocyclohex-2-en-1-yl phosphate (49) 
 
I
OP(O)(OEt)2
 
 
N-Methylimidazole (0.95 mL, 12.0 mmol, 2.40 equiv) was added to the solution of (1S)-2-
iodocyclohex-2-en-1-ol (1.12 g, 5.0 mmol) in dry Et2O (9 mL). The reaction mixture was 
cooled to 0 oC, and then diethyl chlorophosphate (1.74 mL, 12.0 mmol, 2.40 equiv) was 
added dropwise. The reaction mixture was stirred at 25 oC for 16 h, then was quenched with a 
saturated NaCl solution (20 mL) and extracted with Et2O (3 x 20 mL). The combined organic 
phase was dried over Na2SO4 anhydrous. The crude product was purified by column 
chromatography (silica gel, 50% Et2O:pentane) to afford the product (S)-49 as a colourless oil 
(1.53 g, 85% yield). 
HPLC (Chiralcel OJ, heptane:i-PrOH = 99:1, 0.6 mL/min); tR (min) = 21.16 (major), 25.51 
(minor); 94% ee. 
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1H NMR (CDCl3, 300 MHz): δ = 6.61 (t, J = 4.0 Hz, 1 H), 4.89-4.73 (m, 1H), 4.24-4.03 (m, 
4H), 2.21-1.91 (m, 4 H), 1.82-1.63 (m, 2 H), 1.37-1.29 (m, 6 H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 144.3, 95.6, 78.4, 64.6, 64.2, 31.5, 29.6, 18.7, 16.8, 16.5 
ppm. 
IR (film): 1273 (s), 1033 (s), 988 (s) cm-1. 
MS (EI, 70 eV), m/z (%): 356 (1), 315 (1), 233 (100), 205 (24), 177 (30), 155 (12), 127 (15), 
99 (47), 79 (50), 67 (3). 
C10H18IO4P   HRMS (EI): Calcd.: 359.9987 
Found: 359.9977 
 
(2S)-2-Pentylcyclopentanone (52a) 
 
O
Me
 
 
a) Prepared according to TP 7 from (5S)-1-iodo-5-pentylcyclopent-1-ene (48a) (250 mg, 0.95 
mmol), THF (7.6 mL), t-BuLi (1.45 M in pentane, 1.31 mL, 1.90 mmol, 2.0 equiv), (TMSO)2 
(neat, 0.31 mL, 1.43 mmol, 1.50 equiv). The resulting silyl enol ether in THF (3.9 mL) was 
treated with a HF·pyridine complex (70%) (0.04 mL, 0.95 mmol) in dry pyridine (0.8 mL). 
After purification by column chromatography (silica gel, 10% Et2O:pentane), the ketone (S)-
52a was obtained as a colourless oil (102 mg, 70% yield). 
b) Prepared according to TP 8 from (5S)-1-iodo-5-pentylcyclopent-1-ene (48a) (132 mg, 0.50 
mmol), THF (4 mL), t-BuLi (1.60 M in pentane, 0.63 mL, 1.0 mmol), B(OMe)3 (neat, 0.14 
mL, 1.25 mmol, 2.50 equiv) and a suspension of NaBO3·4H2O (10.0 equiv, 769 mg, 5.0 mmol) 
in H2O (6 mL). After purification by column chromatography (silica gel, 10% Et2O:pentane), 
the ketone (S)-52a was obtained as a colourless oil (69 mg, 90% yield). 
The separation of the enantiomers was not possible under a variety of conditions in chiral 
HPLC or capillary GC. The enantiomeric excess was determined for the corresponding 
lactone (see below). 
 
1H NMR (CDCl3, 300 MHz): δ = 2.30-1.87 (m, 6H), 1.85-1.60 (m, 2H), 1.55-1.38 (m, 1H), 
1.35-1.10 (m, 6H), 0.90-0.75 (m, 3H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 221.9, 49.5, 38.5, 32.1, 30.0 (2 carbons), 27.6, 22.9, 21.1, 
14.4 ppm. 
IR (film): 2959 (m), 2930 (m), 2858 (m), 1739 (s), 1454 (w), 1154 (m) cm-1. 
MS (EI, 70 eV), m/z (%): 154 (M+, 7), 112 (1), 111 (1), 97 (13), 84 (100), 69 (4), 55 (9). 
C10H18O  HRMS (EI): Calcd.: 154.1358 
Found: 154.1362 
 
(6S)-6-Pentyltetrahydro-2H-pyran-2-one 
 
O
O
Me
 
 
MMPP (396 mg, 0.80 mmol, 2.0 equiv) and NaHCO3 (67 mg, 0.80 mmol, 2.0 equiv) were 
added to a solution of (2S)-2-pentylcyclopentanone (52a) (62 mg, 0.40 mmol) in a solvent 
mixture of MeOH:H2O (1:1, 3.2 mL) at 25 oC. The reaction mixture was stirred at 25 oC for 
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18 h. The reaction mixture was poured into a saturated NH4Cl solution, extracted with Et2O (3 
x 20 mL). The combined organic phase was washed with brine and dried over Na2SO4 
anhydrous. The crude product was purified by column chromatography (silica gel, 50% 
Et2O:pentane) to give the lactone as a colourless oil (67 mg, 99% yield). 
 
GC (Chiralsil-Dex CB, 25 mm x 0.25 mm); conditions: 60 oC (1 min), ramp of 0.5 oC/ min to 
160 oC; tR (min) = 116.883 (major), 117.466 (minor); 93 % ee. 
1H NMR (CDCl3, 300 MHz): δ = 4.27-4.15 (m, 1H), 2.58-2.45 (m, 1H), 2.44-2.29 (m, 1H), 
1.94-1.12 (m, 12H), 0.92-0.74 (m, 3H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 172.4, 81.0, 36.2, 32.0, 29.8, 28.2, 25.0, 22.9, 18.9, 14.3 
ppm. 
IR (film): 2932 (s), 1738 (s), 1464 (m), 1245 (s), 1052 (m), 1036 (m) cm-1. 
MS (EI, 70 eV), m/z (%): 170 (M+, 1), 152 (3), 134 (2), 114 (12), 99 (100), 71 (41), 55 (26). 
C10H18O2  HRMS (EI):  Calcd.: 171.1385 [M+H]+ 
Found: 171.1383 [M+H]+ 
 
(2S)-2-Isopropylcyclohexanone (52b) 
 
O
Me
Me
 
 
a) Prepared according to TP 7 from (6S)-1-iodo-6-isopropylcyclohexene (48b) (125 mg, 0.50 
mmol), THF (4 mL), t-BuLi (1.60 M in pentane, 0.63 mL, 1.0 mmol), (TMSO)2 (neat, 0.16 
mL, 0.75 mmol, 1.50 equiv). The resulting silyl enol ether in THF (2 mL) was treated with a 
HF·pyridine complex (70%) (0.02 mL, 0.50 mmol) in dry pyridine (0.4 mL). After 
purification by column chromatography (silica gel, 10% Et2O:pentane), the ketone (S)-52b 
was obtained as a colourless oil (65 mg, 93% yield, 94% ee). 
The deprotection of the corresponding silyl enol ether by using a TBAF solution: A TBAF 
solution (1.0 M in THF, 0.50 mL, 1.0 equiv) was added dropwise to the solution of the crude 
silyl enol ether (0.5 mmol) in THF (2 mL) at 0 oC. The reaction mixture was stirred at 0 oC for 
1 h then was poured into water, extracted with Et2O (3 x 25 mL). The combined organic 
phase was washed with brine and dried over MgSO4 anhydrous. After purification by column 
chromatography (silica gel, 10% Et2O:pentane), the ketone (S)-52b was obtained as a 
colourless oil (86% yield, 65% ee). 
b) Prepared according to TP 8 from (6S)-1-iodo-6-isopropylcyclohexene (48b) (125 mg, 0.50 
mmol), THF (4 mL), t-BuLi (1.60 M in pentane, 0.63 mL, 1.0 mmol), B(OMe)3 (neat, 0.14 
mL, 1.25 mmol, 2.50 equiv) and a suspension of NaBO3·4H2O (10.0 equiv, 769 mg, 5.0 mmol) 
in H2O (6 mL). After purification by column chromatography (silica gel, 10% Et2O:pentane), 
the ketone (S)-52b was obtained as a colourless oil (63 mg, 90% yield, 97% ee). 
 
GC (Chirasil-Dex CB, 25 mm x 0.25 mm); conditions: 40 oC (1 min), ramp of 5 oC/ min to 
150 oC; tR(min) = 15.141 (minor), 15.196 (major). 
[α]D20 –58 (c 0.24, MeOH) 
1H NMR (CDCl3, 300 MHz): δ = 2.36-1.40 (m, 10 H), 0.83 (d, J = 2.88 Hz, 3 H), 0.81 (d, J = 
2.88 Hz, 3 H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 213.8, 57.6, 42.4, 29.5, 28.3, 26.7, 24.6, 21.4, 19.4 ppm. 
IR (film): 2935 (s), 2867 (m), 1709 (s), 1448 (w), 1121 (w) cm-1. 
MS (EI, 70 eV), m/z (%): 140 (M+, 27), 125 (37), 111 (8), 98 (100), 83 (34), 69 (39), 55 (47). 
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C9H16O  HRMS (EI): Calcd.: 140.1201 
Found: 140.1197 
 
(2R)-2-Pentylcyclohexanone (52c) 
 
O
Me
 
 
Prepared according to TP 7 from (6R)-1-iodo-6-pentylcyclohexene (48c) (278 mg, 1.0 mmol), 
THF (8 mL), t-BuLi (1.60 M in pentane, 1.25 mL, 2.0 mmol), (TMSO)2 (neat, 0.32 mL, 1.50 
mmol). The resulting silyl enol ether in THF (4 mL) was treated with a HF·pyridine complex 
(70%) (0.04 mL, 1.0 mmol) in dry pyridine (0.8 mL). After purification by column 
chromatography (silica gel, 10% Et2O:pentane), the ketone (R)-52c was obtained as a 
colourless oil (153 mg, 91% yield, 97% ee). 
 
GC (Chirasil-Dex CB, 25 mm x 0.25 mm); conditions: 40 oC (1 min), ramp of 4 oC/ min to 
150 oC; tR (min) = 23.818 (minor), 23.911 (major). 
[α]D20 –22 (c 1, MeOH) 
1H NMR (CDCl3, 300 MHz): δ = 2.37-2.12 (m, 3H), 2.09-1.85 (m, 2H), 1.84-1.50 (m, 4H), 
1.39-1.05 (m, 8H), 0.80-0.75 (m, 3H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 213.9, 51.1, 42.3, 34.2, 32.3, 29.7, 28.4, 27.2, 25.2, 22.9, 
14.4 ppm. 
IR (film): 2931 (s), 2859 (m), 1712 (s), 1449 (m), 1378 (w), 1312 (w), 1122 (w) cm-1. 
MS (EI, 70 eV), m/z (%): 168 (M+, 6), 158 (1), 139 (1), 135 (1), 125 (1), 111 (13), 98 (100), 
83 (18), 70 (15), 55 (15). 
C11H20O  HRMS (EI): Calcd.: 168.1514 
Found: 168.1516 
 
(2S)-2-Cyclohexylcyclohexanone (52d) 
 
O
 
 
Prepared according to TP 7 from (6S)-6-cyclohexyl-1-iodocyclohexene (48d) (290 mg, 1.0 
mmol), THF (8 mL), t-BuLi (1.60 M in pentane, 1.25 mL, 2.0 mmol), (TMSO)2 (neat, 0.32 
mL, 1.50 mmol). The resulting silyl enol ether in THF (4 mL) was treated with a HF·pyridine 
complex (70%) (0.04 mL, 1.0 mmol) in dry pyridine (0.8 mL). After purification by column 
chromatography (silica gel, 10% Et2O:pentane), the ketone (S)-52d was obtained as a 
colourless oil (158 mg, 88% yield, 98% ee). 
 
GC (Chirasil-Dex CB, 25 mm x 0.25 mm); conditions: 40 oC (1 min), ramp of 2 oC/ min to 
150 oC; tR(min) = 49.300 (major), 49.691 (minor). 
[α]D20 –61 (c 0.4, MeOH) 
1H NMR (CDCl3, 300 MHz): δ = 2.31-2.07 (m, 2H), 2.02-1.90 (m, 1H), 1.88-1.34 (m, 12H), 
1.26-0.68 (m, 5H) ppm. 
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13C NMR (CDCl3, 75 MHz): δ = 214.0, 56.9, 42.2, 36.4, 31.9, 29.73, 29.67, 28.3, 26.86 (2 
carbons), 26.79, 24.4 ppm. 
IR (film): 2925 (s), 2852 (s), 1709 (s), 1449 (m), 1129 (w) cm-1. 
MS (EI, 70 eV), m/z (%): 180 (M+, 1), 137 (3), 123 (2), 98 (100), 83 (15), 67 (11), 55 (11). 
C12H20O  HRMS (EI): Calcd.: 180.1514 
Found: 180.1513 
 
(2R)-2-Phenylcyclohexanone (52e) 
 
O
 
 
Prepared according to TP 7 from [(1R)-2-iodocyclohex-2-en-1-yl]benzene (48i) (85 mg, 0.30 
mmol), THF (2.4 mL), t-BuLi (1.60 M in pentane, 0.38 mL, 0.60 mmol, 2.0 equiv), (TMSO)2 
(neat, 0.1 mL, 0.45 mmol, 1.50 equiv). The resulting silyl enol ether in THF (1.2 mL) was 
treated a with HF·pyridine complex (70%) (0.012 mL, 0.30 mmol) in dry pyridine (0.4 mL). 
After purification by column chromatography (silica gel, 10% Et2O:pentane), the ketone (R)-
52e was obtained as a colourless oil (37 mg, 71% yield, 86% ee). 
 
GC (Chirasil-Dex CB, 25 mm x 0.25 mm); conditions: 60 oC (2 min), ramp of 2 oC/ min to 
160 oC; tR (min) = 44.795 (minor), 44.945 (major). 
[α]D20 +68 (c 0.284, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ = 7.27-7.18 (m, 2H), 7.17-7.10 (m, 1H), 7.07-6.99 (m, 2H), 
3.50 (dd, J = 5.25, 11.7 Hz, 1H), 2.47-2.27 (m, 2H), 2.23-2.10 (m, 1H), 2.10-1.97 (m, 1H), 
1.97-1.81 (m, 2H), 1.80-1.63 (m, 2H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 210.6, 139.1, 128.9 (2 carbons), 128.7 (2 carbons), 127.3, 
57.8, 42.6, 35.5, 28.2, 25.7 ppm. 
IR (film): 2948 (m), 2930 (m), 1701 (s), 1499 (w), 1446 (m), 1309 (w), 1126 (m), 758 (m), 
701 (m) cm-1. 
MS (EI, 70 eV), m/z (%): 174 (M+, 42), 130 (100), 117 (52), 104 (33), 91 (28), 78 (10), 65 (5), 
51 (6). 
C12H14O  HRMS (EI): Calcd.: 174.1045 
Found: 174.1055 
 
(2R)-2-(4-Methoxyphenyl)cyclohexanone (52f) 
 
O OMe
 
 
Prepared according to TP 7 from 1-[(1R)-2-iodocyclohex-2-en-1-yl]-4-methoxybenzene (48j) 
(146 mg, 0.46 mmol), THF (4 mL), t-BuLi (1.45 M in pentane, 0.63 mL, 0.92 mmol, 2.0 
equiv), (TMSO)2 (neat, 0.15 mL, 0.69 mmol, 1.50 equiv). The resulting silyl enol ether in 
THF (3 mL) was treated with a HF·pyridine complex (70%) (0.02 mL, 0.46 mmol, without 
additional pyridine). After recrystalization (Et2O), the ketone (R)-52f was obtained as a white 
solid (76 mg, 81% yield, 86% ee). 
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HPLC (Chiralcel OD-H, heptane:i-PrOH = 90:10, 0.6 mL/min); tR (min) = 15.71 (minor), 
18.75 (major). 
mp = 64.6-66.7 oC 
[α]D20 +15 (c 0.26, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ = 7.02-6.93 (m, 2H), 6.84-6.74 (m, 2H), 3.70 (s, 3H), 3.47 
(dd, J = 5.7, 11.7 Hz, 1H), 2.50-2.28 (m, 2H), 2.23-2.11 (m, 1H), 2.10-1.98 (m, 1H), 1.98-
1.82 (m, 2H), 1.82-1.63 (m, 2H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 211.0, 158.8, 131.2, 129.8 (2 carbons), 114.2 (2 carbons), 
57.0, 55.6, 42.6, 35.7, 28.2, 25.8 ppm. 
IR (film): 2949 (m), 2927 (m), 1705 (s), 1615 (w), 1516 (s), 1448 (w), 1254 (s), 1180 (m), 
1124 (m), 1032 (m), 829 (m), 812 (m) cm-1. 
MS (EI, 70 eV), m/z (%): 204 (M+, 59), 176 (17), 160 (14), 147 (100), 134 (28), 121 (34), 91 
(24), 77 (11), 65 (9). 
C13H16O2  HRMS (EI): Calcd.: 204.1150 
Found: 204.1132 
 
 (2R)-3,3-Dimethyl-2-pentylcyclohexanone (52g) 
 
O
Me
Me
Me
 
 
a) Prepared according to TP 7 from (6R)-5,5-dimethyl-1-iodo-6-pentylcyclohexene (28a) 
(129 mg, 0.42 mmol), THF (4 mL), t-BuLi (1.45 M in pentane, 0.58 mL, 2.0 equiv), (TMSO)2 
(neat, 0.14 mL, 0.63 mmol, 1.50 equiv). The resulting silyl enol ether in THF (2 mL) was 
treated with a HF·pyridine complex (70%) (0.017 mL, 0.42 mmol) in dry pyridine (0.35 mL). 
After purification by column chromatography (silica gel, 10% Et2O:pentane), the ketone (R)-
52g was obtained as a colourless oil (69 mg, 84% yield, 93% ee). 
b) Prepared according to TP 8 from (6R)-5,5-dimethyl-1-iodo-6-pentylcyclohexene (28a) 
(153 mg, 0.50 mmol), THF (4 mL), t-BuLi (1.60 M in pentane, 0.63 mL, 1.0 mmol), B(OMe)3 
(neat, 0.14 mL, 1.25 mmol, 2.50 equiv) and a suspension of NaBO3·4H2O (10.0 equiv, 769 
mg, 5.0 mmol) in H2O (6 mL). After purification by column chromatography (silica gel, 10% 
Et2O:pentane), the ketone (R)-52g was obtained as a colourless oil (84 mg, 86% yield, 98% 
ee). 
 
GC (Chirasil-Dex CB, 25 mm x 0.25 mm); conditions: 60 oC (1 min), ramp of 10 oC/ min to 
160 oC; tR (min) = 10.991 (minor), 11.080 (major). 
[α]D20 –23 (c 0.41, Et2O) 
1H NMR (CDCl3, 300 MHz): δ = 2.27-2.05 (m, 2H), 2.00-1.90 (m, 1H), 1.83-1.63 (m, 2H), 
1.62-1.40 (m, 3H), 1.25-1.05 (m, 6H), 1.04-0.83 (m, 4H), 0.82-0.70 (m, 3H), 0.66 (s, 3H) 
ppm. 
13C NMR (CDCl3, 75 MHz): δ = 212.2, 59.6, 39.2, 37.9, 36.9, 30.4, 27.6, 27.0, 22.7, 21.5, 
21.1, 20.9, 12.4 ppm. 
IR (film): 2956 (s), 2872 (m), 1711 (s), 1460 (m), 1369 (w), 1261 (w), 1079 (w) cm-1. 
MS (EI, 70 eV), m/z (%): 196 (M+, 1), 181 (12), 153 (3), 139 (4), 126 (18), 111 (100), 83 (3), 
69 (7). 
C13H24O  HRMS (EI): Calcd.: 196.1827 
Found: 196.1831 
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(2S)-3,3-Dimethyl-2-phenylcyclohexanone (52h) 
 
O
Me
Me
 
 
Prepared according to TP 7 from (6S)-5,5-dimethyl-1-iodo-6-phenylcyclohexene (48k) (156 
mg, 0.50 mmol), THF (4 mL), t-BuLi (1.45 M in pentane, 0.69 mL, 1.0 mmol, 2.0 equiv), 
(TMSO)2 (neat, 0.16 mL, 0.75 mmol, 1.50 equiv). The resulting silyl enol ether in THF (2 mL) 
was treated with a HF·pyridine complex (70%) (0.02 mL, 0.50 mmol) in dry pyridine (0.4 
mL). After recrystalization (Et2O), the ketone (S)-52h was obtained as a white solid (70 mg, 
69% yield, 93% ee). 
 
GC (Chirasil-Dex CB, 25 mm x 0.25 mm); conditions: 40 oC (2 min), ramp of 20 oC/ min to 
160 oC; tR (min) = 13.120 (major), 13.441 (minor). 
mp = 68.8-71.5 oC 
[α]D20 –123 (c 0.24, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ = 7.29-7.16 (m, 3H), 7.16-7.08 (m, 2H), 3.41 (s, 1H), 2.48-
2.28 (m, 2H), 2.00-1.62 (m, 4H), 0.85 (s, 3H), 0.78 (s, 3H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 209.9, 135.3, 131.5 (2 carbons), 127.8 (2 carbons), 127.2, 
67.8, 41.8, 41.2, 41.0, 31.0, 22.9, 22.5 ppm.  
IR (film): 2959 (m), 2929 (m), 1702 (s), 1494 (w), 1456 (w), 1365 (m), 1173 (m), 1076 (m) 
cm-1. 
MS (EI, 70 eV), m/z (%): 202 (M+, 100), 146 (17), 133 (71), 118 (21), 98 (42), 91 (19), 69 
(22). 
C14H18O  HRMS (EI): Calcd.: 202.1358 
Found: 202.1352 
 
(2R)-2-Cyclohexylcycloheptanone (52i) 
 
O
 
 
a) Prepared according to TP 7 from (7R)-7-cyclohexyl-1-iodocycloheptene (48h) (152 mg, 
0.50 mmol), THF (4 mL), t-BuLi (1.60 M in pentane, 0.63 mL, 1.0 mmol, 2.0 equiv), 
(TMSO)2 (neat, 0.16 mL, 0.75 mmol, 1.50 equiv). The resulting silyl enol ether in THF (2 mL) 
was treated with a HF·pyridine complex (70%) (0.02 mL, 0.50 mmol) in dry pyridine (0.4 
mL). After purification by column chromatography (silica gel, 10% Et2O:pentane), the ketone 
(R)-52i was obtained as a colourless oil (74 mg, 76% yield, 97% ee). 
b) Prepared according to TP 8 from (7R)-7-cyclohexyl-1-iodocycloheptene (48h) (122 mg, 
0.4 mmol), THF (3.2 mL), t-BuLi (1.60 M in pentane, 0.50 mL, 0.80 mmol), B(OMe)3 (neat, 
0.11 mL, 1.0 mmol, 2.50 equiv) and a suspension of NaBO3·4H2O (10.0 equiv, 615 mg, 4.0 
mmol) in H2O (4.8 mL). After purification by column chromatography (silica gel, 10% 
Et2O:pentane), the ketone (R)-52i was obtained as a colourless oil (47 mg, 60% yield, 97% 
ee). 
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GC (Chirasil-Dex CB, 25 mm x 0.25 mm); conditions: 60 oC (1 min), ramp of 2 oC/ min to 
160 oC; tR (min) = 44.308 (minor), 44.411 (major). 
[α]D20 +87 (c 0.284, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ = 2.45 (dt, J = 2.88, 12.0 Hz, 1H), 2.32-2.21 (m, 1H), 2.19-
2.07 (m, 1H), 1.94-1.72 (m, 4H), 1.71-1.38 (m, 7H), 1.38-1.00 (m, 6H), 1.00-0.80 (m, 2H) 
ppm. 
13C NMR (CDCl3, 75 MHz): δ = 217.5, 59.6, 43.1, 40.9, 31.7, 30.5, 30.3, 28.2, 28.1, 26.76 (2 
carbons), 26.73, 26.0 ppm. 
IR (film): 2924 (s), 2852 (s), 1702 (s), 1450 (s), 1342 (m), 1323 (m), 1166 (m), 936 (m) cm-1. 
MS (EI, 70 eV), m/z (%): 194 (M+, 1), 151 (3), 123 (3), 112 (100), 97 (11), 84 (14), 67 (8). 
C13H22O  HRMS (EI): Calcd.: 194.1671 
Found: 194.1740 
 
(2S)-2-(2-Phenylethyl)cyclohexanone (52j) 
 
O
 
 
Prepared according to TP 8 from {2-[(1S)-2-iodocyclohex-2-en-1-yl]ethyl}benzene (48e) (156 
mg, 0.50 mmol, 1.0 equiv), THF (4 mL), t-BuLi (1.60 M in pentane, 0.63 mL, 1.0 mmol, 2.0 
equiv),
 
B(OMe)3 (neat, 0.14 mL, 1.25 mmol, 2.50 equiv) and a suspension of NaBO3·4H2O 
(769 mg, 5.0 mmol, 10.0 equiv) in H2O (6 mL). After purification by column chromatography 
(silica gel, 10% Et2O:pentane), the ketone (S)-52j was obtained as a colourless oil (62 mg, 61% 
yield, 95% ee). 
 
GC (Chirasil-Dex CB, 25 mm x 0.25 mm); conditions: 60 oC (1 min), ramp of 2 oC/ min to 
160 oC; tR (min) = 50.501 (minor), 50.712 (major). 
[α]D20 –6.4 (c 0.28, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ = 7.24-7.16 (m, 2H), 7.14-7.06 (m, 3H), 2.56 (t, J = 7.85 Hz, 
2H), 2.38-2.28 (m, 1H), 2.28-2.14 (m, 2H), 2.14-2.02 (m, 2H), 2.02-1.92 (m, 1H), 1.84-1.72 
(m, 1H), 1.70-1.48 (m, 2H), 1.48-1.28 (m, 2H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 213.5, 142.5, 128.8 (2 carbons), 128.7 (2 carbons), 126.2, 
50.3, 42.5, 34.4, 33.6, 31.6, 28.4, 25.3 ppm. 
IR (film): 2931 (m), 1705 (s), 1449 (m), 1128 (m), 748 (m), 698 (s) cm-1. 
MS (EI, 70 eV), m/z (%): 202 (M+, 6), 129 (1), 117 (3), 104 (9), 98 (100), 91 (9), 83 (8), 70 
(8), 65 (4). 
C14H18O  HRMS (EI): Calcd.: 202.1358 
Found: 202.1369 
 
(2S)-2-Benzylcyclohexanone (52k) 
 
O
 
 
Prepared according to TP 8 from {[(1S)-2-iodocyclohex-2-en-1-yl]methyl}benzene (48f) (87 
mg, 0.29 mmol, 1.0 equiv), THF (2.3 mL), t-BuLi (1.60 M in pentane, 0.40 mL, 0.58 mmol, 
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2.0 equiv),
 
B(OMe)3 (neat, 0.08 mL, 0.73 mmol, 2.50 equiv) and a suspension of 
NaBO3·4H2O (446 mg, 2.90 mmol, 10.0 equiv) in H2O (3.5 mL). After purification by 
column chromatography (silica gel, 10% Et2O:pentane), the ketone (S)-52k was obtained as a 
colourless oil (25 mg, 45% yield, 55% ee). 
 
GC (Chirasil-Dex CB, 25 mm x 0.25 mm); conditions: 60 oC (1 min), ramp of 2 oC/ min to 
160 oC; tR (min) = 45.702 (minor), 46.003 (major). 
[α]D20 –20 (c 0.24, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ = 7.25-7.15 (m, 2H), 7.15-7.04 (m, 3H), 3.16 (dd, J = 4.64, 
13.71 Hz, 1H), 2.55-2.41 (m, 1H), 2.41-2.18 (m, 3H), 2.05-1.89 (m, 2H), 1.81-1.70 (m, 1H), 
1.69-1.42 (m, 2H), 1.37-1.17 (m, 1H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 212.9, 140.8, 129.5 (2 carbons), 128.7 (2 carbons), 126.3, 
52.9, 42.5, 35.9, 33.8, 28.4, 25.4 ppm. 
IR (film): 2933 (m), 1705 (s), 1495 (m), 1448 (m), 1128 (m), 731 (s), 698 (s) cm-1. 
MS (EI, 70 eV), m/z (%): 188 (M+, 99), 159 (25), 145 (17), 131 (18), 117 (26), 104 (13), 97 
(35), 91 (100), 78 (9), 65 (11). 
C13H16O  HRMS (EI): Calcd.: 188.1201 
Found: 188.1214 
 
 (2R)-2-But-3-enylcyclohexanone (52l) 
 
O
 
 
Prepared according to TP 8 from (6R)-6-(but-3-en-1-yl)-1-iodocyclohexene (48g) (131 mg, 
0.50 mmol, 1.0 equiv), THF (4 mL), t-BuLi (1.60 M in pentane, 0.63 mL, 1.0 mmol, 2.0 
equiv),
 
B(OMe)3 (neat, 0.14 mL, 1.25 mmol, 2.50 equiv) and a suspension of NaBO3·4H2O 
(769 mg, 5.0 mmol, 10.0 equiv) in H2O (6 mL). After purification by column chromatography 
(silica gel, 10% Et2O:pentane), the ketone (R)-52l was obtained as a colourless oil (35 mg, 
46% yield, 90% ee). 
 
GC (Chirasil-Dex CB, 25 mm x 0.25 mm); conditions: 60 oC (1 min), ramp of 5 oC/ min to 
160 oC; tR (min) = 13.799 (major), 13.955 (minor). 
[α]D20 +15 (c 0.26, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ = 5.80-5.62 (m, 1H), 5.00-4.84 (m, 2H), 2.37-2.15 (m, 3H), 
2.10-1.71 (m, 6H), 1.69-1.50 (m, 2H), 1.40-1.12 (m, 2H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 213.6, 138.9, 115.1, 50.2, 42.4, 34.2, 31.6, 28.9, 28.4, 25.3 
ppm. 
IR (film): 2931 (m), 1708 (s), 1448 (m), 1126 (m), 995 (m), 908 (s) cm-1. 
MS (EI, 70 eV), m/z (%): 152 (M+, 8), 123 (1), 111 (2), 98 (100), 83 (18), 70 (23), 67 (9), 55 
(13). 
C10H16O  HRMS (EI): Calcd.: 152.1201 
Found: 152.1196 
 
(2R)-3,3-Dimethyl-2-isopropylcyclohexanone (52m) 
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O
Me
Me
Me
Me
 
 
Prepared according to TP 8 from (6R)-5,5-dimethyl-1-iodo-6-isopropylcyclohexene (28b) 
(139 mg, 0.50 mmol, 1.0 equiv), THF (4 mL), t-BuLi (1.60 M in pentane, 0.63 mL, 1.0 mmol, 
2.0 equiv),
 
B(OMe)3 (neat, 0.14 mL, 1,25 mmol, 2.50 equiv) and a suspension of 
NaBO3·4H2O (769 mg, 5.0 mmol, 10.0 equiv) in H2O (6 mL). After purification by column 
chromatography (silica gel, pentane), the ketone (R)-52m was obtained as a colourless oil (47 
mg, 56% yield, 98% ee). 
 
GC (Chirasil-Dex CB, 25 mm x 0.25 mm); conditions: 60 oC (1 min), ramp of 5 oC/ min to 
160 oC; tR (min) = 13.746 (major), 13.908 (minor). 
[α]D20 +112 (c 0.26, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ = 2.28-2.23 (m, 2H), 2.06-1.94 (m, 1H), 1.92-1.87 (br, d, J = 
6.2 Hz, 1H), 1.85-1.75 (m, 2H), 1.75-1.65 (m, 1H), 1.44-1.36 (m, 1H), 1.03 (d, J = 6.78 Hz, 
3H), 1.01 (s, 3H), 0.94 (s, 3H), 0.93 (d, J = 6.78 Hz, 3H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 215.0, 67.4, 41.5, 38.8, 37.3, 29.6, 27.6, 26.8, 25.1, 22.5, 
21.6 ppm. 
IR (film): 2957 (m), 1704 (s), 1462 (m), 1388 (m), 1370 (w), 1222 (w), 1071 (w) cm-1. 
MS (EI, 70 eV), m/z (%): 168 (M+, 26), 153 (25), 135 (11), 125 (27), 111 (100), 98 (18), 83 
(20), 69 (23), 55 (16). 
C11H20O  HRMS (EI): Calcd.: 168.1514 
Found: 168.1525 
 
(2R)-3,3-Dimethyl-2-(2-phenylethyl)cyclohexanone (52n) 
 
O
Me
Me
 
 
Prepared according to TP 8 from {2-[(1R)-2-iodo-6,6-dimethylcyclohex-2-en-1-
yl]ethyl}benzene (28j) (170 mg, 0.50 mmol, 1.0 equiv), THF (4 mL), t-BuLi (1.60 M in 
pentane, 0.63 mL, 1.0 mmol, 2.0 equiv),
 
B(OMe)3 (neat, 0.14 mL, 1,25 mmol, 2.50 equiv) and 
a suspension of NaBO3·4H2O (769 mg, 5.0 mmol, 10.0 equiv) in H2O (6 mL). After 
purification by column chromatography (silica gel, 10% Et2O:pentane), the ketone (R)-52n 
was obtained as a colourless oil (75 mg, 65% yield, 97% ee). 
 
GC (Chirasil-Dex CB, 25 mm x 0.25 mm); conditions: 60 oC (1 min), ramp of 2 oC/ min to 
160 oC; tR (min) = 52.226 (minor), 52.735 (major). 
[α]D20 –9 (c 0.3, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ = 7.26-7.16 (m, 2H), 7.16-7.06 (m, 3H), 2.70-2.56 (m, 1H), 
2.36-2.12 (m, 3H), 2.08 (br, d, J = 10.62 Hz, 1H), 2.03-1.64 (m, 3H), 1.62-1.44 (m, 3H), 0.93 
(s, 3H), 0.69 (s, 3H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 213.6, 142.8, 128.8 (2 carbons), 128.7 (2 carbons), 126.1, 
60.6, 41.8, 40.1, 39.6, 35.3, 29.8, 26.4, 23.6, 22.4 ppm. 
IR (film): 2956 (w), 1705 (s), 1455 (w), 746 (m), 698 (s) cm-1. 
MS (EI, 70 eV), m/z (%): 230 (M+, 1), 126 (28), 111 (100), 104 (3), 91 (9), 77 (1), 69 (3). 
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C16H22O  HRMS (EI): Calcd.: 230.1671. 
Found: 230.1684. 
C16H22O  Anal.  Calcd.: C 83.43, H 9.63 
Found: C 83.10, H 9.69 
 
2-Iodo-3-methylcyclopent-2-en-1-one (55) 
 
I
Me
O
 
 
Prepared according to TP 1 from 3-methylcyclopent-2-en-1-one (4.90 mL, 50.0 mmol), 
CH2Cl2 (300 mL), PDC (5.64 g, 15.0 mmol) and I2 (12.7 g, 50.0 mmol). The crude product 
was purified by column chromatography (silica gel, 10% Et2O:pentane) to afford the product 
55 as a white solid (6.16 g, 55% yield). 
The data were in agreement with those reported.126 
mp = 44.6-46.9 oC 
1H NMR (CDCl3, 300 MHz): δ = 2.75-2.66 (m, 2H), 2.56-2.48 (m, 2H), 2.16 (s, 3H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 204.0, 180.2, 103.0, 34.70, 33.58, 22.49 ppm. 
IR (film): 1695 (s), 1600 (s), 1426 (m), 1259 (m), 1156 (m) cm-1. 
MS (EI, 70 eV), m/z (%): 222 (M+, 100), 207 (4), 179 (3), 166 (2), 95 (13), 67 (22), 65 (6), 41 
(17). 
C6H7IO HRMS (EI): Calcd.: 221.9542 
Found: 221.9536 
 
(1S)-2-Iodo-3-methylcyclopent-2-en-1-ol (56) 
 
I
Me
OH
 
 
Prepared according to TP 2 from (R)-diphenylprolinol (253 mg, 1.0 mmol, 5 mol%), THF (20 
mL), B(OMe)3 (0.12 mL, 1.0 mmol, 5 mol%), borane-N,N-diethylaniline complex (3.56 mL, 
20.0 mmol, 1.0 equiv) and the solution of 2-iodo-3-methylcyclopent-2-en-1-one (55) (4.44 g, 
20.0 mmol) in THF (20 mL). The reaction mixture was continuously stirred for 1 h then was 
carefully quenched with MeOH (9 mL). The crude product was purified by column 
chromatography (silica gel, 25% Et2O:pentane) to afford the product (S)-56 as a white solid 
(3.0 g, 67% yield). 
GC (Chirasil Dex CB, 25 mm x 0.25 mm); conditions: 60 oC (1 min), ramp of 20 oC/min to 
160 oC: tR/min = 6.868 (major), 6.960 (minor); 96% ee. 
mp = 92.6-94.6 oC 
[α]D20 –16 (c 0.5, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ = 4.68-4.58 (m, 1H), 2.54-2.38 (m, 1H), 2.36-2.16 (m, 2H), 
1.94-1.76 (m, 2H), 1.75 (s, 3H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 148.7, 99.0, 83.2, 35.6, 32.3, 19.6 ppm. 
IR (film): 3401 (s), 2936 (s), 1435 (m), 1102 (m), 1056 (m), 1008 (m) cm-1. 
                                                 
126
  Shipe, W. D.; Sorensen, E. J. Org. Lett. 2002, 4, 2063. 
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MS (EI, 70 eV), m/z (%): 224 (M+, 64), 208 (6), 127 (5), 97 (100), 79 (16), 67 (8), 53 (12). 
C6H9IO HRMS (EI): Calcd.: 223.9698 
Found: 223.9696 
C6H9IO Anal.  Calcd.: C 32.17, H 4.05 
Found: C 32.40, H 3.81 
 
(1S)-2-Iodo-3-methylcyclopent-2-en-1-yl 2,3,4,5,6-pentafluorobenzoate (57) 
 
I
Me
OCOC6F5
 
 
Pyridine (1.30 equiv, 0.53 mL, 6.50 mmol), DMAP (0.10 equiv, 61 mg, 0.50 mmol) and 
pentafluorobenzoyl chloride (1.30 equiv, 0.94 mL, 6.50 mmol) were added to the solution of 
(1S)-2-iodo-3-methylcyclopent-2-en-1-ol (56) (1.12 g, 5.0 mmol) in dry Et2O (30 mL) at 25 
oC. The resulting suspension was stirred at 25 oC for 3 h. The reaction mixture was poured 
into a saturated NH4Cl solution (20 mL), extracted with Et2O (3 x 20 mL). The combined 
organic phase was washed with brine and dried over Na2SO4 anhydrous. The crude product 
was purified by column chromatography (silica gel, 5% Et2O:pentane) to afford the product 
(S)-57 as a pale yellow solid (1.78 g, 85% yield). 
 
HPLC (Chiralcel OD-H; heptane:i-PrOH = 95:5, 0.5 mL/min): tR/min = 10.402 (major), 
11.204 (minor); 97% ee.  
mp = 38.8-40.4 oC 
[α]D20 –6.8 (c 0.5, CH2Cl2) 
1H NMR (CDCl3, 600 MHz): δ = 5.98-5.89 (m, 1H), 2.60-2.41 (m, 2H), 2.37-2-24 (m, 1H), 
2.06-1.93 (m, 1H), 1.86-1.78 (m, 3H) ppm. 
13C NMR (CDCl3, 150 MHz): δ = 159.1, 154.0, 147.3, 144.0, 141.8, 139.8, 136.4, 108.9, 89.2, 
88.5, 35.7, 30.7, 19.7 ppm. 
IR (film): 1723 (s), 1650 (m), 1493 (s), 1322 (s), 986 (s) cm-1. 
MS (EI, 70 eV), m/z (%): 291 (43), 205 (15), 195 (100), 168 (10), 117 (7), 79 (38). 
C13H8F5IO2  Anal.  Calcd.: C 37.35, H 1.93 
Found: C 37.29, H 1.98 
 
(5S)-1-Iodo-5-methyl-5-pentylcyclopentene (58) 
 
I
MeMe
 
 
A flame-dried round bottom flask equipped with a magnetic stirring bar, an argon inlet and a 
rubber septum was charged with a CuCN·2LiCl solution (1.0 M in THF, 0.60 mL, 0.60 mmol, 
1.20 equiv) and cooled to 0 oC (ice-bath). A dipentylzinc solution (5.60 M in THF, 0.21 mL, 
1.20 mmol, 2.40 equiv) was added dropwise, and the reaction mixture was stirred at 0 oC for 10 
min. The ice-bath was removed and a THF (1 mL) solution of (1S)-2-iodo-3-methyl-
cyclopenten-1-yl 2,3,4,5,6-pentafluorobenzoate (57) (96% ee, 209 mg, 0.50 mmol, 1.0 equiv) 
was added dropwise. The reaction mixture was stirred at 25 oC for 4 h. A saturated aqueous 
NH4Cl solution (20 mL) was added followed by 25% aqueous NH3 solution (1 mL). The 
reaction mixture was stirred at 25 °C until the copper salts had dissolved then extracted with 
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Et2O (3 x 20 mL). The combined organic phase was washed with brine and dried over Na2SO4 
anhydrous. Evaporation of the solvents and the purification by column chromatography (silica 
gel, pentane) afforded the cyclopentenyl iodide (S)-58 as a colourless oil (129 mg, 93% yield). 
GC (Chirasil-Dex CB, 25 mm x 0.25 mm); conditions: 60 oC (1 min), ramp of 20 oC/ min to 
160 oC; tR(min) = 7.057 (major), 7.151 (minor); 95% ee. 
 
[α]D20 +6.2 (c 0.26, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ = 5.95 (t, J = 2.54 Hz, 1H), 2.32-2.12 (m, 2H), 1.90-1.78 (m, 
1H), 1.66-1.54 (m, 1H), 1.32-1.04 (m, 8H), 0.91 (s, 3H), 0.82 (t, J = 6.91 Hz, 3H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 138.3, 111.0, 52.5, 40.6, 33.6, 32.8, 32.3, 27.6, 24.4, 23.0, 
14.5 ppm. 
IR (film): 2954 (s), 2925 (s), 2849 (s), 1738 (m), 1455 (m), 1374 (m), 1217 (m) cm-1. 
MS (EI, 70 eV), m/z (%): 278 (M+, 16), 207 (100), 192 (2), 151 (3), 91 (3), 80 (77). 
C11H19I  HRMS (EI): Calcd.: 278.0531 
Found: 278.0544 
 
(2S)-2-Methyl-2-pentylcyclopentanone (59) 
 
O
Me
Me
 
 
Prepared according to TP 8 from (5S)-1-iodo-5-methyl-5-pentylcyclopentene (58) (217 mg, 
0.78 mmol, 1.0 equiv), THF (6.2 mL), t-BuLi (1.88 M in pentane, 0.83 mL, 1.56 mmol, 2.0 
equiv),
 
B(OMe)3 (neat, 0.22 mL, 1.95 mmol, 2.50 equiv) and a suspension of NaBO3·4H2O 
(1.20 g, 7.80 mmol, 10.0 equiv) in H2O (9.4 mL). After purification by column 
chromatography (silica gel, 10% Et2O:pentane), the ketone (S)-59 was obtained as a 
colourless oil (92 mg, 70% yield, 95% ee). 
GC (Chirasil-Dex CB, 25 mm x 0.25 mm); conditions: 60 oC (1 min), ramp of 5 oC/ min to 
160 oC; tR (min) = 14.223 (minor), 14.336 (major). 
[α]D20 +53 (c 0.24, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ = 2.28-2.02 (m, 2H), 1.72 (m, 3H), 1.70-1.58 (m, 1H), 1.40-
1.00 (m, 8H), 0.92 (s, 3H), 0.80 (t, J = 6.97 Hz, 3H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 224.3, 48.7, 38.1, 37.0, 36.0, 32.8, 24.3, 22.9, 22.2, 19.1, 
14.4 ppm. 
IR (film): 2958 (s), 2931 (s), 2860 (m), 1738 (s), 1461 (m), 1161 (w) cm-1. 
MS (EI, 70 eV), m/z (%): 99 (5), 98 (100), 83 (5), 69 (7), 56 (26). 
C11H20O  HRMS (EI): Calcd.: 168.1514 
Found: 168.1516 
 
(6S)-1-Iodo-6-(4-methylpentyl)cyclohexene (60) 
 
I
Me
Me
 
 
Prepared according to TP 5 using (1S)-2-iodocyclohex-2-en-1-yl 2,3,4,5,6-pentafluorobenzoate 
((S)-45) (98% ee, 418 mg, 1.0 mmol), NMP (1.1 mL), (4-methyl)pentylzinc iodide (1.68 M in 
THF, 1.90 mL, 2.0 mmol, 2.0 equiv) and a CuCN·2LiCl solution (1.0 M in THF, 2.0 mL, 2.0 
mmol, 2.0 equiv). The resulting mixture was slowly warmed up to 25 oC and stirred for 15 h. 
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Purification by column chromatography (silica gel, pentane) afforded the cyclohexenyl iodide 
(S)-60 as a colourless oil (257 mg, 88% yield, 96% ee). 
 
GC (Chirasil-Dex CB, 25 mm x 0.25 mm); conditions: 40 oC (1 min), ramp of 20 oC/ min to 
150 oC; tR(min) = 11.954 (major), 12.167 (minor). 
[α]D20 +3.2 (c 0.5, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ = 6.30 (dt, J = 1.55, 3.6 Hz, 1H), 2.26-2.15 (m, 1H), 2.02-
1.93 (m, 2H), 1.81-1.40 (m, 5H), 1.40-1.05 (m, 6H), 0.86-0.78 (m, 6H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 138.7, 107.7, 45.3, 39.3, 35.3, 30.0, 28.5, 28.3, 24.9, 23.1, 
22.9, 18.9 ppm. 
IR (film): 2930 (s), 2858 (m), 1462 (w), 1384 (w), 1366 (w), 964 (w) cm-1. 
MS (EI, 70 eV), m/z (%): 292 (M+, 32), 208 (30), 165 (8), 149 (2), 123 (7), 109 (61), 95 (54), 
81 (100), 67 (42), 55 (20). 
C12H21I  HRMS (EI): Calcd.: 292.0688 
Found: 292.0705 
 
 (2R)-2-(4-Methylpentyl)cyclohexanone (61) 
 
O
Me
Me
 
 
Prepared according to TP 7 from (6S)-1-iodo-6-(4-methylpentyl)cyclohexene (60) (247 mg, 
0.85 mmol), THF (7 mL), t-BuLi (1.60 M in pentane, 1.06 mL, 2.0 equiv), (TMSO)2 (neat, 
0.27 mL, 1.28 mmol, 1.50 equiv). The resulting silyl enol ether in THF (3.5 mL) was treated 
with a HF·pyridine complex (70%) (0.04 mL, 0.85 mmol) in dry pyridine (0.7 mL). After 
purification by column chromatography (silica gel, 10% Et2O:pentane), the ketone (R)-61 
was obtained as a colourless oil (138 mg, 89% yield, 95% ee). 
 
GC (Chirasil-Dex CB, 25 mm x 0.25 mm); conditions: 40 oC (1 min), ramp of 3 oC/ min to 
150 oC; tR (min) = 31.815 (major), 32.077 (minor). 
[α]D20 +18 (c 3.75, Et2O) 
1H NMR (CDCl3, 300 MHz): δ = 2.33-2.08 (m, 3H), 2.07-1.83 (m, 2H), 1.82-0.97 (m, 11H), 
0.76 (d, J = 6.52 Hz, 6H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 214.0, 51.2, 42.3, 39.4, 34.2, 30.0, 28.4, 28.2, 25.3, 25.2, 
22.99, 22.94 ppm. 
IR (film): 2932 (s), 2864 (m), 1712 (s), 1449 (w), 1366 (w), 1124 (w) cm-1. 
MS (EI, 70 eV), m/z (%): 182 (M+, 3), 149 (1), 121 (1), 111 (9), 98 (100), 83 (16), 70 (11), 55 
(16). 
C12H22O  HRMS (EI): Calcd.: 182.1671 
Found: 182.1679 
 
 (7R)-7-(4-Methylpentyl)oxepan-2-one (10-methyl-6-undecanolide; 62) 
 
O
O
Me
Me
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m-CPBA (70%, 200 mg, 1.16 mmol, 2.0 equiv) was added to a solution of (2R)-2-(4-
methylpentyl)cyclohexanone (61; 106 mg, 0.58 mmol) in CH2Cl2 (3 mL) at 0 oC. The reaction 
mixture was stirred at 25 oC for 18 h, and then was poured into an aqueous Na2SO3 solution (1 
M), extracted with CH2Cl2 (3 x 25 mL). The combined organic phase was washed with a 
saturated NaHCO3, brine and dried over anhydrous MgSO4. Evaporation of the solvents and the 
purification by column chromatography (silica gel, 50% Et2O:pentane) afforded the lactone (R)-
62 as a colourless oil (105 mg, 91% yield, 95% ee). 
 
GC (Chirasil-Dex CB, 25 mm x 0.25 mm); conditions: 40 oC (1 min), ramp of 20 oC/ min to 
160 oC; tR (min) = 12.806 (major), 13.094 (minor). 
[α]D20 –1.5 (c 3.2, Et2O) [Lit.78 [α]D25 -1.2 (c 3.2, Et2O)] 
1H NMR (CDCl3, 300 MHz): δ = 4.08-3.97 (br, s, 1H), 2.50-2.35 (m, 2H), 1.80-1.63 (m, 3H), 
1.55-1.20 (m, 7H), 1.19-1.08 (m, 1H), 1.01-0.90 (m, 2H), 0.66 (d, J = 6.4 Hz, 6H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 177.3, 82.1, 40.2, 38.2, 36.5, 36.1, 29.9, 29.4, 24.8, 24.6, 
24.11, 24.06 ppm. 
IR (film): 2936 (s), 2867 (m), 1731 (s), 1448 (m), 1281 (m), 1256 (m), 1176 (m), 1014 (m) 
cm-1. 
MS (EI, 70 ev), m/z (%): 198 (M+, 1), 180 (1), 165 (2), 155 (4), 137 (4), 125 (5), 113 (43), 95 
(8), 85 (100), 67 (3), 55 (30). 
C12H22O2  HRMS (EI): Calcd.: 198.1620 
Found: 198.1620 
 
5. Formal total synthesis of (+)-estrone via asymmetric allylic substitution 
 
cis-Hex-3-ene-2,5-dione (73) 
 
Me Me
O O
 
 
A solution of magnesium methylperphthalate (MMPP) (12.4 g, 25.0 mmol, 0.50 equiv) in 
H2O (100 mL) was added dropwise to a solution of 2,5-dimethylfuran (72) (5.33 mL, 50.0 
mmol) in abs. EtOH (200 mL) at 25 oC. The reaction mixture was stirred at 25 oC for 12 h and 
then was extracted with CH2Cl2 (3 x 100 mL). The combined organic phase was washed with 
a saturated aqueous NaHCO3 solution, brine and dried over MgSO4 anhydrous. After 
evaporation of the solvents, the obtained cis-hex-3-ene-2,5-dione (73) was used in the next 
step without further purification. The crude product was identified by the NMR analysis and 
mass spectroscopy. 
The data were in agreement with those reported.100 
 
1H NMR (CDCl3, 300 MHz): δ = 6.25 (s, 2H), 2.22 (s, 6H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 200.9 (2 carbons), 136.1 (2 carbons), 30.1 (2 carbons) ppm. 
MS (EI, 70 eV), m/z (%): 112 (M+, 15), 97 (100), 69 (36). 
 
4-Hydroxy-3-methylcyclopent-2-en-1-one (rac-74) 
 
MeHO
O
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The crude product of cis-3-hexene-2,5-dione (73) was slowly added over 2 h to a solution of 
1% aqueous Na2CO3 (50 mL) which was heated at reflux. The reaction mixture was heated at 
reflux for 3 h. After cooling to 25 oC, the mixture was neutralized with 2 M HCl, extracted 
with EtOAc (3 x 50 mL). The combined organic phase was washed with brine and dried over 
Na2SO4 anhydrous. Removal of the solvents afforded the crude 4-hydroxy-3-
methylcyclopent-2-en-1-one (rac-74) as a brown oil, which was used in the next step without 
further purification. An analytical sample was obtained by column chromatography (silica 
gel, Et2O).  
The data were in agreement with those reported.100 
 
1H NMR (CDCl3, 300 MHz): δ = 5.92-5.86 (m, 1H), 4.76-4.67 (br, s, 1H), 2.90-2.72 (br, s, 
1H), 2.72 (dd, J = 6.19, 18.36 Hz, 1H), 2.25 (dd, J = 2.65, 18.36 Hz, 1H), 2.10 (br, s, 3H) 
ppm. 
13C NMR (CDCl3, 75 MHz): δ = 206.2, 177.8, 131.8, 73.0, 45.7, 16.2 ppm. 
IR (neat): 3394 (br), 1683 (s), 1624 (m), 1379 (w), 1294 (w), 1194 (w), 1077 (w) cm-1. 
MS (EI, 70 eV), m/z (%): 112 (M+, 100), 97 (34), 84 (33), 69 (69), 55 (20). 
 
4-[tert-Butyl(dimethyl)silyl]oxy-3-methylcyclopent-2-en-1-one (rac-75) 
 
O
MeTBSO
 
 
Imidazole (3.40 g, 50.0 mmol) was added to a solution of the crude product of 4-hydroxy-3-
methylcyclopent-2-en-1-one (rac-74) obtained as described above in DMF (60 mL) followed 
by gradually adding TBDMSCl (7.54 g, 50.0 mmol) at 25 oC. The reaction mixture was 
stirred at 25 oC for 12 h, then was poured into ice-cooled water, extracted with Et2O (3 x 50 
mL). The combined organic phase was washed with brine and dried over MgSO4 anhydrous. 
Purification by column chromatography (silica gel, 25% Et2O:pentane, 0.3% Et3N) afforded 
4-[tert-butyl(dimethyl)silyl]oxy-3-methylcyclopent-2-en-1-one (rac-75) as a brown oil (3.39 
g, 30% yield, over 3 steps starting from 72). 
 
1H NMR (CDCl3, 300 MHz): δ = 5.86-5.80 (m, 1H), 4.66-4.59 (m, 1H), 2.62 (dd, J = 5.97, 
17.91 Hz, 1H), 2.18 (dd, J = 2.88, 17.91 Hz, 1H), 2.05-1.95 (m, 3H), 0.82 (s, 9H), 0.05 (s, 
3H), 0.02 (s, 3H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 205.6, 177.9, 131.3, 73.3, 46.3, 26.0 (3 carbons), 18.4, 16.3,     
-4.2, -4.6 ppm. 
IR (neat): 2956 (m), 2930 (m), 2858 (m), 1721 (s), 1630 (m), 1253 (m), 1094 (s), 839 (s) cm-1. 
MS (EI, 70 eV), m/z (%): 211 (3), 169 (100), 127 (26), 95 (43), 75 (24). 
C12H22O2Si   HRMS (EI):  Calcd.: 226.1389 
Found: 226.1402 
 
4-{[tert-Butyl(dimethyl)silyl]oxy}-2-iodo-3-methylcyclopent-2-en-1-one (rac-76) 
 
Me
O
TBSO
I
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I2 (1.50 equiv, 4.76 g, 18.8 mmol) and PDC (0.30 equiv, 1.41 g, 3.75 mmol) were added to 
the solution of 4-{[tert-butyl(dimethyl)silyl]oxy}-3-methylcyclopent-2-en-1-one (rac-75) 
(2.75 g, 12.2 mmol) in dry CH2Cl2 (100 mL). The reaction flask was covered with an 
aluminium foil and the reaction mixture was stirred at 25 oC for 22 h. The progress of the 
reaction was followed by GC- or TLC-analysis. Additional I2 (1.0 equiv, 3.10 mg, 12.2 mmol) 
was added and the reaction mixture was stirred for additional 24 h. The reaction mixture was 
filtered and the residue was washed with pentane. The combined organic phase was washed 
with H2O, a saturated Na2S2O3 solution, brine and dried over MgSO4 anhydrous. After 
purification by column chromatography (silica gel, 25% Et2O:pentane, 0.3% Et3N), the 
product rac-76 was obtained as a yellow solid (3.31 g, 77% yield). 
 
mp = 57.8-59.4 oC 
1H NMR (CDCl3, 300 MHz): δ = 4.70-4.60 (m, 1H), 2.75 (dd, J = 6.08, 17.91 Hz, 1H), 2.26 
(dd, J = 2.43, 17.91 Hz, 1H), 2.04 (s, 3H), 0.76 (s, 9H), 0.00 (s, 3H), -0.03 (s, 3H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 199.4, 179.8, 105.1, 73.9, 44.1, 26.0 (3 carbons), 19.3, 18.4, 
-4.2, -4.6 ppm. 
IR (film): 2953 (m), 2930 (m), 1705 (s), 1615 (m), 1253 (m), 1088 (m), 886 (m), 840 (m)  
cm-1. 
MS (EI, 70 eV), m/z (%): 352 (M+, 1), 337 (2), 295 (100), 253 (46), 221 (21), 168 (18), 75 
(49). 
C12H21IO2Si  HRMS (EI): Calcd.: 352.0356 
Found: 352.0350 
 
The asymmetric reduction of rac-76 
 
A flame-dried round bottom flask equipped with a magnetic stirring bar, an argon inlet and a 
rubber septum was charged with (S)-diphenylprolinol (60 mg, 0.23 mmol, 5 mol%) and THF 
(4.3 mL). B(OMe)3 (27 µL, 0.23 mmol, 5 mol%) was added to the reaction mixture, and then 
it was stirred at 25 oC for 1 h. The borane-N,N-diethylaniline complex (0.83 mL, 4.66 mmol) 
was added dropwise followed by the slow addition of a solution of 4-{[tert-
butyl(dimethyl)silyl]oxy}-3-methylcyclopent-2-en-1-one (rac-76) (1.64 g, 4.66 mmol) in 
THF (4.3 mL) over 30 min. The reaction mixture was stirred at 25 oC for 1.5 h then was 
carefully quenched with MeOH (2.1 mL). The solvents were evaporated under reduced 
pressure. The residue oil was partitioned between H2O and Et2O. The organic phase was 
collected and the aqueous phase was further extracted with Et2O (3 x 25 mL). The combined 
organic phase was washed with 7% Na2CO3 solution, brine and dried over Na2SO4 anhydrous. 
After removal of the solvents, the crude product obtained as the mixture of the 
diastereoisomers was purified by column chromatography (silica gel, 20% Et2O:pentane) to 
give the alcohols 77a and 77b in 94% total yield. 
 
 (1R,4S)-4-{[tert-Butyl(dimethyl)silyl]oxy}-2-iodo-3-methylcyclopent-2-en-1-ol (77a) 
 
MeTBSO
I
OH
 
 
The product was obtained in pure form as a white solid (750 mg, 46% yield, 84% ee). 
 
mp = 94.3-95.6 oC 
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HPLC (Chiralcel OD, heptane:i-PrOH = 99:1, 0.4 mL/min); tR (min) = 30.63 (minor), 36.43 
(major). 
[α]D20 +2 (c 0.3, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ = 4.40-4.29 (m, 2H), 2.68 (dt, J = 7.19, 13.33 Hz, 1H), 1.98-
1.80 (br, s, 1H), 1.71 (s, 3H), 1.62 (dt, J = 5.20, 13.33 Hz, 1H), 0.80 (s, 9H), 0.00 (s, 3H),       
-0.01 (s, 3H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 150.5, 104.1, 78.8, 76.5, 43.8, 26.1 (3 carbons), 18.5, 16.9,  
-4.1, -4.5 ppm. 
IR (neat): 3435 (s), 1254 (m), 1112 (m), 1066 (s), 994 (s), 866 (s), 836 (s), 783 (s) cm-1. 
MS (EI, 70 eV), m/z (%): 297 (32), 279 (5), 170 (17), 95 (5), 75 (100). 
C12H23IO2Si  HRMS (EI):  Calcd.: 353.0434 [M-H]+ 
Found: 353.0444 [M-H]+ 
C12H23IO2Si  Anal.   Calcd.: C 40.68, H 6.54 
Found: C 40.75, H 6.53 
 
 (1R,4R)-4-{[tert-Butyl(dimethyl)silyl]oxy}-2-iodo-3-methylcyclopent-2-en-1-ol (77b) 
 
MeTBSO
I
OH
 
 
The product was obtained in pure form as a white solid (800 mg, 49% yield, 99% ee). 
 
mp = 75.4-76.5 oC 
HPLC (Chiralcel OD, heptane:i-PrOH = 95:5, 0.5 mL/min); tR (min) = 10.21 (major). 
[α]D20 +36 (c 0.3, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ = 4.71-4.60 (m, 2H), 2.20 (ddd, J = 2.27, 6.75, 13.95 Hz, 1H), 
1.99 (ddd, J = 4.28, 7.02, 13.95 Hz, 1H), 1.78 (br, s, 1H), 1.70 (s, 3H), 0.80 (s, 9H), 0.00 (s, 
3H), -0.01 (s, 3H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 151.8, 103.1, 81.0, 77.1, 43.6, 26.1 (3 carbons), 18.5, 16.9,    
-4.2, -4.5 ppm. 
IR (neat): 3292 (s), 1249 (m), 1068 (s), 1049 (s), 887 (s), 843 (s), 773 (s) cm-1. 
MS (EI, 70 eV), m/z (%): 354 (M+, 1), 297 (56), 279 (16), 205 (10), 170 (38), 96 (9), 75 (100). 
C12H23IO2Si  HRMS (EI):  Calcd.: 354.0512 
Found: 354.0515 
 
(1R,4S)-4-{[tert-Butyl(dimethyl)silyl]oxy}-2-iodo-3-methylcyclopent-2-en-1-yl 2,3,4,5,6-
pentafluorobenzoate (78a) 
MeTBSO
I
OCOC6F5
 
 
Pyridine (1.30 equiv, 0.30 mL, 3.67 mmol), DMAP (0.10 equiv, 34 mg, 0.28 mmol) and 
pentafluorobenzoyl chloride (1.30 equiv, 0.53 mL, 3.67 mmol) were added to the solution of 
(1R,4S)-4-{[tert-butyl(dimethyl)silyl]oxy}-2-iodo-3-methylcyclopent-2-en-1-ol (77a) (1.0 g, 
2.82 mmol) in dry Et2O (17 mL) at 25 oC. The resulting suspension was stirred at 25 oC for 2 
h, and then was poured into a saturated NH4Cl solution. The mixture was extracted with Et2O 
(3 x 25 mL). The combined organic phase was washed with a saturated NaHCO3 solution, 
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brine and dried over MgSO4 anhydrous. Purification by column chromatography (silica gel, 
10% CH2Cl2:pentane) afforded the product 78a as a white solid (1.41 g, 91% yield, 81% ee). 
 
mp = 40.9-42.8 oC 
HPLC (Chiralcel OD, heptane:i-PrOH = 99:1, 0.5 mL/min); tR (min) = 8.93 (minor), 12.47 
(major). 
[α]D20 –2 (c 0.3, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): δ = 5.71-5.66 (m, 1H), 4.44-4.37 (m, 1H), 2.90 (dt, J = 7.30, 
13.71 Hz, 1H), 1.80-1.69 (m, 4H), 0.79 (s, 9H), 0.00 (s, 3H), -0.02 (s, 3H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 159.0, 154.5, 147.7, 141.6, 139.8, 136.4, 134.9, 108.5, 94.1, 
82.7, 76.2, 41.7, 26.1 (3 carbons), 18.4, 17.0, -4.2, -4.5 ppm. 
IR (neat): 1740 (s), 1497 (s), 1354 (m), 1323 (m), 1225 (s), 1085 (s), 990 (s), 882 (s), 836 (s), 
777 (s) cm-1. 
MS (EI, 70 eV), m/z (%): 491 (3), 269 (100), 195 (15), 168 (10), 75 (14). 
C19H22F5IO3Si  Anal.  Calcd.: C 41.62, H 4.04 
Found: C 41.63, H 4.39 
 
(1R,4R)-4-{[tert-Butyl(dimethyl)silyl]oxy}-2-iodo-3-methylcyclopent-2-en-1-yl 2,3,4,5,6-
pentafluorobenzoate (78b) 
MeTBSO
I
OCOC6F5
 
 
Pyridine (1.30 equiv, 0.53 mL, 6.50 mmol), DMAP (0.10 equiv, 73 mg, 0.50 mmol) and 
pentafluorobenzoyl chloride (1.30 equiv, 0.94 mL, 6.50 mmol) were added to the solution of 
(1R,4R)-4-{[tert-butyl(dimethyl)silyl]oxy}-2-iodo-3-methylcyclopent-2-en-1-ol (77b) (1.77 
g, 5.0 mmol) in dry Et2O (34 mL) at 25 oC. The resulting suspension was stirred at 25 oC for 2 
h, and then was poured into a saturated NH4Cl solution. The mixture was extracted with Et2O 
(3 x 25 mL). The combined organic phase was washed with a saturated NaHCO3 solution, 
brine and dried over MgSO4 anhydrous. Purification by column chromatography (silica gel, 
10% CH2Cl2:pentane) afforded the product 78b as a white solid (2.47 g, 90% yield, 99% ee). 
 
mp = 56.3-57.4 oC 
HPLC (Chiralcel OD-H, heptane:i-PrOH = 99:1, 0.4 mL/min); tR (min) = 12.82 (major). 
[α]D20 +34 (c 0.3, CH2Cl2) 
1H NMR (CDCl3, 600 MHz): 5.92 (m, 1H), 4.77-4.71 (m, 1H), 2.30 (ddd, J = 1.67, 6.91, 
14.40 Hz, 1H), 2.17 (ddd, J = 4.50, 6.91, 14.40 Hz, 1H), 2.06 (s, 3H), 0.79 (s, 9H), 0.00 (s, 
3H),  -0.02 (s, 3H) ppm. 
13C NMR (CDCl3, 150 MHz): δ = 159.2, 157.1, 146.5, 144.5, 142.7, 139.0, 137.2, 108.6, 93.0, 
86.0, 76.6, 42.0, 26.1 (3 carbons), 18.5, 17.0, -4.2, -4.5 ppm. 
IR (neat): 1739 (s), 1498 (s), 1354 (m), 1323 (s), 1225 (s), 1084 (s), 990 (s), 882 (s), 836 (s), 
777 (s) cm-1. 
MS (EI, 70 eV), m/z (%): 491 (3), 473 (4), 421 (2), 336 (31), 279 (16), 195 (46), 168 (38), 75 
(100). 
C19H22F5IO3Si  Anal.  Calcd.: C 41.62, H 4.04 
Found: C 41.67, H 4.25 
 
(1S,2R)-tert-Butyl[(3-iodo-2-methyl-2-pentylcyclopent-3-en-1-yl)oxy]dimethylsilane (79a) 
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I
H
TBSO Me
Me
 
 
A flame-dried round bottom flask equipped with a magnetic stirring bar, an argon inlet and a 
rubber septum was charged with a CuCN·2LiCl solution (1.0 M in THF, 0.75 mL, 0.75 mmol, 
1.50 equiv). The solution was cooled to 0 oC in an ice bath, and then dipentylzinc (5.60 M in 
THF, 0.21 mL, 1.20 mmol, 2.40 equiv) was added. The reaction mixture was stirred at 0 oC 
for 10 min. The ice bath was removed then the solution of (1R,4S)-4-{[tert-
butyl(dimethyl)silyl]oxy}-2-iodo-3-methylcyclopent-2-en-1-yl 2,3,4,5,6-pentafluorobenzoate 
(78a) (274 mg, 0.50 mmol) in THF (1 mL) was added dropwise at 25 oC. The reaction 
mixture was stirred at 25 oC for 12 h, and then was poured into a saturated NH4Cl solution 
(contained 25 % of aqueous NH3). The mixture was extracted with Et2O (3 x 25 mL). The 
combined organic phase was washed with brine and dried over MgSO4 anhydrous. After 
purification by column chromatography (silica gel, pentane), the product 79a was obtained as 
a colourless oil (110 mg, 54% yield, 81% ee).  
 
GC (Chirasil-Dex CB, 25 mm x 0.25 mm); conditions: 60 oC (1 min), ramp of 5 oC/min to 
140 oC (20 min), ramp of 1 oC/min to 160 oC (30 min); tR (min) = 42.322 (minor), 42.777 
(major). 
[α]D20 +0.71 (c 0.28, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): 5.96 (t, J = 2.53 Hz, 1H), 4.17 (t, J = 6.82 Hz, 1H), 2.43 (ddd, J 
= 2.53, 6.82, 15.6 Hz, 1H), 2.14 (ddd, J = 2.53, 6.82, 15.6 Hz, 1H), 1.36-1.08 (m, 8H), 0.88-
0.78 (m, 15H), -0.001 (s, 3H), -0.012 (s, 3H) ppm. 
13C NMR (CDCl3, 75 MHz): 135.5, 109.6, 72.9, 54.8, 42.3, 38.7, 32.9, 26.1 (3 carbons), 24.2, 
23.0, 19.8, 18.4, 14.5, -4.0, -4.6 ppm. 
IR (neat): 2927 (m), 1250 (m), 1115 (s), 864 (s), 834 (s), 773 (s) cm-1. 
MS (EI, 70 eV), m/z (%): 408 (M+, 1), 393 (3), 351 (100), 281 (70), 211 (6), 75 (69). 
C17H33IOSi  HRMS (EI):  Calcd.: 408.1345 
Found: 408.1307 
(1R,2R)-tert-Butyl[(3-iodo-2-methyl-2-pentylcyclopent-3-en-1-yl)oxy]dimethylsilane 
(79b) 
I
MeH
TBSO
Me
 
 
A flame-dried round bottom flask equipped with a magnetic stirring bar, an argon inlet and a 
rubber septum was charged with a CuCN·2LiCl solution (1.0 M in THF, 0.75 mL, 0.75 mmol, 
1.50 equiv). The solution was cooled to 0 oC in an ice bath and then dipentylzinc (5.60 M in 
THF, 0.21 mL, 1.20 mmol, 2.40 equiv) was added. The reaction mixture was stirred at 0 oC 
for 10 min. The ice bath was removed then the solution of (1R,4R)-4-{[tert-
butyl(dimethyl)silyl]oxy}-2-iodo-3-methylcyclopent-2-en-1-yl 2,3,4,5,6-pentafluorobenzoate 
(78b) (274 mg, 0.50 mmol) in THF (1 mL) was added dropwise at 25 oC. The reaction 
mixture was stirred at 25 oC for 12 h, then was poured into a saturated NH4Cl solution 
(contained 25 % of aqueous NH3). The mixture was extracted with Et2O (3 x 25 mL). The 
combined organic phase was washed with brine and dried over MgSO4 anhydrous. After 
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purification by column chromatography (silica gel, pentane), the product 79b was obtained as 
a colourless oil (138 mg, 68% yield, 99% ee). 
 
GC (Chirasil-Dex CB, 25 mm x 0.25 mm); conditions: 60 oC (1 min), ramp of 5 oC/min to 
140 oC (20 min), ramp of 1 oC/min to 160 oC (30 min); tR (min) = 39.628 (major). 
[α]D20 +1.9 (c 0.32, CH2Cl2) 
1H NMR (CDCl3, 300 MHz): 6.02 (dd, J = 2.10, 2.64 Hz, 1H), 4.04 (t, J = 7.80 Hz), 2.39 
(ddd, J = 2.64, 7.80, 15.68 Hz, 1H), 2.14 (ddd, J = 2.10, 7.80, 15.68 Hz, 1H), 1.50-1.02 (m, 
8H), 0.92 (s, 3H), 0.86-0.76 (m, 12H),  -0.009 (s, 3H), -0.032 (s, 3H) ppm. 
13C NMR (CDCl3, 75 MHz): 135.8, 108.9, 73.5, 54.5, 43.4, 35.9, 33.2, 28.0, 26.1 (3 carbons), 
24.5, 23.0, 18.3, 14.5, -4.2, -4.6 ppm. 
IR (neat): 1462 (w), 1256 (m), 1112 (s), 862 (s), 835 (s), 809 (m), 773 (s) cm-1. 
MS (EI, 70 eV), m/z (%): 393 (2), 351 (84), 281 (100), 211 (8), 184 (5), 149 (6), 73 (24). 
C17H33IOSi   HRMS (EI): Calcd.: 407.1267 [M-H]+ 
Found: 407.1277 [M-H]+ 
 
Enzymatic resolution of 4-hydroxy-3-methylcyclopent-2-enone (rac-74) via porcine 
pancreatic lipase (PPL) in vinyl acetate. 
 
O
Me
O
HO Me
O
HO Me
O
AcO Me
O
AcO Me
O
HO Me
PPL, vinyl acetate
+
Guanidine
MeOH
71%
1) DEAD, PPh3
     HCO2H
2) Neutral Alumina, 
    MeOH
    75%
(S)-74: 58% (R)-80: 26%; 91% ee
PPL, vinyl acetate,
25 oC
+
 (R)-80: 20%; 91% ee
         (R)-74: 91% ee
[α]D = -4.7 (c 0.35, CH2Cl2)
       (S)-74: 69%; 90% ee
[α]D = +3.36 (c 0.375, CH2Cl2)
rac-74
HO 25 
oC
 
 
A mixture of 4-hydroxy-3-methylcyclopent-2-enone (rac-74) (1.21 g, 10.8 mmol) and 
porcine pancreatic lipase (PPL; 1.21 g) in vinyl acetate (30 mL) was stirred at 25 oC. The 
separation of the alcohol rac-74 was not possible under a variety of conditions by HPLC or 
capillary GC. Therefore the course of the reaction (the conversion and the enantiomeric 
excess) was monitored from the corresponding acetate (80) by using HPLC (chiracel OJ 
column, i-PrOH:heptane, 10:90, flow rate 0.5 mL/min). An additional portion of PPL (1.2 g) 
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was added after stirring for 4 days (14% conversion, 100% ee of the resulting acetate (R)-80), 
and the reaction mixture was stirred for additional 5 days. The crude mixture was then filtered. 
The residue was washed with CH2Cl2. The combined filtrate was concentrated to give the 
crude product which was purified by column chromatography (silica gel, Et2O) to give the 
acetate (R)-80 (437 mg, 26% yield, 91% ee) and the unreacted alcohol (S)-74 (706 mg, 6.3 
mmol, 58% recovered). The unreacted alcohol was again submitted to enzymatic resolution 
conditions as described above. Purification by column chromatography (silica gel, Et2O) gave 
the additional acetate (R)-80 as a brown oil (194 mg, 20% yield, 91% ee) and the unreacted 
alcohol (S)-74 (487 mg, 90% ee (determined for the corresponding acetate)), which could be 
inverted into the desired (R)-74 by using the Mitsunobu reaction (see below). 
 
Deacetylation of (1R)-2-methyl-4-oxo-2-cyclopenten-1-yl acetate (80) 
 
A stock solution of guanidine (0.5 M in methanol) was prepared by adding sodium (350 mg, 
15.0 mmol) to ice-cooled methanol (30 mL) under an argon atmosphere. When all the sodium 
had reacted, guanidine carbonate (2.77 g, 15.0 mmol) was added. The resulting solution was 
stirred at 25 oC for 30 min, and then the mixture was allowed to settle out the precipitated 
salts.  
A flamed-dried round bottom flask was charged with (1R)-2-methyl-4-oxo-2-cyclopenten-1-
yl acetate ((R)-80) (420 mg, 2.73 mmol) in abs. methanol (3 mL) under an argon atmosphere. 
The reaction mixture was cooled to 0 oC and the solution of 0.5 M guanidine in methanol 
prepared as described above was added dropwise. The reaction mixture was stirred below 15 
oC for 5 min. The completion of the reaction was checked by TLC (Et2O). Glacial acetic acid 
(0.17 mL) was then added to the reaction mixture to neutralize the guanidine. The reaction 
mixture was stirred for 5 min, and then the solvent was evaporated at reduced pressure to give 
a thick slurry. The residue was partitioned between water (100 mL) and toluene-EtOAc (1:1, 
100 mL). The aqueous layer was neutralized by 2 M HCl and further extracted with EtOAc. 
The combined organic layer was washed with H2O, brine and dried over Na2SO4. After 
removal of the solvents, the obtained crude product was purified by column chromatography 
(Et2O) to give (4R)-4-hydroxy-2-iodo-3-methyl-2-cyclopenten-1-one [(R)-74; 217 mg, 71%, 
91% ee (determined for the corresponding acetate (R)-80)]. 
 
Me
O
HO
91% ee
 
 
[α]D20 –4.7 (c 0.35, CH2Cl2) 
HPLC (Determined for the corresponding acetate (R)-80) (Chiralcel OJ, heptane:i-PrOH = 
90:10, 0.5 mL/min); tR (min) = 25.118 (major), 30.043 (minor); 91% ee. 
1H NMR (CDCl3, 300 MHz): δ = 5.92-5.86 (m, 1H), 4.76-4.67 (br, s, 1H), 2.90-2.72 (br, s, 
1H), 2.72 (dd, J = 6.19, 18.36 Hz, 1H), 2.25 (dd, J = 2.65, 18.36 Hz, 1H), 2.10 (br, s, 3H) 
ppm. 
13C NMR (CDCl3, 75 MHz): δ = 206.2, 177.8, 131.8, 73.0, 45.7, 16.2 ppm. 
IR (neat): 3394 (br), 1683 (s), 1624 (m), 1379 (w), 1294 (w), 1194 (w), 1077 (w) cm-1. 
MS (EI, 70 eV), m/z (%): 112 (M+, 100), 97 (34), 84 (33), 69 (69), 55 (20). 
C6H8O2  HRMS (EI):  Calcd.: 112.0524 
Found: 112.0517 
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Mitsunobu inversion of (4S)-4-hydroxy-2-iodo-3-methylcyclopent-2-en-1-one ((S)-74) 
 
Me
O
HO Me
O
HO
(S)-74 (R)-74
 
 
Formic acid (0.23 mL, 6.0 mmol) was added dropwise to a mixture of (4S)-4-hydroxy-2-iodo-
3-methylcyclopent-2-en-1-one ((S)-74) (336 mg, 3.0 mmol) and PPh3 (1.57 g, 6.0 mmol) in 
THF (10 mL) under an argon atmosphere. The reaction mixture was cooled to 10 oC (ice bath), 
and was maintained below 15 oC while DEAD (1.10 mL, 6.0 mmol) was added dropwise. The 
reaction mixture was warmed to 25 oC and stirred for 12 h. The solvents were evaporated at 
reduced pressure and the residue was dissolved in tert-butyl methyl ether (TBME; 20 mL). To 
the reaction mixture was slowly added hexane (40 mL). The solution                                                                                                                                                                                                                                                                          
was stirred for 20 min at 25 oC and then was filtered. The residue was washed with 1:1 
TBME:hexane (2 x 100 mL). The combined filtrate was concentrated to give an oil, which 
was further dissolved in abs. methanol (30 mL). To the solution was added gradually neutral 
alumina (20.0 g). The reaction mixture was stirred at 25 oC for 5 h to saponified the formate 
ester intermediate. The mixture was filtered through a glass-fritted funnel, and the residue was 
washed with methanol (3 x 100 mL). After removal of the solvents, the resulting crude 
product was purified by column chromatography (Et2O) to give (4R)-4-hydroxy-2-iodo-3-
methylcyclopent-2-en-1-one ((R)-74) as a brown oil (252 mg, 75% yield, 91% ee (determined 
for the corresponding acetate)).  
 
(4R)-4-{[tert-Butyl(dimethyl)silyl]oxy}-2-iodo-3-methylcyclopent-2-en-1-one ((R)-76) 
 
Me
O
TBSO
I
 
 
Imidazole (2.13 g, 31.4 mmol, 1.50 equiv) was added to a solution of (4R)-4-hydroxy-3-
methylcyclopent-2-en-1-one ((R)-74) (2.34 g, 20.9 mmol) in DMF (50 mL) followed by 
gradually adding TBDMSCl (4.73 g, 31.4 mmol, 1.50 equiv) at 25 oC. The reaction mixture 
was stirred at 25 oC for 12 h. The reaction mixture was poured into ice-cooled water, and was 
extracted with Et2O (3 x 50 mL). The combined organic phase was washed with brine and 
dried over MgSO4. The crude product which was obtained as a brown oil was used in the next 
step without purification. 
I2 (1.50 equiv, 8.0 g, 31.4 mmol) and PDC (0.30 equiv, 2.36 g, 6.27 mmol) were added to the 
solution of the crude (4R)-4-{[tert-butyl(dimethyl)silyl]oxy}-3-methylcyclopent-2-en-1-one 
obtained as described above in dry CH2Cl2 (180 mL). The reaction mixture was stirred at 25 
oC for 24 h. Additional I2 (1.0 equiv, 5.30 g, 20.9 mmol) was added and the reaction mixture 
was stirred for additional 24 h. The mixture was filtered and the residue was washed with 
pentane. The combined organic layer was washed with H2O, a saturated Na2S2O3 solution, 
brine and dried over MgSO4. After purification by column chromatography (silica gel, 25% 
Et2O:pentane, 0.3% Et3N), the product (R)-76 was obtained as a yellow solid (5.37 g, 73% 
yield). 
The data were in agreement with rac-76. 
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(1R,4R)-4-{[tert-Butyl(dimethyl)silyl]oxy}-2-iodo-3-methylcyclopent-2-en-1-ol (77b) 
 
N
B
O
Ph
Ph
OMe
H
MeTBSO
I
OH
Me
O
TBSO
(5 mol%)
PhNEt2·BH3 (1 equiv),
THF, rt, 1.5 h
I
(R)-76 (1R, 4R)-77b
 
 
A flame-dried round bottom flask equipped with a magnetic stirring bar, an argon inlet and a 
rubber septum was charged with (S)-diphenylprolinol (193 mg, 0.76 mmol, 5 mol%) and THF 
(16 mL). B(OMe)3 (90 µL, 0.76 mmol, 5 mol%) was added to the solution, and the reaction 
mixture was stirred at 25 oC for 1 h. The borane-N,N-diethylaniline complex (2.71 mL, 15.3 
mmol) was added dropwise followed by the slow addition of a solution of (4R)-4-{[tert-
butyl(dimethyl)silyl]oxy}-3-methylcyclopent-2-en-1-one ((R)-76) (5.37 g, 15.3 mmol) in 
THF (16 mL) over 1 h. The reaction mixture was stirred at 25 oC for 1.5 h, then was carefully 
quenched with MeOH (7 mL). The solvents were evaporated under reduced pressure. The 
residue oil was partitioned between H2O and Et2O. The organic phase was collected and the 
aqueous phase was further extracted with Et2O (3 x 50 mL). The combined organic phase was 
washed with 7% Na2CO3 solution, brine and dried over Na2SO4. The solvents were 
evaporated affording the crude product which was purified by column chromatography (silica 
gel, 20% Et2O:pentane) to give the pure allylic alcohol (1R, 4R)-77b as a major product in 
95% yield (5.13 g, 99% ee). The separable minor product, diastereoisomer (1R, 4S)-77a, was 
obtained in less than 5% yield.  
 
(1R,4R)-4-{[tert-Butyl(dimethyl)silyl]oxy}-2-iodo-3-methylcyclopent-2-en-1-yl 2,3,4,5,6-
pentafluorobenzoate (78b) 
 
MeTBSO
OH
I
MeTBSO
OCOC6F5
IF5C6COCl, Pyridine,
DMAP, Et2O, rt, 2 h
(1R, 4R)-77b (1R, 4R)-78b
 
 
Pyridine (1.30 equiv, 1.52 mL, 18.8 mmol), DMAP (0.10 equiv, 177 mg, 1.45 mmol) and 
pentafluorobenzoyl chloride (1.30 equiv, 2.71 mL, 18.8 mmol) were added to the solution of 
the allylic alcohol (1R, 4R)-77b (5.13 g, 14.5 mmol) in dry Et2O (85 mL) at 25 oC. The 
resulting suspension was stirred at 25 oC for 2 h, and then was poured into a saturated NH4Cl 
solution. The mixture was extracted with Et2O (3 x 50 mL). The combined organic phase was 
washed with a saturated NaHCO3 solution, brine and dried over MgSO4. Purification by 
column chromatography (silica gel, 10% CH2Cl2:pentane) afforded the product (1R, 4R)-78b 
as a white solid (7.23 g, 91% yield, 99% ee). 
 
7-Methoxy-4-vinyl-1,2-dihydronaphthalene (Dane’s diene; 81) 
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MeO
 
 
A solution of 6-methoxytetralone (6.34 g, 36.0 mmol) in THF (36 mL) was added to a 
solution of vinylmagnesium bromide (1.60 M in THF, 1.20 equiv, 25.0 mL) over 30 min. The 
reaction mixture was heated at reflux for 1 h. The reaction mixture was cooled in ice bath and 
a saturated NH4Cl solution was added. The layers were separated, and the aqueous layer was 
extracted with Et2O (3 x 50 mol). The etheral phases were combined, washed with brine, 
dried over Na2SO4. The solvents were evaporated to give the resulting allylic alcohol as a 
brown oil.  
Quinoline (0.5 equiv, 2.25 mL) and a crystal of iodine were added to a solution of the crude 
allylic alcohol obtained as described above in dry benzene (135 mL). The reaction flask was 
fitted with a Dean-Stark apparatus, and the reaction mixture was heated at reflux under a 
nitrogen atmosphere until the theoretical amount of water had been removed. The reaction 
mixture was cooled, washed with a saturated NaHCO3 solution, brine and dried over MgSO4. 
Purification by column chromatography (silica gel: 25% Et2O:pentane) gave 7-methoxy-4-
vinyl-1,2-dihydronaphthalene (Dane’s diene; 81) in 5.54 g (83% yield). 
The data were in agreement with those reported.110 
 
1H NMR (CDCl3, 300 MHz): δ = 7.19 (d, J = 8.85 Hz, 1H), 6.69-6.60 (m, 2H), 6.58-6.45 (m, 
1H), 5.98 (dt, J = 0.89, 4.87 Hz, 1H), 5.43 (dd, J = 1.77, 17.36 HZ, 1H), 5.09 (dd, J = 1.77, 
10.84 Hz, 1H), 3.72 (s, 3H), 2.65 (t, J = 7.80 Hz,  2H), 2.27-2.14 (m, 2H) ppm. 
13C NMR (CDCl3, 75 MHz): δ = 159.0, 138.9, 136.6, 136.1, 127.6, 125.4, 124.5, 115.3, 114.2, 
111.2, 55.6, 29.1, 23.6 ppm. 
 
Di[2-(6-methoxy-3,4-dihydro-1-naphthalenyl)ethyl]zinc (71) 
 
MeO
Zn2
 
 
a) Hydroboration step: A flame-dried Schlenk flask equipped with a magnetic stirring bar, an 
argon inlet and a rubber septum was charged with Dane’s diene (81) (3.56 g, 19.1 mmol) and 
cooled to 0 oC in an ice bath. Diethylborane (Et2BH; 1.0 equiv, 4.92 mL) which was prepared 
by mixing BH3·Me2S (1.64 mL) and Et3B (3.28 mL) in ratio 1:2 was added dropwise. The 
reaction mixture was stirred at 0 oC for 3 h. The volatiles were evaporated under high vacuum 
(0.1 mmHg) at 0 oC affording the crude hydroboration product.  
b) Boron-Zinc exchange step: The organoborane prepared above was placed under an argon 
atmosphere, and then Et2Zn (2.0 equiv, 4.11 mL) was added at 0 oC. The reaction mixture was 
warmed to 25 oC and stirred for 16 h. The excess of Et2Zn and Et3B which was formed were 
evaporated under high vacuum (0.1 mmHg) at 25 oC. The resulting dialkylzinc was dissolved 
in toluene (5 mL) and stirred for 10 min then was evaporated under high vacuum. The process 
(addition of toluene (5 mL), then pumping off) was repeated 2 times to ensure the removal of 
residual Et2Zn. The resulting dialkylzinc was dissolved in THF (5 mL) and titrated yielding 
the dialkylzinc 71 as a solution in THF. 
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(1R, 2R)-tert-Butyl({3-iodo-2-[2-(6-methoxy-3,4-dihydronaphthalen-1-yl)ethyl]-2-methyl-
cyclopent-3-en-1-yl}oxy)dimethylsilane (82) 
MeO
OTBS
I
Me
 
 
A flame-dried round bottom flask equipped with a magnetic stirring bar, an argon inlet and a 
rubber septum was charged with a CuCN·2LiCl solution (1.0 M in THF, 2.40 mL, 2.40 mmol, 
2.40 equiv). The solution was cooled to 0 oC in an ice bath, and then the dialkylzinc 71 (2.40 
M in THF, 1.0 mL, 2.40 mmol, 2.40 equiv) was added. The reaction mixture was stirred at 0 
oC for 30 min. The ice bath was removed then the solution of (1R, 4R)-78b (548 mg, 1.0 
mmol) in THF (2 mL) was added dropwise at 25 oC. The reaction mixture was stirred at 25 oC. 
The complete consumption of the starting material was checked by TLC. The reaction 
mixture was poured into a saturated NH4Cl solution (contained 25 % of aqueous NH3), 
extracted with Et2O (3 x 25 mL). The combined organic phase was washed with brine and 
dried over MgSO4. After purification by column chromatography (silica gel, 5% 
CH2Cl2:pentane), the product (1R, 2R)-82 was obtained as a colourless oil (346 mg, 66% 
yield). 
 
HPLC (Determined for the resulting alcohol) (Chiralcel OJ, heptane:i-PrOH = 85:15, 0.5 
mL/min); tR (min) = 16.134 (minor), 18.919 (major), 97% ee. 
[α]D20 –10.4 (c 0.365, Et2O) 
1H NMR (for the resulting alcohol) (C6D6, 400 MHz): δ = 7.31 (d, J = 8.38 Hz, 1H), 6.53 (dd, 
J = 2.61, 8.38 Hz, 1H), 6.47 (d, J = 2.61 Hz, 1H), 5.55-5.52 (m, 1H), 5.52-5.48 (m, 1H), 3.46-
3.39 (m, 1H), 3.11 (s, 3H), 2.46-2.35 (m, 1H), 2.35-2.23 (m, 3H), 1.88 (ddd, J = 2.81, 7.70, 
16.00 Hz, 1H), 1.84-1.76 (m, 2H), 1.69 (ddd, J = 2.22, 6.10, 16.00 Hz, 1H), 1.53-1.36 (m, 2H), 
0.87 (br, s, 1H), 0.62 (s, 3H) ppm. 
13C NMR (for the resulting alcohol) (C6D6, 100 MHz): δ = 158.9, 138.7, 137.6, 135.7, 128.4, 
124.8, 122.3, 114.2, 111.3, 108.6, 76.7, 54.6, 54.4, 42.4, 35.3, 29.2, 28.7, 26.1, 23.4 ppm. 
IR (neat): 2927 (m), 1606 (w), 1499 (w), 1249 (s), 1114 (s), 861 (s), 835 (s), 774 (s) cm-1. 
MS (EI, 70 eV), m/z (%): 522 (4), 465 (4), 397 (26), 265 (27), 187 (100), 73 (43). 
C25H37IO2Si  HRMS (EI):  Calcd.: 522.1451 [M-H2]+ 
Found: 522.1428 [M-H2]+ 
 
(6bR,8aS,9R,11aS,11bR)-4-Methoxy-8a-methyl-1,7,8,8a,9,11b-hexahydro-2H-pentaleno-
[6a',1':3,1]cyclopropa[1,2-a]naphthalen-9-ol (85) 
 
MeO
Me
OH
H
 
 
A flame-dried round bottom flask equipped with a magnetic stirring bar, an argon inlet and a 
rubber septum was charged with the cycloalkenyl iodide (1R, 2R)-82 (173 mg, 0.33 mmol) 
and THF (20 mL). Ph3P (26 mg, 0.10 mmol, 0.30 equiv), Ag2CO3 (100 mg, 0.36 mmol, 1.10 
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equiv) and Pd(OAc)2 (11 mg, 0.05 mmol, 0.15 equiv) were added to the reaction mixture. The 
resulting suspension was stirred at 25 oC for 15 min, and then was heated at 65 oC for 16 h. A 
black suspension resulted after 10-20 min at 65 oC. After GC-analysis of a filtered aliquot 
showed that the reaction had proceeded to the completion, the suspension was cooled to 25 oC 
and filtered through a plug of silica gel (Et2O), and the filtrate was concentrated to give the 
crude Heck product as a yellow oil. This sample was dissolved in THF (3.3 mL), and a TBAF 
solution (1.0 M in THF, 1.0 mL) was added at 0 oC. The reaction mixture was stirred at 25 oC 
for 16 h and quenched with a saturated NH4Cl solution. The mixture was extracted with Et2O 
(3 x 25 mL). The combined organic phase was washed with brine and dried over Na2SO4. The 
crude product was purified by column chromatography (silica gel, 40% Et2O:pentane) to 
provide the product 85 as a colourless oil (53 mg, 57% yield). 
The product decomposes slowly in a chloroform solution. 
 
1H NMR (C6D6, 400 MHz): δ = 7.26 (d, J = 9.39 Hz, 1H), 6.67-6.63 (m, 2H), 5.60 (dd, J = 
2.35, 5.87 Hz, 1H), 5.48 (d, J = 5.87 Hz, 1H), 3.89 (br, s, 1H), 3.31 (s, 3H), 2.75-2.63 (m, 1H), 
2.61-2.50 (m, 1H, 2.31-2.21 (m, 1H), 2.13-2.03 (m, 1H), 1.96-1.85 (m, 2H), 1.66-1.55 (m, 
1H), 1.42 (dd, J = 5.09, 7.04 Hz, 1H), 1.09-0.97 (m, 1H), 0.85 (s, 3H), 0.79 (br, s, 1H) ppm. 
13C NMR (C6D6, 100 MHz): δ = 157.7, 138.0, 134.9, 132.5, 129.6, 128.4, 114.2, 112.1, 81.9, 
57.5, 55.3, 54.6, 37.0, 35.1, 30.3, 29.2, 25.1, 23.1, 22.2 ppm. 
IR (neat): 3386 (br), 2930 (m), 1725 (m), 1606 (m), 1497 (m), 1454 (m), 1243 (s), 1111 (s), 
1034 (s), 811 (s), 734 (s) cm-1. 
MS (EI, 70 eV), m/z (%): 282 (M+, 7), 264 (100), 249 (57), 234 (16), 221 (10), 202 (17), 189 
(12), 178 (12), 165 (16), 152 (9), 141 (7), 128 (12), 115 (15), 101 (7), 91 (11). 
C19H22O2  HRMS (EI):  Calcd.: 282.1620 
Found: 282.1628 
 
(2R,3R)-3-{[tert-Butyl(dimethyl)silyl]oxy}-2-[2-(6-methoxy-3,4-dihydronaphthalen-1-yl)-
ethyl]-2-methylcyclopentanone (87) 
MeO
OTBS
Me
O
 
 
A flame-dried round bottom flask equipped with a magnetic stirring bar, an argon inlet and a 
rubber septum was charged with the cycloalkenyl iodide 82 (131 mg, 0.25 mmol) and THF (2 
mL). The reaction mixture was cooled to –78 oC, and then t-BuLi (1.53 M in pentane, 0.50 
mmol, 0.33 mL) was added dropwise. The reaction mixture was stirred at –78 oC for 30 min, 
and then B(OMe)3 (neat, 70 µL, 0.63 mmol) was added dropwise. The reaction mixture was 
stirred at temperatures from –78 oC to 25 oC for 24 h, then a suspension of NaBO3·4H2O (385 
mg, 2.50 mmol) in H2O (3 mL) was added at 25 oC. After stirring at 25 oC for 24 h, the 
reaction mixture was poured into water, extracted with Et2O (3 x 25 mL). The combined 
organic phase was washed with brine and dried over MgSO4. The solvents were evaporated 
and the crude product was purified by column chromatography (silica gel, 10% Et2O:pentane, 
0.1% Et3N) to yield the ketone (2R, 3R)-87 as a colourless oil (46 mg, 45% yield). 
 
[α]D20 +4.2 (c 0.29, CH2Cl2) 
1H NMR (C6D6, 300 MHz): δ = 7.68 (d, J = 8.82 Hz, 1H), 6.75 (dd, J = 2.65, 8.82 Hz, 1H), 
6.57 (d, J = 2.65 Hz, 1H), 6.15-6.05 (m, 1H), 3.80 (t, J = 5.29 Hz, 1H), 3.34 (s, 3H), 2.60-2.49 
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(m, 4H), 2.49-2.35 (m, 2H), 2.30-2.15 (m, 1H), 1.98-1.82 (m, 1H), 1.75-1.57 (m, 4H), 0.92 (s, 
3H), 0.90 (s, 9H), 0.02 (s, 3H), 0.01 (s, 3H) ppm. 
13C NMR (C6D6, 75 MHz): δ = 221.85, 163.01, 142.72, 140.11, 133.59, 129.32, 121.64, 
117.51, 116.81, 82.33, 58.61, 57.80, 38.22, 34.98, 33.71, 32.50, 30.93, 29.80 (3 carbons), 
27.50, 23.89, 22.05, –0.38,  –0.90 ppm. 
IR (neat): 2929 (m), 1739 (s), 1606 (m), 1496 (m), 1463 (m), 1255 (s), 1157 (m), 1110 (m), 
1039 (m), 836 (s), 776 (s) cm-1. 
MS (EI, 70 eV), m/z (%): 414 (M+, 8), 187 (100), 174 (2), 161 (2), 146 (2), 73 (2). 
C25H38O3Si  HRMS (EI):  Calcd.: 414.2590 
Found: 414.2571 
 
3-Methoxyestra-1(10),2,4,8,14-pentaen-17-one (Torgov diene) (67) 
 
MeO
OMe
 
 
A flame-dried round bottom flask equipped with a magnetic stirring bar, an argon inlet and a 
rubber septum was charged with the ketone (2R, 3R)-87 (40 mg, 0.10 mmol), dry benzene (10 
mL) and anhydrous p-TsOH (114 mg). The reaction mixture was stirred at 25 oC for 12 h then 
was diluted with Et2O, washed with 5% Na2CO3, and dried over MgSO4.  
The crude product was dissolved in THF (1 mL) and cooled to 0 oC. A TBAF solution (1.0 M 
in THF, 0.2 mL) was added to the reaction mixture. The reaction mixture was stirred at 25 oC 
for 16 h then was poured into a saturated NH4Cl solution, extracted with Et2O (3 x 10 mL). 
The combined organic phase was washed with brine and dried over Na2SO4.  
The crude alcohol was dissolved in Et2O (4 mL) and CH2Cl2 (12 mL). The reaction mixture 
was cooled to 0 oC. To the mixture were added Celite (77 mg) and CrO3 (30 mg). The 
reaction mixture was stirred at 25 oC for 12 h. The resulting suspension was filtered and 
washed with Et2O. The solvents were evaporated. The crude product was purified by column 
chromatography (silica gel, 20% Et2O:pentane) affording the Torgov diene (67) as a yellow 
solid (17 mg, 61% yield). 
  
mp = 141-144 oC (Lit.: mp = 144-145 oC)96, 99 
HPLC (Chiralcel OJ, heptane:i-PrOH = 80:20, 0.5 mL/min); tR (min) = 19.896 (major), 
38.345 (major); 99% ee. 
[α]D20 = –95.6 (c 0.50, CHCl3) (Lit.: [α]D20 = –102.6 (c 0.904, CHCl3)96, 99 
1H NMR (CDCl3, 400 MHz): δ = 7.24 (d, J = 8.22 Hz, 1H), 6.76-6.70 (m, 2H), 5.85 (t, J = 
2.54 Hz, 1H), 3.80 (s, 3H), 3.30 (d, J = 23.48 Hz, 1H), 2.92 (dd, J = 3.13, 23.48 Hz, 1H), 
2.82-2.75 (m, 2H), 2.68-2.54 (m, 3H), 2.35-2.24 (m, 1H), 2.06-1.99 (m, 1H), 1.63-1.53 (m, 
1H), 1.13 (s, 3H) ppm. 
13C NMR (CDCl3, 100 MHz): δ = 220.18, 158.91, 147.15, 138.40, 130.09, 128.83, 125.55, 
124.35, 114.89, 113.86, 111.38, 55.50, 49.27, 42.17, 28.67, 27.57, 23.18, 22.98, 20.81 ppm.  
IR (neat): 1735 (s), 1425 (m), 1250 (s), 1139 (s), 1037 (s), 816 (s), 792 (s) cm-1. 
MS (EI, 70 eV), m/z (%): 280 (M+, 91), 252 (100), 237 (30), 223 (10), 165 (8). 
C19H20O2  HRMS (EI):  Calcd.: 280.1463 
Found: 280.1454 
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6. Abbreviations 
 
Ac acetyl 
br broad 
t-Bu      tert-butyl 
cat. catalytic 
c-Hex cyclohexyl 
o
 C degree celcius 
d doublet 
δ chemical shift 
DEAD diethyl azodicarboxylate 
DMAP 4-dimethylaminopyridine 
DMF dimethylformamide 
DMSO dimethylsulfoxide 
dppf 1,1´-bisdiphenylphosphinoferrocene 
dba dibenzylideneacetone 
ee  enantiomeric excess 
equiv. equivalent 
Et  ethyl 
EtOAc ethyl acetate 
EI  electron ionization 
FG  functional group 
GC  gas chromatography 
h  hour 
HPLC high-pressure liquid chromatography 
HRMS high resolution mass spectroscopy 
Hz  herz 
i-Pr  isopropyl 
IR  infrared spectroscopy 
J  coupling constant 
LG  leaving group 
m  multiplet 
M  molar 
Me  methyl 
min.  minute 
mp.  melting point 
MMPP magnesium methylperphtalate  
MS  mass spectroscopy     
M+ molecular ion peak 
mmol millimole 
NMP N-methyl-pyrrolidinone 
NMR nuclear magnetic resonance 
Nu nucleophile 
PDC pyridinium dichlorochromate 
Pent pentyl 
PG protecting group 
Ph phenyl 
py pyridine 
q quartet 
quant. quantitative 
rac racemic 
Abbreviations  120 
s singlet 
t triplet 
THF tetrahydrofuran 
TLC thin layer chromatography 
TMSCl chlorotrimethylsilane 
TP typical procedure 
tR retention time 
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